{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T17:23:23Z","timestamp":1791825803349,"version":"4.3.4"},"update-to":[{"DOI":"10.1002\/14651858.cd012069","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2018,5,10]],"date-time":"2018-05-10T00:00:00Z","timestamp":1525910400000}}],"reference-count":883,"publisher":"Wiley","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd012069.pub2","type":"journal-article","created":{"date-parts":[[2018,5,10]],"date-time":"2018-05-10T01:18:44Z","timestamp":1525915124000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":183,"title":["Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of adverse events in non-randomised studies"],"prefix":"10.1002","author":[{"given":"Ole Jakob","family":"Storeb\u00f8","sequence":"first","affiliation":[{"name":"Region Zealand; Child and Adolescent Psychiatric Department; Birkevaenget 3 Roskilde Denmark 4300"},{"name":"Region Zealand Psychiatry; Psychiatric Research Unit; Slagelse Denmark"},{"name":"University of Southern Denmark; Department of Psychology, Faculty of Health Science; Campusvej 55 Odense Denmark 5230"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Pedersen","sequence":"additional","affiliation":[{"name":"Region Zealand Psychiatry; Psychiatric Research Unit; Slagelse Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Ramstad","sequence":"additional","affiliation":[{"name":"Region Zealand; Child and Adolescent Psychiatric Department; Birkevaenget 3 Roskilde Denmark 4300"},{"name":"Region Zealand Psychiatry; Psychiatric Research Unit; Slagelse Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maja Laerke","family":"Kielsholm","sequence":"additional","affiliation":[{"name":"Region Zealand Psychiatry; Psychiatric Research Unit; Slagelse Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Signe Sofie","family":"Nielsen","sequence":"additional","affiliation":[{"name":"Region Zealand Psychiatry; Psychiatric Research Unit; Slagelse Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helle B","family":"Krogh","sequence":"additional","affiliation":[{"name":"Region Zealand; Child and Adolescent Psychiatric Department; Birkevaenget 3 Roskilde Denmark 4300"},{"name":"Region Zealand Psychiatry; Psychiatric Research Unit; Slagelse Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos R","family":"Moreira-Maia","sequence":"additional","affiliation":[{"name":"Federal University of Rio Grande do Sul; Department of Psychiatry; Rua Ramiro Barcelos, 2350-2201A Porto Alegre RS Brazil 90035-003"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederik L","family":"Magnusson","sequence":"additional","affiliation":[{"name":"Region Zealand Psychiatry; Psychiatric Research Unit; Slagelse Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathilde","family":"Holmskov","sequence":"additional","affiliation":[{"name":"Region Zealand Psychiatry; Psychiatric Research Unit; Slagelse Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trine","family":"Gerner","sequence":"additional","affiliation":[{"name":"Region Zealand Psychiatry; Psychiatric Research Unit; Slagelse Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Skoog","sequence":"additional","affiliation":[{"name":"Clinical Studies Sweden - Forum South; Clinical Study Support; Lund Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Rosendal","sequence":"additional","affiliation":[{"name":"Psychiatric Centre North Zealand; The Capital Region of Denmark Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilla","family":"Groth","sequence":"additional","affiliation":[{"name":"Herlev University Hospital; Pediatric Department; Capital Region Herlev Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna","family":"Gillies","sequence":"additional","affiliation":[{"name":"Sydney NSW Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten","family":"Buch Rasmussen","sequence":"additional","affiliation":[{"name":"Region Zealand Psychiatry; Psychiatric Research Unit; Slagelse Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorothy","family":"Gauci","sequence":"additional","affiliation":[{"name":"Department of Health; Directorate for Health Information and Research; 95 G'Mangia Hill G'Mangia Malta PTA 1313"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morris","family":"Zwi","sequence":"additional","affiliation":[{"name":"Whittington Health; Islington Child and Adolescent Mental Health Service; 580 Holloway Road London London UK N7 6LB"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Kirubakaran","sequence":"additional","affiliation":[{"name":"Christian Medical College; Cochrane South Asia, Prof. BV Moses Centre for Evidence-Informed Healthcare and Health Policy; Carman Block II Floor CMC Campus, Bagayam Vellore India 632002"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sasja J","family":"H\u00e5konsen","sequence":"additional","affiliation":[{"name":"Aalborg University; Department of Health Science and Technology; Niels Jernes Vej 14 Aalborg Denmark 9220"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lise","family":"Aagaard","sequence":"additional","affiliation":[{"name":"Havemann Law Firm; Copenhagen Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Simonsen","sequence":"additional","affiliation":[{"name":"Region Zealand Psychiatry; Psychiatric Research Unit; Slagelse Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Gluud","sequence":"additional","affiliation":[{"name":"Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 7812, Rigshospitalet, Copenhagen University Hospital; Cochrane Hepato-Biliary Group; Blegdamsvej 9 Copenhagen Denmark DK-2100"},{"name":"Copenhagen University Hospital; Copenhagen Trial Unit, Centre for Clinical Intervention Research; Copenhagen Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2018,5,10]]},"reference":[{"key":"10.1002\/14651858.CD012069.pub2-BIB0001|cit1","unstructured":"Abali O Mukaddes NM Methylphenidate induced hallucinations: case report Klinik Psikofarmakoloji B\u00fclteni [Bulletin of Clinical Psychopharmacology] 2007 195 7"},{"issue":"Suppl 107","key":"10.1002\/14651858.CD012069.pub2-BIB0002|cit2","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/j.1469-8749.2006.tb12600.x","article-title":"Use of methylphenidate for attention-deficit-hyperactivity disorder in childhood","volume":"48","author":"Abbas","year":"2006","journal-title":"Developmental Medicine and Child Neurology"},{"issue":"3","key":"10.1002\/14651858.CD012069.pub2-BIB0003|cit3","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s10578-011-0220-y","article-title":"Acetyl-L-carnitine as an adjunctive therapy in the treatment of attention-deficit\/hyperactivity disorder in children and adolescents: a placebo-controlled trial","volume":"42","author":"Abbasi","year":"2011","journal-title":"Child Psychiatry and Human Development"},{"issue":"6","key":"10.1002\/14651858.CD012069.pub2-BIB0004|cit4","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1097\/00004583-200106000-00002","article-title":"Explosive outbursts associated with methylphenidate","volume":"40","author":"Adrian","year":"2001","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD012069.pub2-BIB0005|cit5","first-page":"160","article-title":"Combination of atomoxetine and methylphenidate in attention deficit\/hyperactivity disorder: a case report","volume":"17","author":"Agarwal","year":"2008","journal-title":"Journal of the Canadian Academy of Child and Adolescent Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD012069.pub2-BIB0006|cit6","first-page":"254","article-title":"Hallucinations caused by the introduction of methylphenidate at low doses","volume":"51","author":"Aguilera-Albesa","year":"2010","journal-title":"Revista de Neurologia"},{"issue":"5","key":"10.1002\/14651858.CD012069.pub2-BIB0007|cit7","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/S0278-5846(03)00117-9","article-title":"Selegiline in the treatment of attention deficit hyperactivity disorder in children: a double blind and randomized trial","volume":"27","author":"Akhondzadeh","year":"2003","journal-title":"Progress in Neuro Psychopharmacology and Biological Psychiatry"},{"issue":"9","key":"10.1002\/14651858.CD012069.pub2-BIB0008|cit8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-244X-4-9","article-title":"Zinc sulfate as an adjunct to methylphenidate for the treatment of attention deficit hyperactivity disorder in children: a double blind and randomized trial","volume":"4","author":"Akhondzadeh","year":"2004","journal-title":"BMC Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD012069.pub2-BIB0009|cit9","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1097\/JCP.0000000000000403","article-title":"Stuttering associated with the use of short-acting oral methylphenidate","volume":"35","author":"Alpaslan","year":"2015","journal-title":"Klinik Psikofarmakoloji B\u00fclteni [Journal of Clinical Psychopharmacology]"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0010|cit10","doi-asserted-by":"publisher","first-page":"212260","DOI":"10.7573\/dic.212260","article-title":"Pharmacological treatment for attention deficit hyperactivity disorder: functional outcomes in children and adolescents from non-Western countries","volume":"2013","author":"Altin","year":"2013","journal-title":"Drugs in Context"},{"issue":"7","key":"10.1002\/14651858.CD012069.pub2-BIB0011|cit11","doi-asserted-by":"publisher","first-page":"987","DOI":"10.2147\/PPA.S50628","article-title":"Predictors and consequences of adherence to the treatment of pediatric patients with attention-deficit\/hyperactivity disorder in Central Europe and East Asia","volume":"30","author":"Hong","year":"2013","journal-title":"Patient Preference and Adherence"},{"issue":"9","key":"10.1002\/14651858.CD012069.pub2-BIB0012|cit12","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1111\/ijcp.12437","article-title":"Predictors of pharmacological treatment outcomes with atomoxetine or methylphenidate in patients with attention-deficit\/hyperactivity disorder from China, Egypt, Lebanon, Russian Federation, Taiwan, and United Arab Emirates","volume":"68","author":"Truer","year":"2014","journal-title":"International Journal of Clinical Practice"},{"issue":"1","key":"10.1002\/14651858.CD012069.pub2-BIB0013|cit13","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.pnpbp.2007.07.025","article-title":"Modafinil as a treatment for Attention-Deficit\/Hyperactivity Disorder in children and adolescents: a double blind, randomized clinical trial","volume":"32","author":"Amiri","year":"2008","journal-title":"Progress in Neuro Psychopharmacology & Biological Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD012069.pub2-BIB0014|cit14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5812\/ijp.265","article-title":"Risperidone versus methylphenidate in treatment of preschool children with attention-deficit hyperactivity disorder","volume":"25","author":"Arabgol","year":"2015","journal-title":"Iranian Journal of Pediatrics"},{"issue":"4","key":"10.1002\/14651858.CD012069.pub2-BIB0015|cit15","doi-asserted-by":"publisher","first-page":"342","DOI":"10.5455\/bcp.20141009112739","article-title":"Osmotic release oral system methylphenidate is more effective than immediate release methylphenidate: a retrospective chart review in Turkish children with attention deficit hyperactivity disorder","volume":"24","author":"Ardic","year":"2014","journal-title":"Klinik Psikofarmakoloji B\u00fclteni [Bulletin of Clinical Psychopharmacology]"},{"issue":"1","key":"10.1002\/14651858.CD012069.pub2-BIB0016|cit16","doi-asserted-by":"publisher","first-page":"306","DOI":"10.5455\/bcp.20141009112739","article-title":"OROS-MPH is more effective than IR-MPH in Turkish children: a retrospective chart review","volume":"24","author":"Ercan","year":"2014","journal-title":"Klinik Psikofarmakoloji B\u00fclteni [Bulletin of Clinical Psychopharmacology]"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0017|cit17","unstructured":"Arman AR Yilmaz S Carkaxhiu G Soysal D Akalin F Risk assessment using heart rate variability due to methylphenidate treatment in children with attention deficit hyperactivity disorder European Child and Adolescent Psychiatry. 15th International Congress of European Society for Child and Adolescent Psychiatry (ESCAP); 2013 Jul 1; Dublin (Ireland) New York Springer 2013 S302 S303"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0019|cit18","unstructured":"Arnold LE Questions regarding your study \"A double-blind, placebo-controlled withdrawal trial of dexmethylphenidate hydrochloride in children with attention deficit hyperactivity disorder\" [personal communication] Email to: EL Ramstad"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0018|cit19","doi-asserted-by":"crossref","unstructured":"Arnold LE Lindsay RL Conners CK Wigal SB Levine AJ Johnson DE A double-blind, placebo-controlled withdrawal trial of dexmethylphenidate hydrochloride in children with attention deficit hyperactivity disorder Journal of Child and Adolescent Psychopharmacology 2004 542 54 10.1089\/cap.2004.14.542","DOI":"10.1089\/cap.2004.14.542"},{"issue":"1","key":"10.1002\/14651858.CD012069.pub2-BIB0020|cit20","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1185\/03007990903437412","article-title":"Switching from oral extended-release methylphenidate to the methylphenidate transdermal system: continued attention-deficit\/hyperactivity disorder symptom control and tolerability after abrupt conversion","volume":"26","author":"Arnold","year":"2010","journal-title":"Current Medical Research and Opinion"},{"issue":"1","key":"10.1002\/14651858.CD012069.pub2-BIB0021|cit21","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/1753-2000-3-39","article-title":"Does switching from oral extended-release methylphenidate to the methylphenidate transdermal system affect health-related quality-of-life and medication satisfaction for children with attention-deficit\/hyperactivity disorder?","volume":"3","author":"Bukstein","year":"2009","journal-title":"Child and Adolescent Psychiatry and Mental Health"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0022|cit22","doi-asserted-by":"publisher","first-page":"319162","DOI":"10.1155\/2014\/319162","article-title":"Severe recurrent pancreatitis in a child with ADHD after starting treatment with methylphenidate (Ritalin)","volume":"2014","author":"Artul","year":"2014","journal-title":"Case Reports in Gastrointestinal Medicine"},{"issue":"1","key":"10.1002\/14651858.CD012069.pub2-BIB0023|cit23","doi-asserted-by":"publisher","first-page":"79","DOI":"10.4103\/0019-5545.124721","article-title":"Methylphenidate and suicidal ideation: report of two cases","volume":"56","author":"Arun","year":"2014","journal-title":"Indian Journal of Psychiatry"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD012069.pub2-BIB0024|cit24","doi-asserted-by":"publisher","first-page":"S33","DOI":"10.1007\/s00415-012-6524-4","article-title":"Effect of transdermal methylphenidate wear times on sleep in children with ADHD","volume":"259","author":"Ashkenasi","year":"2012","journal-title":"Journal of Neurology"},{"issue":"6","key":"10.1002\/14651858.CD012069.pub2-BIB0025|cit25","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.pediatrneurol.2011.09.003","article-title":"Effect of transdermal methylphenidate wear times on sleep in children with attention deficit hyperactivity disorder","volume":"45","author":"Ashkenasi","year":"2011","journal-title":"Pediatric Neurology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD012069.pub2-BIB0026|cit26","doi-asserted-by":"publisher","first-page":"S73","DOI":"10.1016\/S0924-977X(06)80087-8","article-title":"Predictive parameters for methylphenidate use and compliance in children with attention deficit hyperactivity disorder","volume":"16","author":"Atzori","year":"2006","journal-title":"European Neuropsychopharmacology"},{"issue":"6","key":"10.1002\/14651858.CD012069.pub2-BIB0027|cit27","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1089\/cap.2008.0146","article-title":"Predictive factors for persistent use and compliance of immediate-release methylphenidate: a 36-month naturalistic study","volume":"19","author":"Atzori","year":"2009","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"issue":"8","key":"10.1002\/14651858.CD012069.pub2-BIB0028|cit28","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1089\/cap.2014.0002","article-title":"Medication persistence in Turkish children and adolescents with attention-deficit\/hyperactivity disorder","volume":"24","author":"Ayaz","year":"2014","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"issue":"2","key":"10.1002\/14651858.CD012069.pub2-BIB0029|cit29","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1089\/cap.2010.0030","article-title":"Methylphenidate treatment and dyskinesia in children with attention-deficit\/hyperactivity disorder","volume":"21","author":"Bal\u00e1zs","year":"2011","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"issue":"4","key":"10.1002\/14651858.CD012069.pub2-BIB0030|cit30","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1542\/peds.2012-2354","article-title":"Mortality, ADHD, and psychosocial adversity in adults with childhood ADHD: a prospective study","volume":"132","author":"Barbaresi","year":"2013","journal-title":"Pediatrics"},{"issue":"3","key":"10.1002\/14651858.CD012069.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1001\/archpedi.156.3.217","article-title":"How common is attention-deficit\/hyperactivity disorder? Incidence in a population-based birth cohort in Rochester, Minn","volume":"156","author":"Barbaresi","year":"2002","journal-title":"Archives of Pediatrics and Adolescent Medicine"},{"issue":"1","key":"10.1002\/14651858.CD012069.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00004703-200602000-00001","article-title":"Long-term stimulant medication treatment of attention-deficit\/hyperactivity disorder: results from a population-based study","volume":"27","author":"Barbaresi","year":"2006","journal-title":"Journal of Developmental and Behavioral Pediatrics"},{"issue":"1","key":"10.1002\/14651858.CD012069.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1097\/DBP.0000000000000099","article-title":"Long-term stimulant medication treatment of attention-deficit\/hyperactivity disorder: results from a population-based study","volume":"27","author":"Barbaresi","year":"2014","journal-title":"Journal of Developmental and Behavioral Pediatrics"},{"issue":"3","key":"10.1002\/14651858.CD012069.pub2-BIB0034|cit34","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1542\/peds.2012-3588","article-title":"ADHD and learning disabilities in former late preterm infants: a population-based birth cohort","volume":"132","author":"Harris","year":"2013","journal-title":"Pediatrics"},{"issue":"4","key":"10.1002\/14651858.CD012069.pub2-BIB0035|cit35","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1542\/peds.2014-0428","article-title":"ADHD, stimulant treatment, and growth: a longitudinal study","volume":"134","author":"Harstad","year":"2014","journal-title":"Pediatrics."},{"issue":"6","key":"10.1002\/14651858.CD012069.pub2-BIB0036|cit36","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.annepidem.2004.12.004","article-title":"Case definition in epidemiologic studies of ADHD","volume":"15","author":"Katusic","year":"2005","journal-title":"Annals of Epidemiology"},{"issue":"11","key":"10.1002\/14651858.CD012069.pub2-BIB0037|cit37","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.4065\/73.11.1053","article-title":"Potential influence of migration bias in birth cohort studies","volume":"73","author":"Katusic","year":"1998","journal-title":"Mayo Clinic Proceedings"},{"issue":"4","key":"10.1002\/14651858.CD012069.pub2-BIB0038|cit38","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.acap.2013.02.008","article-title":"Incidence of enuresis and encopresis among children with attention-deficit\/hyperactivity disorder in a population-based birth cohort","volume":"13","author":"Mellon","year":"2013","journal-title":"Academic Pediatrics"},{"issue":"3","key":"10.1002\/14651858.CD012069.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1542\/peds.2010-2581","article-title":"Written-language disorder among children with and without ADHD in a population-based birth cohort.","volume":"128","author":"Yoshimasu","year":"2011","journal-title":"Pediatrics"},{"issue":"10","key":"10.1002\/14651858.CD012069.pub2-BIB0040|cit40","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1111\/j.1469-7610.2012.02567.x","article-title":"Childhood ADHD is strongly associated with a broad range of psychiatric disorders during adolescence: a population-based birth cohort study","volume":"53","author":"Yoshimasu","year":"2012","journal-title":"Journal of Child Psychology and Psychiatry, and Allied Disciplines"},{"issue":"5","key":"10.1002\/14651858.CD012069.pub2-BIB0041|cit41","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1097\/00004583-199505000-00017","article-title":"Bupropion versus methylphenidate in the treatment of attention-deficit hyperactivity disorder","volume":"34","author":"Barrickman","year":"1995","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD012069.pub2-BIB0042|cit42","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/S0924-9338(10)70372-2","article-title":"Transitioning onto OROS MPH is associated with improved functioning and quality of life in adolescents with ADHD","volume":"25","author":"Alfred","year":"2010","journal-title":"European Psychiatry. 18th European Congress of Psychiatry. 2010 Feb 27-March 2; Munich (Germany)"},{"issue":"1","key":"10.1002\/14651858.CD012069.pub2-BIB0043|cit43","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/1753-2000-5-26","article-title":"Improved functionality, health related quality of life and decreased burden of disease in patients with ADHD treated with OROS\u00ae MPH: is treatment response different between children and adolescents?","volume":"5","author":"Berek","year":"2011","journal-title":"Child & Adolescent Psychiatry & Mental Health"},{"key":"#cr-split#-10.1002\/14651858.CD012069.pub2-BIB0044|cit44.1","doi-asserted-by":"crossref","unstructured":"Kordon A Hultzsch W Mattejat F Dichter S Schaeuble B Transitioning onto OROS MPH is associated with improved functioning and quality of life in children and adolescents with ADHD European Psychiatry. 18th European Congress of Psychiatry. 2010 Feb 27-March 2","DOI":"10.1016\/S0924-9338(10)70953-6"},{"key":"#cr-split#-10.1002\/14651858.CD012069.pub2-BIB0044|cit44.2","unstructured":"Munich (Germany) 2010 962 10.1016\/S0924-9338(10)70953-6"},{"issue":"4","key":"10.1002\/14651858.CD012069.pub2-BIB0045|cit45","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1586\/ern.11.18","article-title":"Transitioning to OROS\u00ae methylphenidate from atomoxetine is effective in children and adolescents with ADHD","volume":"11","author":"Niederkirchner","year":"2011","journal-title":"Expert Review of Neurotherapeutics"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0046|cit46","unstructured":"Schaeuble B Mattejat F Rettig K Kordon A Berek M Changes in function and quality of life aspects in children with ADHD after transitioning onto OROS MPH European Child and Adolescent Psychiatry.14th International Congress of European Society for Child and Adolescent Psychiatry (ESCAP); June 11-15 2011; Helsinki (Finland) 2011 S131"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD012069.pub2-BIB0047|cit47","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1185\/03007995.2011.601733","article-title":"Effect of transitioning from extended-release methylphenidate onto osmotic, controlled-release methylphenidate in children\/adolescents with ADHD: results of a 3-month non-interventional study","volume":"27","author":"Wolff","year":"2011","journal-title":"Current Medical Research and Opinion"},{"issue":"4","key":"10.1002\/14651858.CD012069.pub2-BIB0048|cit48","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1159\/000084683","article-title":"Height, weight, IGF-I, IGFBP-3 and thyroid functions in prepubertal children with attention deficit hyperactivity disorder: effect of methylphenidate treatment","volume":"63","author":"Bereket","year":"2005","journal-title":"Hormone Research"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0049|cit49","unstructured":"Bernhard MK Hugle B Merkenschlager A Elevated liver enzymes under therapy with methylphenidate in a boy with T-cell leukemia Journal of Pediatric Neurology 2009 297 9 10.3233\/JPN-2009-0303"},{"issue":"4","key":"10.1002\/14651858.CD012069.pub2-BIB0050|cit50","doi-asserted-by":"publisher","first-page":"e796","DOI":"10.1542\/peds.2010-0086","article-title":"Stimulant-responsive and stimulant-refractory aggressive behavior among children with ADHD","volume":"126","author":"Blader","year":"2010","journal-title":"Pediatrics"},{"issue":"12","key":"10.1002\/14651858.CD012069.pub2-BIB0051|cit51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/cpu.20129","article-title":"Methylphenidate dose may reduce aggressive behavior in children with ADHD","volume":"12","author":"Blader Joseph","year":"2010","journal-title":"Brown University Child & Adolescent Psychopharmacology Update"},{"issue":"9","key":"10.1002\/14651858.CD012069.pub2-BIB0052|cit52","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/j.biopsych.2007.05.010","article-title":"Restoration of disturbed intracortical motor inhibition and facilitation in attention deficit hyperactivity disorder children by methylphenidate","volume":"62","author":"Buchmann","year":"2007","journal-title":"Biological Psychiatry"},{"issue":"1-2","key":"10.1002\/14651858.CD012069.pub2-BIB0053|cit53","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.neulet.2006.06.026","article-title":"Modulation of transcallosally mediated motor inhibition in children with attention deficit hyperactivity disorder (ADHD) by medication with methylphenidate (MPH)","volume":"405","author":"Buchmann","year":"2006","journal-title":"Neuroscience Letters"},{"issue":"11","key":"10.1002\/14651858.CD012069.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1016\/S1388-2457(03)00208-6","article-title":"Disturbed transcallosally mediated motor inhibition in children with attention deficit hyperactivity disorder (ADHD)","volume":"114","author":"Buchmann","year":"2003","journal-title":"Clinical Neurophysiology"},{"issue":"4","key":"10.1002\/14651858.CD012069.pub2-BIB0055|cit55","first-page":"430","article-title":"Priapism associated with methylphenidate: a case report","volume":"52","author":"Cakin-Memik","year":"2010","journal-title":"Turkish Journal of Pediatrics"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0056|cit56","unstructured":"\u00c7etin FH I\u015fik Taner Y Ta\u015f Torun Y Tunca H Atomoxetine and methylphenidate for the treatment of attention deficit hyperactivity disorder: a six-month follow-up study Improved choices of psychotropic medications: better mental health outcomes. 5th International Congress on Psychopharmacology and International Symposium on Child and Adolescent Psychopharmacology (TAP-ICP); October 30-November 3 2013; Antalya (Turkey) 2013 S80"},{"issue":"2","key":"10.1002\/14651858.CD012069.pub2-BIB0057|cit57","doi-asserted-by":"publisher","first-page":"88","DOI":"10.5336\/medsci.2015-43336","article-title":"Atomoxetine versus OROS methylphenidate in attention deficit hyperactivity disorder: a six-month follow up study for efficacy and adverse effects","volume":"35","author":"\u00c7etin","year":"2015","journal-title":"Turkiye Klinikleri Journal of Medical Sciences"},{"issue":"1","key":"10.1002\/14651858.CD012069.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/00004714-198902000-00027","article-title":"Tryptophan antagonism of stimulant-induced tics","volume":"9","author":"Chandler","year":"1989","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"5","key":"10.1002\/14651858.CD012069.pub2-BIB0059|cit59","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1038\/tpj.2012.25","article-title":"Association of a carboxylesterase 1 polymorphism with appetite reduction in children and adolescents with attention-deficit\/hyperactivity disorder treated with methylphenidate","volume":"13","author":"Bruxel","year":"2013","journal-title":"Pharmacogenomics Journal"},{"issue":"3","key":"10.1002\/14651858.CD012069.pub2-BIB0060|cit60","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1097\/JCP.0b013e318217b4df","article-title":"Do phenotypic characteristics, parental psychopathology, family functioning, and environmental stressors have a role in the response to methylphenidate in children with attention-deficit\/hyperactivity disorder? A naturalistic study from a developing count","volume":"31","author":"Chazan","year":"2011","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"3","key":"10.1002\/14651858.CD012069.pub2-BIB0061|cit61","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.biopsych.2011.03.025","article-title":"Catechol-O-methyltransferase valine158methionine polymorphism moderates methylphenidate effects on oppositional symptoms in boys with attention-deficit\/hyperactivity disorder","volume":"70","author":"Salatino-Oliveira","year":"2011","journal-title":"Biological Psychiatry"},{"issue":"8","key":"10.1002\/14651858.CD012069.pub2-BIB0062|cit62","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1177\/070674379904400810","article-title":"Psychotic side effects of psychostimulants: a 5-year review","volume":"44","author":"Cherland","year":"1999","journal-title":"Canadian Journal of Psychiatry"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0063|cit63","doi-asserted-by":"crossref","unstructured":"Cho S-C Kim B-N Cummins TD Kim J-W Bellgrove MA Norepinephrine transporter -3081(A\/T) and alpha-2A-adrenergic receptor MspI polymorphisms are associated with cardiovascular side effects of OROS-methylphenidate treatment Journal of Psychopharmacology 2012 380 9 10.1177\/0269881111405356","DOI":"10.1177\/0269881111405356"},{"issue":"3","key":"10.1002\/14651858.CD012069.pub2-BIB0064|cit64","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1089\/cap.2011.0006","article-title":"Remission in children and adolescents diagnosed with attention-deficit\/ hyperactivity disorder via an effective and tolerable titration scheme for osmotic release oral system methylphenidate","volume":"22","author":"Chou","year":"2012","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"issue":"5S","key":"10.1002\/14651858.CD012069.pub2-BIB0065|cit65","doi-asserted-by":"publisher","first-page":"S262","DOI":"10.1016\/j.neurenf.2012.04.683","article-title":"The family impact in children and adolescent with ADHD after the switch of treatment from immediate-release MPH to OROS-MPH","volume":"60","author":"WJ","year":"2012","journal-title":"Neuropsychiatrie de l'Enfance et de l'Adolescence"},{"issue":"4","key":"10.1002\/14651858.CD012069.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"275","DOI":"10.4314\/ajpsy.v12i4.49043","article-title":"Sleep and daytime sleepiness in methylphenidate medicated and un-medicated children with attention-deficit\/hyperactivity disorder (ADHD)","volume":"12","author":"Cockcroft","year":"2009","journal-title":"African Journal of Psychiatry"},{"issue":"11","key":"10.1002\/14651858.CD012069.pub2-BIB0067|cit67","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1177\/106002809202601107","article-title":"Fixed drug eruption of the scrotum due to methylphenidate","volume":"26","author":"Cohen","year":"1992","journal-title":"Annals of Pharmacotherapy"},{"issue":"1","key":"10.1002\/14651858.CD012069.pub2-BIB0068|cit68","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.amp.2008.11.006","article-title":"From hyperactivity to schizophrenia? Clinical, neurobiological and therapeutic discussion of a case","volume":"167","author":"Coignoux","year":"2009","journal-title":"Annales M\u00e9dico-psychologiques, Revue Psychatrique"},{"issue":"4","key":"10.1002\/14651858.CD012069.pub2-BIB0069|cit69","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1089\/cap.2005.15.703","article-title":"Successful desensitization of methylphenidate-induced rash","volume":"15","author":"Confino-Cohen","year":"2005","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"issue":"4","key":"10.1002\/14651858.CD012069.pub2-BIB0070|cit70","first-page":"365","article-title":"Immediate effects of methylphenidate on vocal acoustic parameters in children with attention deficit hyperactivity disorder","volume":"19","author":"Congologlu","year":"2009","journal-title":"Klinik Psikofarmakoloji B\u00fclteni [Bulletin of Clinical Psychopharmacology]"},{"issue":"11","key":"10.1002\/14651858.CD012069.pub2-BIB0071|cit71","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1097\/00004583-199611000-00005","article-title":"Methylphenidate euphoria","volume":"35","author":"Corrigall","year":"1996","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"issue":"10","key":"10.1002\/14651858.CD012069.pub2-BIB0072|cit72","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1007\/s40263-015-0266-7","article-title":"Safety of methylphenidate and atomoxetine in children with Attention-Deficit\/Hyperactivity Disorder (ADHD): data from the Italian National ADHD Registry","volume":"29","author":"Cortese","year":"2015","journal-title":"CNS Drugs"},{"issue":"6","key":"10.1002\/14651858.CD012069.pub2-BIB0073|cit73","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1097\/JCP.0b013e31818ce752","article-title":"Tactile and visual hallucinations in a child with methylphenidate and fluoxetine combination","volume":"28","author":"Co\u015fkun","year":"2008","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0074|cit74","doi-asserted-by":"crossref","unstructured":"Co\u015fkun M Tutkunkardas MD Zoroglu S OROS methylphenidate-induced skin eruptions Journal of Child and Adolescent Psychopharmacology 2009 593 4 10.1089\/cap.2009.0009","DOI":"10.1089\/cap.2009.0009"},{"issue":"4","key":"10.1002\/14651858.CD012069.pub2-BIB0075|cit75","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1089\/cap.2008.0161","article-title":"A report of two cases of sexual side effects with OROS methylphenidate","volume":"19","author":"Co\u015fkun","year":"2009","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"issue":"3","key":"10.1002\/14651858.CD012069.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1080\/10177833.2010.11790666","article-title":"Mirtazapine treatment for comorbid anxiety\/depressive disorders in young subjects with attention-deficit hyperactivity disorder: case series","volume":"20","author":"Co\u015fkun","year":"2010","journal-title":"Klinik Psikofarmakoloji B\u00fclteni [Bulletin of Clinical Psychopharmacology]"},{"issue":"3","key":"10.1002\/14651858.CD012069.pub2-BIB0077|cit77","doi-asserted-by":"publisher","first-page":"274","DOI":"10.5455\/bcp.20110904061403","article-title":"Methylphenidate induced obsessive-compulsive symptoms treated with sertraline","volume":"21","author":"Co\u015fkun","year":"2011","journal-title":"Klinik Psikofarmakoloji B\u00fclteni [Bulletin of Clinical Psychopharmacology]"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0078|cit78","unstructured":"Babaki ME Ashtiani RD Razjooyan K Amini H Comparing the effects of buspirone and methylphenidate in children with attention deficit hyperactivity disorder Iranian Journal of Psychiatry and Clinical Psychology 2009 223 30"},{"issue":"6","key":"10.1002\/14651858.CD012069.pub2-BIB0079|cit79","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1007\/s10578-010-0193-2","article-title":"Buspirone versus methylphenidate in the treatment of attention deficit hyperactivity disorder: a double-blind and randomized trial","volume":"41","author":"Davari-Ashtiani","year":"2010","journal-title":"Child Psychiatry and Human Development"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0080|cit80","unstructured":"Shahrbabaki ME Sabzevari L Haghdoost A Davari-Ashtiani R Buspiron versus methylphenidate in the treatment of children with ADHD Brain, Mind and Development. 20th World IACAPAP (International Association for Child and Adolescent Psychiatry and Allied Professions) Congress; July 21-25 2012; Paris (France) 2012 Suppl 1"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0081|cit81","doi-asserted-by":"crossref","unstructured":"Delignieres A Querne L Bourel-Ponchel E Ardoint A Berquin P Attention-deficit disorders and epilepsy in childhood: use methylphenidate treatment? European Journal of Paediatric Neurology. 9th Congress of the European Paediatric Neurology Society (EPNS); May 11-14 2011; Cavtat (Croatia) 2011 S127 8","DOI":"10.1016\/S1090-3798(11)70446-9"},{"issue":"7","key":"10.1002\/14651858.CD012069.pub2-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1185\/030079902125001100","article-title":"A postmarketing clinical experience study of Metadate CD","volume":"18","author":"Dirksen","year":"2002","journal-title":"Current Medical Research and Opinion"},{"issue":"2014","key":"10.1002\/14651858.CD012069.pub2-BIB0083|cit83","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s12402-014-0136-z","article-title":"Findings from the observational COMPLY study in children and adolescents with ADHD: core symptoms, ADHD-related difficulties, and patients' emotional expression during psychostimulant or nonstimulant ADHD treatment","volume":"6","author":"Dittmann","year":"2014","journal-title":"Attention Deficit and Hyperactivity Disorders"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0084|cit84","unstructured":"Dodangi N Tehrani-Doost M Mahmoudi-Gharaei J Rajabi G Duloxetine in comparison with methylphenidate in treatment of adolescents with ADHD European Child and Adolescent Psychiatry. 14th International Congress of ESCAP European Society for Child and Adolescent Psychiatry; June 11-15 2011; Helsinki (Finland) 2011 S116"},{"issue":"2","key":"10.1002\/14651858.CD012069.pub2-BIB0085|cit85","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1002\/hup.1188","article-title":"Duloxetine in the treatment of adolescents with attention deficit\/hyperactivity disorder: an open-label study","volume":"26","author":"Mahmoudi-Gharaei","year":"2011","journal-title":"Human Psychopharmacology"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD012069.pub2-BIB0086|cit86","doi-asserted-by":"publisher","first-page":"S267","DOI":"10.1007\/s00787-011-0204-2","article-title":"Relationship between quality of life and psychopathological profile: data from an observational study in children with ADHD","volume":"20","author":"Becker","year":"2011","journal-title":"European Child and Adolescent Psychiatry"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD012069.pub2-BIB0087|cit87","doi-asserted-by":"publisher","first-page":"S289","DOI":"10.1007\/s00787-011-0206-0","article-title":"Assessment of daily profiles of ADHD and ODD symptoms, and symptomatology related to ADHD medication, by parent and teacher ratings","volume":"20","author":"Breuer","year":"2011","journal-title":"European Child and Adolescent Psychiatry"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD012069.pub2-BIB0088|cit88","doi-asserted-by":"publisher","first-page":"S277","DOI":"10.1007\/s00787-011-0205-1","article-title":"An observational study of once-daily modified-release methylphenidate in ADHD: the effect of previous treatment on ADHD symptoms, other externalising symptoms and quality-of-life outcomes","volume":"20","author":"D\u00f6pfner","year":"2011","journal-title":"European Child and Adolescent Psychiatry"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD012069.pub2-BIB0089|cit89","doi-asserted-by":"publisher","first-page":"S243","DOI":"10.1007\/s00787-011-0202-4","article-title":"An observational study of once-daily modified-release methylphenidate in ADHD: effectiveness on symptoms and impairment, and safety","volume":"20","author":"D\u00f6pfner","year":"2011","journal-title":"European Child and Adolescent Psychiatry"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD012069.pub2-BIB0090|cit90","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1017\/S1461145708009462","article-title":"Assessment of Equasym XL under routine conditions by physicians, parents, teachers, and children","volume":"11","author":"D\u00f6pfner","year":"2008","journal-title":"International Journal of Neuropsychopharmacology"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0091|cit91","doi-asserted-by":"crossref","unstructured":"G\u00f6rtz-Dorten A Breuer D Hautmann C Rothenberger A D\u00f6pfner M What contributes to patient and parent satisfaction with medication in the treatment of children with ADHD? A report on the development of a new rating scale European Child and Adolescent Psychiatry 2011 S297 307 10.1007\/s00787-011-0207-z","DOI":"10.1007\/s00787-011-0207-z"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD012069.pub2-BIB0092|cit92","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s00787-011-0203-3","article-title":"An observational study of once-daily modified-release methylphenidate in ADHD: quality of life, satisfaction with treatment and adherence","volume":"20","author":"Rothenberger","year":"2011","journal-title":"European Child and Adolescent Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD012069.pub2-BIB0093|cit93","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1089\/cap.2010.0082","article-title":"Comparison of the efficacy of two different modified release methylphenidate preparations for children and adolescents with attention-deficit\/hyperactivity disorder in a natural setting: comparison of the efficacy of Medikinet\u00ae retard and Concerta\u00ae - a randomized, controlled, double-blind multicenter clinical crossover trial","volume":"21","author":"D\u00f6pfner","year":"2011","journal-title":"Journal of Child & Adolescent Psychopharmacology"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0094|cit94","first-page":"S116","article-title":"The CoMeCo-trial: comparison of the efficacy of two methylphenidate preparations for children and adolescents with ADHD in a natural setting","volume":"20","author":"D\u00f6pfner","year":"2011","journal-title":"European Child and Adolescent Psychiatry.14th International Congress of ESCAP European Society for Child and Adolescent Psychiatry (ESCAP); June 11-15, 2011; Helsinki (Finland)"},{"issue":"11","key":"10.1002\/14651858.CD012069.pub2-BIB0095|cit95","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1007\/s00112-011-2413-7","article-title":"Methylphenidate with modified release in routine treatment","volume":"159","author":"D\u00f6pfner","year":"2011","journal-title":"Monatsschrift Kinderheilkunde"},{"issue":"3","key":"10.1002\/14651858.CD012069.pub2-BIB0096|cit96","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1177\/0883073810380051","article-title":"Body mass index of children with attention-deficit\/hyperactivity disorder","volume":"26","author":"Dubnov-Raz","year":"2011","journal-title":"Journal of Child Neurology"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0097|cit97","doi-asserted-by":"crossref","unstructured":"Yang R Mao S Zhang S Li R Zhao Z Body mass index of children with attention-deficit\/hyperactivity disorder Journal of Child Neurology 2012 545 6 10.1177\/0883073811435326","DOI":"10.1177\/0883073811435326"},{"issue":"3","key":"10.1002\/14651858.CD012069.pub2-BIB0098|cit98","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.ijpsycho.2008.07.012","article-title":"EEG coherence in girls with attention-deficit\/hyperactivity disorder: stimulant effects in good responders","volume":"70","author":"Dupuy","year":"2008","journal-title":"International Journal of Psychophysiology"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0099|cit99","doi-asserted-by":"crossref","unstructured":"Dur\u00e1-Trav\u00e9 T Yoldi-Petri ME Gallinas-Victoriano F Zardoya-Santos P Effects of osmotic-release methylphenidate on height and weight in children with attention-deficit hyperactivity disorder (ADHD) following up to four years of treatment Journal of Child Neurology 2012 604 9 10.1177\/0883073811422752","DOI":"10.1177\/0883073811422752"},{"issue":"5","key":"10.1002\/14651858.CD012069.pub2-BIB0100|cit100","first-page":"257","article-title":"Nutrition and attention deficit hyperactivity disorder: developmental follow-up of the anthropometric variables of a group of patients receiving treatment with osmotic controlled-release methylphenidate","volume":"53","author":"Dur\u00e1-Trav\u00e9","year":"2011","journal-title":"Revista de Neurologia"},{"issue":"5","key":"10.1002\/14651858.CD012069.pub2-BIB0105|cit101","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1097\/00004583-199905000-00009","article-title":"Methylphenidate versus dextroamphetamine in ADHD","volume":"38","author":"Efron","year":"1999","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD012069.pub2-BIB0101|cit102","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1046\/j.1440-1754.1998.00224.x","article-title":"Child and parent perceptions of stimulant medication treatment in attention deficit hyperactivity disorder","volume":"34","author":"Efron","year":"1998","journal-title":"Journal of Paediatrics and Child Health"},{"issue":"5","key":"10.1002\/14651858.CD012069.pub2-BIB0102|cit103","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1046\/j.1440-1754.2000.00555.x","article-title":"Medium-term outcomes are comparable with short-term outcomes in children with attention deficit hyperactivity disorder treated with stimulant medication","volume":"36","author":"Efron","year":"2000","journal-title":"Journal of Paediatrics and Child Health"},{"issue":"6","key":"10.1002\/14651858.CD012069.pub2-BIB0103|cit104","doi-asserted-by":"crossref","first-page":"E6","DOI":"10.1542\/peds.100.6.e6","article-title":"Methylphenidate versus dexamphetamine in children with attention deficit hyperactivity disorder: a double-blind, crossover trial","volume":"100","author":"Efron","year":"1997","journal-title":"Pediatrics"},{"issue":"4","key":"10.1002\/14651858.CD012069.pub2-BIB0104|cit105","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1542\/peds.100.4.662","article-title":"Side effects of methylphenidate and dexamphetamine in children with attention deficit hyperactivity disorder: a double-blind, crossover trial","volume":"100","author":"Efron","year":"1997","journal-title":"Pediatrics"},{"issue":"5","key":"10.1002\/14651858.CD012069.pub2-BIB0106|cit106","first-page":"1","article-title":"Study the gender differences in ADHD children: is the response to CNS stimulants a case of one fits both?","volume":"4","author":"El-Fiky","year":"2014","journal-title":"Indian Streams Research Journal"},{"issue":"2","key":"10.1002\/14651858.CD012069.pub2-BIB0107|cit107","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.canlet.2005.01.003","article-title":"Cytogenetic effects in children treated with methylphenidate","volume":"230","author":"El-Zein","year":"2005","journal-title":"Cancer Letters"},{"issue":"2","key":"10.1002\/14651858.CD012069.pub2-BIB0108|cit108","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.canlet.2005.05.038","article-title":"Comments on 'Cytogenetic effects in children treated with methylphenidate' by El-Zein et al","volume":"230","author":"Preston","year":"2005","journal-title":"Cancer Letters"},{"issue":"3","key":"10.1002\/14651858.CD012069.pub2-BIB0109|cit109","first-page":"112","article-title":"The effect of methylphenidate on school grades in children with attention deficit disorder without hyperactivity: a preliminary report","volume":"48","author":"Famularo","year":"1987","journal-title":"Journal of Clinical Psychiatry"},{"issue":"9","key":"10.1002\/14651858.CD012069.pub2-BIB0110|cit110","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1097\/chi.0b013e31806ad1d7","article-title":"Long-term effects of methylphenidate transdermal delivery system treatment of ADHD on growth","volume":"46","author":"Faraone","year":"2007","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"issue":"8","key":"10.1002\/14651858.CD012069.pub2-BIB0111|cit111","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1097\/00004583-199708000-00007","article-title":"Medication-induced seizures","volume":"36","author":"Feeney","year":"1997","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"issue":"9","key":"10.1002\/14651858.CD012069.pub2-BIB0112|cit112","first-page":"573","article-title":"Cardiovascular side effects secondary to treatment with methylphenidate","volume":"50","author":"Fern\u00e1ndez-Fern\u00e1ndez","year":"2010","journal-title":"Revista de Neurologia"},{"issue":"7","key":"10.1002\/14651858.CD012069.pub2-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"446","DOI":"10.33588\/rn.5207.2010739","article-title":"Infantile psychosis secondary to methylphenidate","volume":"52","author":"Fern\u00e1ndez-Fern\u00e1ndez","year":"2011","journal-title":"Revista de Neurologia"},{"issue":"3","key":"10.1002\/14651858.CD012069.pub2-BIB0114|cit114","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1089\/cap.1996.6.165","article-title":"Open-label treatment of comorbid depression and attentional disorders with co-administration of serotonin reuptake inhibitors and psychostimulants in children, adolescents, and adults: a case series","volume":"6","author":"Findling","year":"1996","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"issue":"8","key":"10.1002\/14651858.CD012069.pub2-BIB0115|cit115","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1016\/j.clinthera.2009.08.002","article-title":"Long-term tolerability of the methylphenidate transdermal system in pediatric attention-deficit\/hyperactivity disorder: a multicenter, prospective, 12-month, open-label, uncontrolled, phase III extension of four clinical trials","volume":"31","author":"Findling","year":"2009","journal-title":"Clinical Therapeutics"},{"issue":"s4","key":"10.1002\/14651858.CD012069.pub2-BIB0116|cit116","doi-asserted-by":"publisher","first-page":"S562","DOI":"10.1016\/S0924-977X(08)70857-5","article-title":"12-month safety and efficacy of methylphenidate transdermal system in attention-deficit\/hyperactivity disorder","volume":"18","author":"Turnbow","year":"2008","journal-title":"European Neuropsychopharmacology"},{"issue":"5","key":"10.1002\/14651858.CD012069.pub2-BIB0117|cit117","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1089\/cap.2009.0122","article-title":"A 6-month, open-label, extension study of the tolerability and effectiveness of the methylphenidate transdermal system in adolescents diagnosed with attention-deficit\/hyperactivity disorder","volume":"20","author":"Findling","year":"2010","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"issue":"7","key":"10.1002\/14651858.CD012069.pub2-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1017\/S1092852900000353","article-title":"A randomized, double-blind, multicenter, parallel-group, placebo-controlled, dose-optimization study of the methylphenidate transdermal system for the treatment of ADHD in adolescents","volume":"15","author":"Findling","year":"2010","journal-title":"CNS Spectrums"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0119|cit119","doi-asserted-by":"crossref","unstructured":"Keating GM Methylphenidate transdermal system in attention-deficit hyperactivity disorder in adolescents: profile report Drugs in R&D 2012 171 3 10.2165\/11207490-000000000-00000","DOI":"10.2165\/11207490-000000000-00000"},{"issue":"3","key":"10.1002\/14651858.CD012069.pub2-BIB0120|cit120","doi-asserted-by":"crossref","first-page":"167-76","DOI":"10.1097\/00004703-199506000-00004","article-title":"School observations of children with attention-deficit hyperactivity disorder and comorbid tic disorder: effects of methylphenidate treatment","volume":"16","author":"Gadow","year":"1995","journal-title":"Journal of Developmental and Behavioral Pediatrics"},{"issue":"6","key":"10.1002\/14651858.CD012069.pub2-BIB0121|cit121","first-page":"494","article-title":"Efficacy of methylphenidate for attention-deficit hyperactivity disorder in children with tic disorder","volume":"52","author":"Gadow","year":"1995","journal-title":"Annual Progress in Child Psychiatry and Child Development"},{"issue":"3","key":"10.1002\/14651858.CD012069.pub2-BIB0123|cit122","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1097\/00004583-199205000-00012","article-title":"Methylphenidate in hyperactive boys with comorbid tic disorder: II. Short-term behavioral effects in school settings","volume":"31","author":"Gadow","year":"1992","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD012069.pub2-BIB0122|cit123","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/00004714-200206000-00007","article-title":"Anxiety and depression symptoms and response to methylphenidate in children with attention-deficit hyperactivity disorder and tic disorder","volume":"22","author":"Gadow","year":"2002","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"4","key":"10.1002\/14651858.CD012069.pub2-BIB0124|cit124","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1001\/archpsyc.56.4.330","article-title":"Long-term methylphenidate therapy in children with comorbid attention-deficit hyperactivity disorder and chronic multiple tic disorder","volume":"56","author":"Gadow","year":"1999","journal-title":"Archives of General Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD012069.pub2-BIB0125|cit125","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1097\/00004583-199705000-00009","article-title":"Children with ADHD and tic disorder and their classmates: behavioral normalization with methylphenidate","volume":"36","author":"Nolan","year":"1997","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD012069.pub2-BIB0126|cit126","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1207\/s15374424jccp2301_10","article-title":"Relation between ratings and observations of stimulant drug response in hyperactive children","volume":"23","author":"Nolan","year":"1994","journal-title":"Journal of Clinical Child Psychology"},{"issue":"4","key":"10.1002\/14651858.CD012069.pub2-BIB0127|cit127","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1089\/cap.1996.6.215","article-title":"Double-blind versus open evaluations of stimulant drug response in children with attention-deficit hyperactivity disorder","volume":"6","author":"Sprafkin","year":"1996","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0128|cit128","unstructured":"Sverd J Gadow KD Nolan EE Sprafkin J Ezor SN Methylphenidate in hyperactive boys with comorbid tic disorder: I. Clinic evaluations Advances in Neurology 1992 271 81"},{"issue":"3","key":"10.1002\/14651858.CD012069.pub2-BIB0129|cit129","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s11325-010-0357-0","article-title":"Apnea-hypopnea indices and snoring in children diagnosed with ADHD: a matched case-control study","volume":"15","author":"Galland","year":"2011","journal-title":"Sleep and Breathing"},{"issue":"3","key":"10.1002\/14651858.CD012069.pub2-BIB0130|cit130","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/cpu.20111","article-title":"Methylphenidate effects on sleep in children","volume":"12","author":"Galland","year":"2010","journal-title":"Brown University Child and Adolescent Psychopharmacology Update"},{"issue":"2","key":"10.1002\/14651858.CD012069.pub2-BIB0131|cit131","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1111\/j.1365-2869.2009.00795.x","article-title":"The sleep of children with attention deficit hyperactivity disorder on and off methylphenidate: a matched case-control study","volume":"19","author":"Galland","year":"2010","journal-title":"Journal of Sleep Research"},{"issue":"2","key":"10.1002\/14651858.CD012069.pub2-BIB0132|cit132","doi-asserted-by":"publisher","first-page":"114","DOI":"10.4103\/2229-516X.157162","article-title":"Comparative efficacy of methylphenidate and atomoxetine in oppositional defiant disorder comorbid with attention deficit hyperactivity disorder","volume":"5","author":"Garg","year":"2015","journal-title":"International Journal of Applied and Basic Medical Research"},{"issue":"7","key":"10.1002\/14651858.CD012069.pub2-BIB0133|cit133","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1007\/s13312-014-0445-5","article-title":"Comparative short term efficacy and tolerability of methylphenidate and atomoxetine in attention deficit hyperactivity disorder","volume":"51","author":"Garg","year":"2014","journal-title":"Indian Pediatrics"},{"issue":"4","key":"10.1002\/14651858.CD012069.pub2-BIB0134|cit134","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1089\/cap.2006.16.441","article-title":"An open-label, randomized, active-controlled equivalent trial of osmotic release oral system methylphenidate in children with attention-deficit\/hyperactivity disorder in Taiwan","volume":"16","author":"Gau","year":"2006","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"issue":"1","key":"10.1002\/14651858.CD012069.pub2-BIB0135|cit135","doi-asserted-by":"crossref","first-page":"131","DOI":"10.4088\/JCP.v69n0118","article-title":"National survey of adherence, efficacy, and side effects of methylphenidate in children with attention-deficit\/hyperactivity disorder in Taiwan","volume":"69","author":"Gau","year":"2008","journal-title":"Journal of Clinical Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD012069.pub2-BIB0136|cit136","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1089\/cap.2012.0014","article-title":"Cardiovascular measures in children and adolescents with attention-deficit\/hyperactivity disorder who are new users of methylphenidate and atomoxetine","volume":"22","author":"Arcieri","year":"2012","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD012069.pub2-BIB0137|cit137","doi-asserted-by":"publisher","first-page":"S80","DOI":"10.1016\/S0924-977X(13)70090-7","article-title":"Long term therapy with methylphenidate induces modest effects on growth in ADHD children","volume":"23","author":"Balia","year":"2013","journal-title":"European Neuropsychopharmacology"},{"issue":"10","key":"10.1002\/14651858.CD012069.pub2-BIB0138|cit138","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1007\/s00228-011-1050-3","article-title":"One-year prospective follow-up of pharmacological treatment in children with attention-deficit\/hyperactivity disorder","volume":"67","author":"Didoni","year":"2011","journal-title":"European Journal of Clinical Pharmacology"},{"issue":"7","key":"10.1002\/14651858.CD012069.pub2-BIB0139|cit139","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1089\/cap.2012.0086","article-title":"Attention-deficit\/hyperactivity disorder drugs and growth: an Italian prospective observational study","volume":"23","author":"Germinario","year":"2013","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"issue":"6","key":"10.1002\/14651858.CD012069.pub2-BIB0142|cit140","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1701\/1295.14326","article-title":"ADHD register: post-marketing evaluation of the benefit-risk profile of drugs and promotion of the appropriateness","volume":"104","author":"Panei","year":"2013","journal-title":"Recenti Progressi in Medicina"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0140|cit141","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1097\/FAD.0b013e3283383a63","article-title":"Safety of psychotropic drug prescribed for attention-deficit\/hyperactivity disorder in Italy","volume":"260","author":"Panei","year":"2010","journal-title":"Adverse Drug Reaction Bulletin"},{"issue":"2","key":"10.1002\/14651858.CD012069.pub2-BIB0141|cit142","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1542\/peds.114.2.514","article-title":"Italian attention-deficit\/hyperactivity disorder registry","volume":"114","author":"Panei","year":"2004","journal-title":"Pediatrics"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD012069.pub2-BIB0143|cit143","doi-asserted-by":"publisher","first-page":"S125","DOI":"10.1007\/s00787-011-0181-5","article-title":"The Italian ADHD National Registry: 3 years of active pharmacovigilance in developmental neuropsychiatry","volume":"20","author":"Peddis","year":"2011","journal-title":"European Child and Adolescent Psychiatry"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD012069.pub2-BIB0144|cit144","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.1007\/s00787-010-0117-5","article-title":"Active pharmacovigilance in developmental neuropsychiatry: the Italian ADHD National Registry","volume":"19","author":"Peddis","year":"2010","journal-title":"European Child and Adolescent Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD012069.pub2-BIB0145|cit145","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1089\/cap.2012.0003","article-title":"Safety of attention-deficit\/hyperactivity disorder medications in children: an intensive pharmacosurveillance monitoring study","volume":"22","author":"Ruggiero","year":"2012","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"issue":"2","key":"10.1002\/14651858.CD012069.pub2-BIB0146|cit146","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s12402-009-0010-6","article-title":"Tolerability and effects of OROS\u00ae MPH (Concerta\u00ae) on functioning, severity of disease and quality of life in children and adolescents with ADHD: results from a prospective, non-interventional trial","volume":"1","author":"Gerwe","year":"2009","journal-title":"Attention Deficit and Hyperactivity Disorders"},{"issue":"6","key":"10.1002\/14651858.CD012069.pub2-BIB0147|cit147","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1097\/JCP.0b013e31818ce741","article-title":"Insomnia, night terror, and depression related to clonidine in attention-deficit\/hyperactivity disorder","volume":"28","author":"Ghanizadeh","year":"2008","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"4","key":"10.1002\/14651858.CD012069.pub2-BIB0148|cit148","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.jpurol.2007.10.001","article-title":"Methylphenidate-associated enuresis in attention deficit hyperactivity disorder","volume":"4","author":"Ghanizadeh","year":"2008","journal-title":"Journal of Pediatric Urology"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0150|cit149","unstructured":"Ghanizadeh A Questions regarding 'Insomnia, night terror, and depression related to clonidine in attention-deficit\/hyperactivity disorder' [personal communication] Email to: EL Ramstad"},{"issue":"1","key":"10.1002\/14651858.CD012069.pub2-BIB0149|cit150","first-page":"171","article-title":"Photophobia and methylphenidate","volume":"41","author":"Ghanizadeh","year":"2008","journal-title":"Psychopharmacology Bulletin"},{"issue":"1","key":"10.1002\/14651858.CD012069.pub2-BIB0151|cit151","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1055\/s-0028-1083821","article-title":"Excessive talking triggered by methylphenidate in a boy with ADHD","volume":"42","author":"Ghanizadeh","year":"2009","journal-title":"Pharmacopsychiatry"},{"issue":"11","key":"10.1002\/14651858.CD012069.pub2-BIB0152|cit152","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1007\/s00467-012-2211-z","article-title":"Nortriptyline for treating enuresis in ADHD--a randomized double-blind controlled clinical trial","volume":"27","author":"Ghanizadeh","year":"2012","journal-title":"Pediatric Nephrology"},{"issue":"3","key":"10.1002\/14651858.CD012069.pub2-BIB0153|cit153","first-page":"108","article-title":"Effect of methylphenidate and folic acid on ADHD symptoms and quality of life and aggression: a randomized double blind placebo controlled clinical trial","volume":"8","author":"Ghanizadeh","year":"2013","journal-title":"Iranian Journal of Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD012069.pub2-BIB0154|cit154","first-page":"619","article-title":"Long lasting complex nocturnal hallucinations during Osmotic Release Oral System (OROS) methylphenidate treatment in a 7-year old girl","volume":"32","author":"Goetz","year":"2011","journal-title":"Neuro Endocrinology Letters"},{"issue":"12","key":"10.1002\/14651858.CD012069.pub2-BIB0155|cit155","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1177\/0883073812439101","article-title":"Using the test of variables of attention to determine the effectiveness of modafinil in children with attention-deficit hyperactivity disorder (ADHD): a prospective methylphenidate-controlled trial","volume":"27","author":"Goez","year":"2012","journal-title":"Journal of Child Neurology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD012069.pub2-BIB0156|cit156","doi-asserted-by":"publisher","first-page":"S126","DOI":"10.1016\/S1090-3798(11)70442-1","article-title":"Modafinil vs. methylphenidate for children and adolescents with ADHD","volume":"15","author":"Zelnik","year":"2011","journal-title":"European Journal of Paediatric Neurology"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0157|cit157","first-page":"s 219","article-title":"Suicide attempt in a 12 year old boy after switching 27 mg to 36 mg of OROS methylphenidate","volume":"24","author":"G\u00f6kce","year":"2015","journal-title":"European Child and Adolescent Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD012069.pub2-BIB0158|cit158","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1097\/YIC.0000000000000034","article-title":"The beneficial effect of methylphenidate in ADHD with comorbid separation anxiety","volume":"29","author":"Golubchik","year":"2014","journal-title":"International Clinical Psychopharmacology"},{"issue":"5","key":"10.1002\/14651858.CD012069.pub2-BIB0159|cit159","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1097\/WNF.0b013e31829eb204","article-title":"Attention-deficit\/hyperactivity disorder and comorbid subsyndromal depression: what is the impact of methylphenidate on mood?","volume":"36","author":"Golubchik","year":"2013","journal-title":"Clinical Neuropharmacology"},{"issue":"4","key":"10.1002\/14651858.CD012069.pub2-BIB0161|cit160","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1097\/YIC.0000000000000029","article-title":"Methylphenidate treatment in children with attention deficit hyperactivity disorder and comorbid social phobia","volume":"29","author":"Golubchik","year":"2014","journal-title":"International Clinical Psychopharmacology"},{"issue":"3","key":"10.1002\/14651858.CD012069.pub2-BIB0160|cit161","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1097\/WNF.0b013e31821f4da9","article-title":"Methylphenidate treatment in pediatric patients with attention-deficit\/hyperactivity disorder and comorbid trichotillomania: a preliminary report","volume":"34","author":"Golubchik","year":"2011","journal-title":"Clinical Neuropharmacology"},{"issue":"2","key":"10.1002\/14651858.CD012069.pub2-BIB0162|cit162","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1089\/cap.1999.9.125","article-title":"Atrioventricular nodal re-entrant tachycardia associated with stimulant treatment","volume":"9","author":"Gracious","year":"1999","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"issue":"1","key":"10.1002\/14651858.CD012069.pub2-BIB0163|cit163","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1089\/104454601750143401","article-title":"Retrospective comparison of Adderall and methylphenidate in the treatment of attention deficit hyperactivity disorder","volume":"11","author":"Grcevich","year":"2001","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"issue":"6","key":"10.1002\/14651858.CD012069.pub2-BIB0164|cit164","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1089\/cap.2011.0042","article-title":"The effect of methylphenidate on prefrontal cognitive functioning, inattention, and hyperactivity in velocardiofacial syndrome","volume":"21","author":"Green","year":"2011","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"issue":"Suppl 8","key":"10.1002\/14651858.CD012069.pub2-BIB0165|cit165","first-page":"147 S","article-title":"Effect of methylphenidate on neurocognitive functioning in velocardiofacial syndrome: a randomized placebo-controlled trial","volume":"65","author":"Green","year":"2009","journal-title":"Biological Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD012069.pub2-BIB0166|cit166","first-page":"279","article-title":"An objective measure of methylphenidate response: clinical use of the MCA","volume":"23","author":"Greenberg","year":"1987","journal-title":"Psychopharmacology Bulletin"},{"issue":"2","key":"10.1002\/14651858.CD012069.pub2-BIB0167|cit167","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1093\/sleep\/6.2.91","article-title":"Sleep architecture and REM sleep measures in prepubertal children with attention deficit disorder with hyperactivity","volume":"6","author":"Greenhill","year":"1983","journal-title":"Sleep"},{"issue":"3","key":"10.1002\/14651858.CD012069.pub2-BIB0168|cit168","first-page":"302","article-title":"Methylphenidate and idiopathic thrombocytopenic purpura--is there an association?","volume":"20","author":"Grossman","year":"1985","journal-title":"Journal of Family Practice"},{"issue":"4","key":"10.1002\/14651858.CD012069.pub2-BIB0169|cit169","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1212\/01.WNL.0000134656.93147.F1","article-title":"Hallucinations during methylphenidate therapy","volume":"63","author":"Gross-Tsur","year":"2004","journal-title":"Neurology"},{"issue":"2","key":"10.1002\/14651858.CD012069.pub2-BIB0170|cit170","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1542\/peds.114.2.514","article-title":"Italian attention-deficit\/hyperactivity disorder registry","volume":"114","author":"Panei","year":"2004","journal-title":"Pediatrics"},{"issue":"2","key":"10.1002\/14651858.CD012069.pub2-BIB0171|cit171","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1177\/08830738030180020601","article-title":"Use of methylphenidate for attention-deficit hyperactivity disorder in patients with epilepsy or electroencephalographic abnormalities","volume":"18","author":"Gucuyener","year":"2003","journal-title":"Journal of Child Neurology"},{"issue":"1","key":"10.1002\/14651858.CD012069.pub2-BIB0172|cit172","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1590\/S0004-282X1996000100004","article-title":"Attention deficit disorder: treatment with methylphenidate","volume":"54","author":"Guerreiro","year":"1996","journal-title":"Arquivos de Neuro-Psiquiatria"},{"issue":"2","key":"10.1002\/14651858.CD012069.pub2-BIB0173|cit173","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s12402-014-0154-x","article-title":"Effectiveness and safety of a long-acting, once-daily, two-phase release formulation of methylphenidate (Ritalin\u00ae LA) in school children under daily practice conditions","volume":"7","author":"Haertling","year":"2015","journal-title":"Attention Deficit and Hyperactivity Disorders"},{"issue":"8","key":"10.1002\/14651858.CD012069.pub2-BIB0174|cit174","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1177\/0883073808331357","article-title":"Methylphenidate induction of complex visual hallucinations","volume":"24","author":"Halevy","year":"2009","journal-title":"Journal of Child Neurology"},{"issue":"8","key":"10.1002\/14651858.CD012069.pub2-BIB0176|cit175","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/cpu.20097","article-title":"Effects of high-dose OROS methylphenidate","volume":"11","year":"2009","journal-title":"Brown University Child and Adolescent Psychopharmacology Update"},{"issue":"1","key":"10.1002\/14651858.CD012069.pub2-BIB0175|cit176","doi-asserted-by":"publisher","first-page":"A3","DOI":"10.1016\/j.jpeds.2009.05.023","article-title":"Cardiovascular effects of methylphenidate","volume":"155","author":"Daniels","year":"2009","journal-title":"Journal of Pediatrics"},{"issue":"5","key":"10.1002\/14651858.CD012069.pub2-BIB0177|cit177","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1089\/cap.2008.0126","article-title":"An open study of adjunct OROS-methylphenidate in children who are atomoxetine partial responders: II. Tolerability and pharmacokinetics","volume":"19","author":"Hammerness","year":"2009","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0178|cit178","doi-asserted-by":"crossref","unstructured":"Hammerness P Biederman J Petty C Henin A Moore CM Brain biochemical effects of methylphenidate treatment using proton magnetic spectroscopy in youth with attention-deficit hyperactivity disorder: a controlled pilot study CNS Neuroscience and Therapeutics 2012 34 40 10.1111\/j.1755-5949.2010.00226.x","DOI":"10.1111\/j.1755-5949.2010.00226.x"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0179|cit179","volume-title":"Attention Deficit Hyperactivity Disorder ADHD - A Retrospective Population-based Analysis Concerning the Treatment of Children and Adolescents with Stimulant Medication in a Child and Adolescent Psychiatry Practice [PhD thesis]","author":"Haubold","year":"2009"},{"issue":"8","key":"10.1002\/14651858.CD012069.pub2-BIB0180|cit180","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1097\/01.CHI.0000046908.27264.00","article-title":"A randomized controlled trial of clonidine added to psychostimulant medication for hyperactive and aggressive children","volume":"42","author":"Hazell","year":"2003","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD012069.pub2-BIB0181|cit181","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1503\/jpn.110020","article-title":"Treatment of ADHD in patients unresponsive to methylphenidate","volume":"36","author":"Hechtman","year":"2011","journal-title":"Journal of Psychiatry and Neuroscience"},{"issue":"2","key":"10.1002\/14651858.CD012069.pub2-BIB0182|cit182","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0887-8994(00)00240-X","article-title":"Stimulant therapy and seizure risk in children with ADHD","volume":"24","author":"Hemmer","year":"2001","journal-title":"Pediatric Neurology"},{"issue":"4","key":"10.1002\/14651858.CD012069.pub2-BIB0183|cit183","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.pediatrneurol.2007.05.017","article-title":"Acute dyskinesia on starting methylphenidate after risperidone withdrawal","volume":"37","author":"Hollis","year":"2007","journal-title":"Pediatric Neurology"},{"issue":"1","key":"10.1002\/14651858.CD012069.pub2-BIB0184|cit184","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1089\/10445460252943579","article-title":"Methylphenidate-related growth impairment","volume":"12","author":"Holtkamp","year":"2002","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0185|cit185","doi-asserted-by":"crossref","unstructured":"Hong SB Kim JW Cho SC Shin MS Kim BN Yoo HJ Dopaminergic and noradrenergic gene polymorphisms and response to methylphenidate in Korean children with attention-deficit\/Hyperactivity disorder: is there an interaction? Journal of Child and Adolescent Psychopharmacology 2012 343 52 10.1089\/cap.2011.0076","DOI":"10.1089\/cap.2011.0076"},{"issue":"1S","key":"10.1002\/14651858.CD012069.pub2-BIB0186|cit186","first-page":"444S","article-title":"Methylphenidate treatment of chronic irritability: symptom improvement and underlying neural mechanisms","volume":"77","author":"Hulvershorn","year":"2015","journal-title":"Biological Psychiatry"},{"issue":"8","key":"10.1002\/14651858.CD012069.pub2-BIB0187|cit187","first-page":"193S","article-title":"The impact of methylphenidate on corticolimbic functional connectivity in children with ADHD and chronic irritability","volume":"71","author":"Hulvershorn","year":"2012","journal-title":"Biological Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD012069.pub2-BIB0188|cit188","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1007\/BF02850007","article-title":"Acute effect of methylphenidate on QT interval duration and dispersion in children with attention deficit hyperactivity disorder","volume":"24","author":"Ilgenli","year":"2007","journal-title":"Advances in Therapy"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD012069.pub2-BIB0189|cit189","first-page":"226","article-title":"Treatment choice in association of attention deficit-hyperactivity disorder with Williams and Moebius Syndromes: case reports","volume":"24","author":"Irmak","year":"2014","journal-title":"Klinik Psikofarmakoloji B\u00fclteni [Bulletin of Clinical Psychopharmacology]"},{"issue":"1","key":"10.1002\/14651858.CD012069.pub2-BIB0190|cit190","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1358\/mf.2007.29.1.1063491","article-title":"Effects of methylphenidate on leptin and appetite in children with attention-deficit hyperactivity disorder: an open label trial","volume":"29","author":"I\u015feri","year":"2007","journal-title":"Methods and Findings in Experimental and Clinical Pharmacology"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0191|cit191","doi-asserted-by":"crossref","unstructured":"Jafarinia M Mohammadi MR Modabbernia A Ashrafi M Khajavi D Tabrizi M Bupropion versus methylphenidate in the treatment of children with attention-deficit\/hyperactivity disorder: randomized double-blind study Human Psychopharmacology 2012 411 8 10.1002\/hup.2242","DOI":"10.1002\/hup.2242"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0192|cit192","doi-asserted-by":"crossref","unstructured":"Abikoff H Tailored psychosocial treatments for ADHD: the search for a good fit Journal of Clinical Child Psychology 2001 122 5 10.1207\/S15374424JCCP3001_14","DOI":"10.1207\/S15374424JCCP3001_14"},{"issue":"9","key":"10.1002\/14651858.CD012069.pub2-BIB0193|cit193","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1001\/archpsyc.1997.01830210113015","article-title":"National Institute of Mental Health Collaborative Multimodal Treatment Study of Children with ADHD (the MTA). Design challenges and choices","volume":"54","author":"Arnold","year":"1997","journal-title":"Archives of General Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD012069.pub2-BIB0194|cit194","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1177\/108705479700200301","article-title":"NIMH collaborative multimodal treatment study of children with ADHD (MTA): design, methodology, and protocol evolution","volume":"2","author":"Arnold","year":"1997","journal-title":"Journal of Attention Disorders"},{"issue":"1","key":"10.1002\/14651858.CD012069.pub2-BIB0195|cit195","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1023\/B:JACP.0000007579.61289.31","article-title":"Nine months of multicomponent behavioral treatment for ADHD and effectiveness of MTA fading procedures","volume":"32","author":"Arnold","year":"2004","journal-title":"Journal of Abnormal Child Psychology"},{"issue":"4","key":"10.1002\/14651858.CD012069.pub2-BIB0196|cit196","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1037\/0022-006X.71.4.713","article-title":"Effects of ethnicity on treatment attendance, stimulant response\/dose, and 14-month outcome in ADHD","volume":"71","author":"Arnold","year":"2003","journal-title":"Journal of Consulting and Clinical Psychology"},{"issue":"4","key":"10.1002\/14651858.CD012069.pub2-BIB0197|cit197","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1542\/peds.105.4.863","article-title":"What the multimodal treatment study of children with attention deficit\/hyperactivity disorder did and did not say about the use of methylphenidate for attention deficits","volume":"105","author":"Carey","year":"2000","journal-title":"Pediatrics"},{"issue":"2","key":"10.1002\/14651858.CD012069.pub2-BIB0198|cit198","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1097\/00004583-200102000-00010","article-title":"Multimodal treatment of ADHD in the MTA: an alternative outcome analysis","volume":"40","author":"Conners","year":"2001","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD012069.pub2-BIB0199|cit199","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1089\/104454603322163844","article-title":"Response to methylphenidate in children with attention deficit hyperactivity disorder and manic symptoms in the multimodal treatment study of children with attention deficit hyperactivity disorder titration trial","volume":"13","author":"Galanter","year":"2003","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"issue":"1","key":"10.1002\/14651858.CD012069.pub2-BIB0200|cit200","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1207\/S15374424JCCP3001_13","article-title":"What does the MTA study tell us about effective psychosocial treatment for ADHD?","volume":"30","author":"Greene","year":"2001","journal-title":"Journal of Clinical Child Psychology"},{"issue":"10","key":"10.1002\/14651858.CD012069.pub2-BIB0201|cit201","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1097\/00004583-199610000-00017","article-title":"Medication treatment strategies in the MTA Study: relevance to clinicians and researchers","volume":"35","author":"Greenhill","year":"1996","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD012069.pub2-BIB0202|cit202","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1097\/00004583-200102000-00012","article-title":"Impairment and deportment responses to different methylphenidate doses in children with ADHD: the MTA titration trial","volume":"40","author":"Greenhill","year":"2001","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"issue":"48","key":"10.1002\/14651858.CD012069.pub2-BIB0203|cit203","first-page":"4555","article-title":"How to treat ADHD\/DAMP? Is there a conclusive answer? A critical survey of the MTA trial?","volume":"167","author":"Hansen","year":"2005","journal-title":"Ugeskr Laeger"},{"issue":"12","key":"10.1002\/14651858.CD012069.pub2-BIB0205|cit204","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1001\/archpsyc.56.12.1088","article-title":"Moderators and mediators of treatment response for children with attention-deficit\/hyperactivity disorder: the Multimodal Treatment Study of children with attention-deficit\/hyperactivity disorder","volume":"56","author":"Hinshaw","year":"1999","journal-title":"Archives of General Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD012069.pub2-BIB0204|cit205","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1177\/108705479700100403","article-title":"Comprehensive assessment of childhood Attention-Deficit Hyperactivity Disorder in the context of a multisite, multimodal clinical trial","volume":"1","author":"Hinshaw","year":"1997","journal-title":"Journal of Attention Disorders"},{"issue":"8","key":"10.1002\/14651858.CD012069.pub2-BIB0206|cit206","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1097\/CHI.0b013e3180686d48","article-title":"3-year follow-up of the NIMH MTA study","volume":"46","author":"Jensen","year":"2007","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0207|cit207","doi-asserted-by":"crossref","unstructured":"Jensen PS Hinshaw SP Kraemer HC Leonora N Newcorn JH Abikoff HB ADHD comorbidity findings from the MTA study: comparing comorbid subgroups Journal of the American Academy of Child and Adolescent Psychiatry 2001 147 58 10.1097\/00004583-200102000-00009","DOI":"10.1097\/00004583-200102000-00009"},{"issue":"1","key":"10.1002\/14651858.CD012069.pub2-BIB0208|cit208","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/00004703-200102000-00008","article-title":"Findings from the NIMH Multimodal Treatment Study of ADHD (MTA): implications and applications for primary care providers","volume":"22","author":"Jensen","year":"2001","journal-title":"Journal of Developmental and Behavioral Pediatrics"},{"issue":"12","key":"10.1002\/14651858.CD012069.pub2-BIB0209|cit209","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1001\/archpsyc.56.12.1073","article-title":"A 14-month randomized clinical trial of treatment strategies for attention-deficit\/hyperactivity disorder","volume":"56","author":"MTA Cooperative Group","year":"1999","journal-title":"Archives of General Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD012069.pub2-BIB0210|cit210","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1542\/peds.113.4.754","article-title":"National Institute of Mental Health multimodal treatment study of ADHD follow-up: 24-month outcomes of treatment strategies for attention-deficit\/hyperactivity disorder","volume":"113","author":"MTA Cooperative Group","year":"2004","journal-title":"Pediatrics"},{"issue":"4","key":"10.1002\/14651858.CD012069.pub2-BIB0211|cit211","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1542\/peds.113.4.762","article-title":"National Institute of Mental Health multimodal treatment study of ADHD follow-up: changes in effectiveness and growth after the end of treatment","volume":"113","author":"MTA Cooperative Group","year":"2004","journal-title":"Pediatrics"},{"issue":"6","key":"10.1002\/14651858.CD012069.pub2-BIB0212|cit212","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1023\/A:1005179014321","article-title":"Anxiety as a predictor and outcome variable in the multimodal treatment study of children with ADHD (MTA)","volume":"28","author":"March","year":"2000","journal-title":"Journal of Abnormal Child Psychology"},{"issue":"8","key":"10.1002\/14651858.CD012069.pub2-BIB0213|cit213","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1097\/chi.0b013e3180686d96","article-title":"Delinquent behavior and emerging substance use in the MTA at 36 months: prevalence, course, and treatment effects","volume":"46","author":"Molina","year":"2007","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD012069.pub2-BIB0214|cit214","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.jaac.2012.12.014","article-title":"Adolescent substance use in the multimodal treatment study of attention-deficit\/hyperactivity disorder (ADHD) (MTA) as a function of childhood ADHD, random assignment to childhood treatments, and subsequent medication","volume":"52","author":"Molina","year":"2013","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD012069.pub2-BIB0215|cit215","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1097\/CHI.0b013e31819c23d0","article-title":"The MTA at 8 years: prospective follow-up of children treated for combined-type ADHD in a multisite study","volume":"48","author":"Molina","year":"2009","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD012069.pub2-BIB0216|cit216","first-page":"245","article-title":"Does ADHD medication stop working after 2-3 years? On the surprising, but little known follow-up of the MTA study","volume":"52","author":"Nieweg","year":"2010","journal-title":"Tijdschrift voor Psychiatrie"},{"issue":"3","key":"10.1002\/14651858.CD012069.pub2-BIB0217|cit217","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1037\/0022-006X.71.3.540","article-title":"Which treatment for whom for ADHD? Moderators of treatment response in the MTA","volume":"71","author":"Owens","year":"2003","journal-title":"Journal of Consulting and Clinical Psychology"},{"issue":"10","key":"10.1002\/14651858.CD012069.pub2-BIB0218|cit218","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1177\/070674379904401004","article-title":"The NIMH multimodal treatment study for attention-deficit hyperactivity disorder: just say yes to drugs alone?","volume":"44","author":"Pelham","year":"1999","journal-title":"Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie"},{"issue":"6","key":"10.1002\/14651858.CD012069.pub2-BIB0219|cit219","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1023\/A:1005127030251","article-title":"Behavioral versus behavioral and pharmacological treatment in ADHD children attending a summer treatment program","volume":"28","author":"Pelham","year":"2000","journal-title":"Journal of Abnormal Child Psychology"},{"issue":"8","key":"10.1002\/14651858.CD012069.pub2-BIB0220|cit220","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1097\/00004583-199508000-00008","article-title":"NIMH collaborative multisite multimodal treatment study of children with ADHD: I. Background and rationale","volume":"34","author":"Richters","year":"1995","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD012069.pub2-BIB0221|cit221","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1177\/1087054708319525","article-title":"Evidence, interpretation, and qualification from multiple reports of long-term outcomes in the Multimodal Treatment Study of children with ADHD (MTA): Part II: supporting details","volume":"12","author":"Swanson","year":"2008","journal-title":"Journal of Attention Disorders"},{"issue":"1","key":"10.1002\/14651858.CD012069.pub2-BIB0222|cit222","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1177\/1087054708319345","article-title":"Evidence, interpretation, and qualification from multiple reports of long-term outcomes in the Multimodal Treatment study of Children With ADHD (MTA): part I: executive summary","volume":"12","author":"Swanson","year":"2008","journal-title":"Journal of Attention Disorders"},{"issue":"8","key":"10.1002\/14651858.CD012069.pub2-BIB0223|cit223","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1097\/chi.0b013e3180686d7e","article-title":"Effects of stimulant medication on growth rates across 3 years in the MTA follow-up","volume":"46","author":"Swanson","year":"2007","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"issue":"8","key":"10.1002\/14651858.CD012069.pub2-BIB0224|cit224","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1097\/CHI.0b013e3180686d63","article-title":"Secondary evaluations of MTA 36-month outcomes: propensity score and growth mixture model analyses","volume":"46","author":"Swanson","year":"2007","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD012069.pub2-BIB0225|cit225","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1097\/00004583-200102000-00011","article-title":"Clinical relevance of the primary findings of the MTA: success rates based on severity of ADHD and ODD symptoms at the end of treatment","volume":"40","author":"Swanson","year":"2001","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0226|cit226","doi-asserted-by":"crossref","unstructured":"Vitiello B Elliott GR Swanson JM Arnold LE Hechtman L Abikoff H Blood pressure and heart rate over 10 years in the multimodal treatment study of children with ADHD American Journal of Psychiatry 2012 167 77 10.1176\/appi.ajp.2011.10111705","DOI":"10.1176\/appi.ajp.2011.10111705"},{"issue":"2","key":"10.1002\/14651858.CD012069.pub2-BIB0227|cit227","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1097\/00004583-200102000-00013","article-title":"Methylphenidate dosage for children with ADHD over time under controlled conditions: lessons from the MTA","volume":"40","author":"Vitiello","year":"2001","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"issue":"10","key":"10.1002\/14651858.CD012069.pub2-BIB0228|cit228","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1089\/cap.2013.0032","article-title":"Methylphenidate side effect profile is influenced by genetic variation in the attention-deficit\/hyperactivity disorder-associated CES1 gene","volume":"23","author":"Johnson","year":"2013","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"issue":"1","key":"10.1002\/14651858.CD012069.pub2-BIB0229|cit229","first-page":"31","article-title":"Multicenter, open-label study to evaluate the effects of methylphenidate-OROS (Concerta\u00ae) on cognitive functions in children with attention deficit hyperactivity disorder","volume":"5","author":"Jung","year":"2007","journal-title":"Clinical Psychopharmacology and Neuroscience"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD012069.pub2-BIB0230|cit230","doi-asserted-by":"publisher","first-page":"S571","DOI":"10.1016\/S0924-977X(07)70890-8","article-title":"Multi-center study for evaluation of efficacy and safety of methylphenidate-OROS in children with ADHD","volume":"17","author":"Lee","year":"2007","journal-title":"European Neuropsychopharmacology"},{"issue":"1","key":"10.1002\/14651858.CD012069.pub2-BIB0231|cit231","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1080\/13651500701435954","article-title":"Can we predict short-term side effects of methylphenidate immediate-release?","volume":"12","author":"Karabekiroglu","year":"2008","journal-title":"International Journal of Psychiatry in Clinical Practice"},{"issue":"9","key":"10.1002\/14651858.CD012069.pub2-BIB0233|cit232","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/cpu.20123","article-title":"Pulmonary arterial hypertension with methylphenidate OROS initiation","volume":"12","year":"2010","journal-title":"Brown University Child & Adolescent Psychopharmacology Update"},{"issue":"3","key":"10.1002\/14651858.CD012069.pub2-BIB0232|cit233","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1089\/cap.2009.0095","article-title":"Pulmonary arterial hypertension in an adolescent treated with methylphenidate","volume":"20","author":"Karaman","year":"2010","journal-title":"Journal of Child & Adolescent Psychopharmacology"},{"issue":"1","key":"10.1002\/14651858.CD012069.pub2-BIB0234|cit234","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s00405-013-2763-y","article-title":"Sudden hearing loss associated with methylphenidate therapy","volume":"271","author":"Karapinar","year":"2014","journal-title":"European Archives of Otorhinolaryngology"},{"issue":"4","key":"10.1002\/14651858.CD012069.pub2-BIB0235|cit235","doi-asserted-by":"publisher","first-page":"399","DOI":"10.5455\/bcp.20150902042021","article-title":"Should we continue methylphenidate treatment despite orofacial or extremity dyskinesias?","volume":"25","author":"Kazanci","year":"2015","journal-title":"Klinik Psikofarmakoloji B\u00fclteni [Bulletin of Clinical Psychopharmacology]"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0236|cit236","doi-asserted-by":"publisher","first-page":"S273","DOI":"10.1017\/S1461145704004547","article-title":"Greater symptom improvement and response rates with OROS\u00ae MPH vs. atomoxetine in children with ADHD","volume":"7","author":"Kemner","year":"2004","journal-title":"International Journal of Neuropsychopharmacology"},{"issue":"5","key":"10.1002\/14651858.CD012069.pub2-BIB0237|cit237","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1007\/BF02849870","article-title":"Outcomes of OROS methylphenidate compared with atomoxetine in children with ADHD: a multicenter, randomized prospective study","volume":"22","author":"Kemner","year":"2005","journal-title":"Advances in Therapy"},{"issue":"10","key":"10.1002\/14651858.CD012069.pub2-BIB0238|cit238","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1592\/phco.24.14.1419.43157","article-title":"Greater improvement and response rates with OROS (R) methylphenidate compared with atomoxetine in children with attention-deficit\/hyperactivity disorder","volume":"24","author":"Kemner","year":"2004","journal-title":"Pharmacotherapy"},{"issue":"10 Suppl","key":"10.1002\/14651858.CD012069.pub2-BIB0239|cit239","first-page":"11S","article-title":"Multicenter, randomized, open-label study of OROS methylphenidate versus atomoxetine: treatment outcomes in African-American children with ADHD","volume":"97","author":"Starr","year":"2005","journal-title":"Journal of the National Medical Association"},{"issue":"4","key":"10.1002\/14651858.CD012069.pub2-BIB0240|cit240","doi-asserted-by":"publisher","first-page":"130","DOI":"10.4103\/2279-042X.145389","article-title":"Adverse reactions of Methylphenidate in children with attention deficit-hyperactivity disorder: report from a referral center","volume":"3","author":"Khajehpiri","year":"2014","journal-title":"Journal of Research in Pharmacy Practice"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0241|cit241","unstructured":"Khodadust N Jalali A-H Ahmadzad-Asl M Khademolreza N Shirazi E Comparison of two brands of methylphenidate (Stimdate\u00ae vs. Ritalin\u00ae) in children and adolescents with attention deficit hyperactivity disorder: a double-blind, randomized clinical trial Iranian Journal of Psychiatry and Behavioral Sciences 2012 26 32"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD012069.pub2-BIB0242|cit242","doi-asserted-by":"crossref","first-page":"S624","DOI":"10.1016\/S0924-977X(10)70957-3","article-title":"The effect of prolonged-release methylphenidate on the sleep of children with attention-deficit\/hyperactivity disorders","volume":"20","author":"Chung","year":"2010","journal-title":"European Neuropsychopharmacology"},{"issue":"2","key":"10.1002\/14651858.CD012069.pub2-BIB0243|cit243","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1097\/YIC.0b013e3283364411","article-title":"The effect of OROS methylphenidate on the sleep of children with attention-deficit\/hyperactivity disorder","volume":"25","author":"Kim","year":"2010","journal-title":"International Clinical Psychopharmacology"},{"issue":"1","key":"10.1002\/14651858.CD012069.pub2-BIB0244|cit244","doi-asserted-by":"publisher","first-page":"29","DOI":"10.9758\/cpn.2011.9.1.29","article-title":"Switching from Methylphenidate-Immediate Release (MPH-IR) to Methylphenidate-OROS (OROS-MPH): a multi-center, open-label study in Korea","volume":"9","author":"Kim","year":"2011","journal-title":"Clinical Psychopharmacology and Neuroscience"},{"issue":"8","key":"10.1002\/14651858.CD012069.pub2-BIB0245|cit245","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1089\/cap.2014.0025","article-title":"Effect of methylphenidate on height and weight in Korean children and adolescents with attention-deficit\/hyperactivity disorder: a retrospective chart review","volume":"24","author":"Kim","year":"2014","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"issue":"7","key":"10.1002\/14651858.CD012069.pub2-BIB0246|cit246","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1111\/pcn.12155","article-title":"Parental quality of life and depressive mood following methylphenidate treatment of children with attention-deficit hyperactivity disorder","volume":"68","author":"Kim","year":"2014","journal-title":"Psychiatry and Clinical Neurosciences"},{"issue":"5","key":"10.1002\/14651858.CD012069.pub2-BIB0247|cit247","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.3349\/ymj.2015.56.5.1365","article-title":"Changes of heart rate variability during methylphenidate treatment in attention-deficit hyperactivity disorder children: a 12-week prospective study","volume":"56","author":"Kim","year":"2015","journal-title":"Yonsei Medical Journal"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0248|cit248","doi-asserted-by":"crossref","unstructured":"Kim E Cheon KA Joung YS Kim JY Song DH The relationship between symptomatic and functional changes of Korean children and adolescents with attention-deficit\/hyperactivity disorder treated with osmotic-controlled release oral delivery system-methylphenidate Clinical Neuropharmacology 2015 30 5 10.1097\/WNF.0000000000000064","DOI":"10.1097\/WNF.0000000000000064"},{"issue":"7","key":"10.1002\/14651858.CD012069.pub2-BIB0249|cit249","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1097\/01.chi.0000128796.84202.eb","article-title":"Academic achievement and emotional status of children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment","volume":"43","author":"Hechtman","year":"2004","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"issue":"7","key":"10.1002\/14651858.CD012069.pub2-BIB0250|cit250","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1097\/01.chi.0000128798.91601.fe","article-title":"Design and rationale of controlled study of long-term methylphenidate and multimodal psychosocial treatment in children with ADHD","volume":"43","author":"Klein","year":"2004","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD012069.pub2-BIB0251|cit251","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3810\/pgm.2011.09.2457","article-title":"Exploring the impact of once-daily OROS\u00ae methylphenidate (MPH) on symptoms and quality of life in children and adolescents with ADHD transitioning from immediate-release MPH","volume":"123","author":"Kordon","year":"2011","journal-title":"Postgraduate Medicine"},{"issue":"7","key":"10.1002\/14651858.CD012069.pub2-BIB0252|cit252","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1097\/00004583-200207000-00008","article-title":"Atomoxetine and methylphenidate treatment in children with ADHD: a prospective, randomized, open-label trial","volume":"41","author":"Kratochvil","year":"2002","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0253|cit253","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1471-244X-13-11","article-title":"Comorbidities in ADHD children treated with methylphenidate: a database study","volume":"13","author":"Kraut","year":"2013","journal-title":"BMC Psychiatry"},{"issue":"7","key":"10.1002\/14651858.CD012069.pub2-BIB0254|cit254","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1177\/088307380001500702","article-title":"Bone mineral density and turnover in children with attention-deficit hyperactivity disorder receiving methylphenidate","volume":"15","author":"Lahat","year":"2000","journal-title":"Journal of Child Neurology"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0255|cit255","doi-asserted-by":"crossref","unstructured":"Lakic A Kesic A Dronjak D Tics in children with attention-deficit\/hyperactivity disorder under treatment with the sustained-release form of methylphenidate European Neuropsychopharmacology 2012 S420 10.1016\/S0924-977X(12)70658-2","DOI":"10.1016\/S0924-977X(12)70658-2"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0256|cit256","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.2147\/NDT.S79866","article-title":"Evaluation of acute cardiovascular effects of immediate-release methylphenidate in children and adolescents with attention-deficit hyperactivity disorder","volume":"11","author":"Lamberti","year":"2015","journal-title":"Neuropsychiatric Disease and Treatment"},{"issue":"1","key":"10.1002\/14651858.CD012069.pub2-BIB0257|cit257","first-page":"53","article-title":"Attention deficit hyperactivity disorder (ADHD) in children, seasonal photoperiods, nocturnal movements and diurnal agitation","volume":"21","author":"Langevin","year":"2012","journal-title":"Journal of the Canadian Academy of Child and Adolescent Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD012069.pub2-BIB0258|cit258","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.jaapos.2015.04.005","article-title":"The effects of methylphenidate on refraction and anterior segment parameters in children with attention deficit hyperactivity disorder","volume":"19","author":"Larra\u00f1aga-Fragoso","year":"2015","journal-title":"Journal of AAPOS"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0259|cit259","doi-asserted-by":"crossref","unstructured":"Lee SI Hong SD Kim S Efficacy and tolerability of OROS methylphenidate in Korean children with AD\/HD - Reply Progress in Neuro-Psychopharmacology and Biological Psychiatry 2007 1151 2 10.1016\/j.pnpbp.2007.03.019","DOI":"10.1016\/j.pnpbp.2007.03.019"},{"issue":"1","key":"10.1002\/14651858.CD012069.pub2-BIB0260|cit260","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.pnpbp.2006.09.002","article-title":"Efficacy and tolerability of OROS methylphenidate in Korean children with attention-deficit\/hyperactivity disorder","volume":"31","author":"Lee","year":"2007","journal-title":"Progress in Neuro-Psychopharmacology and Biological Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD012069.pub2-BIB0261|cit261","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/j.pnpbp.2007.03.018","article-title":"Comments on efficacy and tolerability of OROS methylphenidate in Korean children with attention-deficit\/hyperactivity disorder","volume":"31","author":"Pae","year":"2007","journal-title":"Progress in Neuro-Psychopharmacology and Biological Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD012069.pub2-BIB0262|cit262","doi-asserted-by":"publisher","first-page":"650","DOI":"10.3349\/ymj.2009.50.5.650","article-title":"Variability of response time as a predictor of methylphenidate treatment response in Korean children with attention deficit hyperactivity disorder","volume":"50","author":"Lee","year":"2009","journal-title":"Yonsei Medical Journal"},{"issue":"4","key":"10.1002\/14651858.CD012069.pub2-BIB0263|cit263","doi-asserted-by":"publisher","first-page":"384","DOI":"10.4306\/pi.2012.9.4.384","article-title":"Effect of methylphenidate on sleep parameters in children with ADHD","volume":"9","author":"Lee","year":"2012","journal-title":"Psychiatry Investigation"},{"issue":"9","key":"10.1002\/14651858.CD012069.pub2-BIB0264|cit264","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1002\/phar.1455","article-title":"Drugs associated with adverse events in children and adolescents","volume":"34","author":"Lee","year":"2014","journal-title":"Pharmacotherapy"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0265|cit265","doi-asserted-by":"crossref","unstructured":"Lewis H Lewis J Safe and effective methylphenidate therapy in a pediatric patient with glaucoma ADHD Attention Deficit and Hyperactivity Disorders 2012 37 9 10.1007\/s12402-012-0071-9","DOI":"10.1007\/s12402-012-0071-9"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0266|cit266","doi-asserted-by":"crossref","unstructured":"Li JJ Li ZW Wang SZ Qi FH Zhao L Lv H Ningdong granule: a complementary and alternative therapy in the treatment of attention deficit\/hyperactivity disorder Psychopharmacology 2011 501 9 10.1007\/s00213-011-2238-z","DOI":"10.1007\/s00213-011-2238-z"},{"issue":"11","key":"10.1002\/14651858.CD012069.pub2-BIB0267|cit267","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/cpu.20127","article-title":"Dexmethylphenidate in youth with ADHD and Tourette's","volume":"12","year":"2010","journal-title":"Brown University Child and Adolescent Psychopharmacology Update"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD012069.pub2-BIB0268|cit268","first-page":"292","article-title":"Improving TIC-related response inhibition: comparing the effects of dexmethylphenidate to placebo in children and adolescents with ADHD and chronic TIC disorders","volume":"11","author":"Lyon","year":"2008","journal-title":"International Journal of Neuropsychopharmacology"},{"issue":"6","key":"10.1002\/14651858.CD012069.pub2-BIB0269|cit269","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1089\/cap.2010.2064","article-title":"Improving tic-related response inhibition: comparing the effects of dexmethylphenidate to no medication in children and adolescents with Attention Deficit Hyperactivity Disorder (ADHD) and chronic tic disorders","volume":"20","author":"Lyon","year":"2010","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"issue":"4","key":"10.1002\/14651858.CD012069.pub2-BIB0270|cit270","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1089\/cap.2010.0032","article-title":"Testing tic suppression: comparing the effects of dexmethylphenidate to no medication in children and adolescents with attention-deficit\/hyperactivity disorder and Tourette's disorder","volume":"20","author":"Lyon","year":"2010","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"issue":"7","key":"10.1002\/14651858.CD012069.pub2-BIB0272|cit271","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/cpu.20095","article-title":"Methylphenidate for preschool ADHD","volume":"11","year":"2009","journal-title":"Brown University Child and Adolescent Psychopharmacology Update"},{"issue":"2","key":"10.1002\/14651858.CD012069.pub2-BIB0271|cit272","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1089\/cap.2008.053","article-title":"The open-label treatment of attention-deficit\/hyperactivity disorder in 4- and 5-year-old children with beaded methylphenidate","volume":"19","author":"Maayan","year":"2009","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"issue":"5","key":"10.1002\/14651858.CD012069.pub2-BIB0273|cit273","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1089\/cap.2005.15.729","article-title":"A pilot study of methylphenidate preference assessment in children diagnosed with attention-deficit\/hyperactivity disorder","volume":"15","author":"MacDonald Fredericks","year":"2005","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"issue":"3","key":"10.1002\/14651858.CD012069.pub2-BIB0274|cit274","doi-asserted-by":"publisher","first-page":"352.e20","DOI":"10.1176\/jnp.2010.22.3.352.e20","article-title":"Is methylphenidate-induced chorea responsive to chlorpromazine?","volume":"22","author":"Machado","year":"2010","journal-title":"Journal of Neuropsychiatry and Clinical Neurosciences"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0276|cit275","volume-title":"Evalution of the Exchange of Immediate Release Methylphenidate for Prolonged Release Methylphenidate in Attention Deficit\/Hyperactivity Disorder [Availa\u00e7\u00e3o da troca do metilfenidato de libera\u00e7\u00e3o imediata para o metilfenidato de libera\u00e7\u00e3o prolongada no tra","author":"Maia","year":"2009"},{"issue":"3","key":"10.1002\/14651858.CD012069.pub2-BIB0275|cit276","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s00787-007-0647-7","article-title":"Switching from methylphenidate immediate release to MPH-SODAS in attention-deficit\/hyperactivity disorder","volume":"17","author":"Maia","year":"2008","journal-title":"European Child and Adolescent Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD012069.pub2-BIB0277|cit277","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1542\/peds.2014-1738","article-title":"Methylphenidate and the risk of trauma","volume":"135","author":"Man","year":"2015","journal-title":"Pediatrics"},{"issue":"12","key":"10.1002\/14651858.CD012069.pub2-BIB0278|cit278","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1111\/j.1469-8749.1994.tb11811.x","article-title":"Methylphenidate and ADHD: influence of age, IQ and neurodevelopmental status","volume":"36","author":"Mayes","year":"1994","journal-title":"Developmental Medicine and Child Neurology"},{"issue":"11","key":"10.1002\/14651858.CD012069.pub2-BIB0279|cit279","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.2165\/11317630-000000000-00000","article-title":"Mortality associated with attention-deficit hyperactivity disorder: a retrospective cohort study of children, adolescents and young adults using the general practice research database","volume":"32","author":"McCarthy","year":"2009","journal-title":"Drug Safety"},{"issue":"8","key":"10.1002\/14651858.CD012069.pub2-BIB0280|cit280","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.jaac.2016.04.020","article-title":"Effects of d-Methylphenidate, Guanfacine, and their combination on electroencephalogram resting state spectral power in Attention-Deficit\/Hyperactivity Disorder","volume":"55","author":"Loo","year":"2016","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"issue":"8","key":"10.1002\/14651858.CD012069.pub2-BIB0281|cit281","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.jaac.2016.05.015","article-title":"Combined stimulant and Guanfacine administration in Attention-Deficit\/Hyperactivity Disorder: a controlled, comparative study","volume":"55","author":"McCracken","year":"2016","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD012069.pub2-BIB0282|cit282","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1097\/JCP.0b013e3181c92eb2","article-title":"Aripiprazole induced acute dystonia after discontinuation of a stimulant medication","volume":"30","author":"McLaren","year":"2010","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"1","key":"10.1002\/14651858.CD012069.pub2-BIB0283|cit283","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1055\/s-0035-1557417","article-title":"Efficacy and tolerability of ADHD medications in a clinical practice","volume":"6","author":"Miller-Horn","year":"2008","journal-title":"Journal of Pediatric Neurology"},{"issue":"2","key":"10.1002\/14651858.CD012069.pub2-BIB0284|cit284","doi-asserted-by":"publisher","first-page":"81","DOI":"10.11482\/KMJ25(2)81-85.1999.pdf","article-title":"Methylphenidate-induced psychosis in an adolescent with hyperkinetic disorder","volume":"25","author":"Mino","year":"1999","journal-title":"Kawasaki Medical Journal"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0285|cit285","unstructured":"Mino Y Ohara H Nagamatsu I Nagamatsu K Methylphenidate psychosis in an adolescent with attention deficit disorder Japanese Journal of Child and Adolescent Psychiatry 1986 178 87"},{"issue":"3","key":"10.1002\/14651858.CD012069.pub2-BIB0286|cit286","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1300\/J184v0803_06","article-title":"Hemoencephalography - a new therapy for attention deficit hyperactivity disorder (ADHD): case report","volume":"8","author":"Mize","year":"2004","journal-title":"Journal of Neurotherapy"},{"issue":"2","key":"10.1002\/14651858.CD012069.pub2-BIB0287|cit287","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/j.1365-2710.2004.00545.x","article-title":"Efficacy of theophylline compared to methylphenidate for the treatment of attention-deficit hyperactivity disorder in children and adolescents: a pilot double-blind randomized trial","volume":"29","author":"Mohammadi","year":"2004","journal-title":"Journal of Clinical Pharmacy and Therapeutics"},{"issue":"1","key":"10.1002\/14651858.CD012069.pub2-BIB0288|cit288","first-page":"31","article-title":"Comparison of Stimdate with Ritalin in children and adolescents with attention deficit hyperactivity disorder","volume":"4","author":"Mohammadi","year":"2009","journal-title":"Iranian Journal of Psychiatry"},{"issue":"7-8","key":"10.1002\/14651858.CD012069.pub2-BIB0289|cit289","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1002\/hup.1154","article-title":"Amantadine versus methylphenidate in children and adolescents with attention deficit\/hyperactivity disorder: a randomized, double-blind trial","volume":"25","author":"Mohammadi","year":"2010","journal-title":"Human Psychopharmacology"},{"issue":"2","key":"10.1002\/14651858.CD012069.pub2-BIB0290|cit290","first-page":"87","article-title":"Melatonin effects in methylphenidate treated children with attention deficit hyperactivity disorder: a randomized double blind clinical trial","volume":"7","author":"Mohammadi","year":"2012","journal-title":"Iranian Journal of Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD012069.pub2-BIB0291|cit291","first-page":"114","article-title":"Dietary intake, growth and development of children with ADHD in a randomized clinical trial of Ritalin and Melatonin co-administration: through circadian cycle modification or appetite enhancement?","volume":"7","author":"Mostafavi","year":"2012","journal-title":"Iranian Journal of Psychiatry"},{"issue":"11","key":"10.1002\/14651858.CD012069.pub2-BIB0292|cit292","first-page":"723","article-title":"Buspirone versus methylphenidate in the treatment of children with attention- deficit\/ hyperactivity disorder: randomized double-blind study","volume":"50","author":"Mohammadi","year":"2012","journal-title":"Acta Medica Iranica"},{"issue":"1","key":"10.1002\/14651858.CD012069.pub2-BIB0293|cit293","first-page":"50","article-title":"Extended release methylphenidate (medikinet\u00ae) twice a day, a prospective open trial","volume":"29","author":"Monta\u00f1\u00e9s Rada","year":"2012","journal-title":"Revista de Psiquiatria Infanto-Juvenil"},{"issue":"3","key":"10.1002\/14651858.CD012069.pub2-BIB0294|cit294","first-page":"201","article-title":"A pilot study of methylphenidate and parent training in the treatment of children with attention deficit hyperactivity disorder","volume":"35","author":"Montiel-Nava","year":"2002","journal-title":"Revista de Neurologia"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD012069.pub2-BIB0295|cit295","first-page":"S158","article-title":"Long-term effects of short-acting methylphenidate on growth rates of children with attention deficit hyperactivity disorder at Queen Sirikit National Institute of Child Health","volume":"94","author":"Moungnoi","year":"2011","journal-title":"Journal of the Medical Association of Thailand"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0296|cit296","doi-asserted-by":"publisher","first-page":"905097","DOI":"10.1155\/2015\/905097","article-title":"Cardiac arrest following a myocardial infarction in a child treated with methylphenidate","volume":"2015","author":"Munk","year":"2015","journal-title":"Case Reports in Pediatrics"},{"issue":"1","key":"10.1002\/14651858.CD012069.pub2-BIB0297|cit297","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1089\/cap.2012.0018","article-title":"Two different solicitation methods for obtaining information on adverse events associated with methylphenidate in adolescents: a 12-week multicenter, open-label study","volume":"23","author":"Lee","year":"2013","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"issue":"4","key":"10.1002\/14651858.CD012069.pub2-BIB0298|cit298","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1097\/YIC.0b013e3283612509","article-title":"Effect of osmotic-release oral system methylphenidate on learning skills in adolescents with attention-deficit\/hyperactivity disorder: an open-label study","volume":"28","author":"Na","year":"2013","journal-title":"International Clinical Psychopharmacology"},{"issue":"3","key":"10.1002\/14651858.CD012069.pub2-BIB0299|cit299","first-page":"330","article-title":"Atomoxetine may improve methylphenidates' efficacy in treatment of ADHD?","volume":"21","author":"Niederhofer","year":"2009","journal-title":"Psychiatria Danubina"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0300|cit300","unstructured":"Niederhofer H Questions regarding your study 'Combining carbamazepine, neuroleptics and acetylcholinesterase inhibitors with methylphenidate only reduces adverse side effects, but is less effective than a combination with atomoxetine' [personal communication] Email to: HB Krogh"},{"issue":"5","key":"10.1002\/14651858.CD012069.pub2-BIB0301|cit301","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.mehy.2011.02.011","article-title":"Combining carbamazepine, neuroleptics and acetylcholinesterase inhibitors with methylphenidate only reduces adverse side effects, but is less effective than a combination with atomoxetine","volume":"76","author":"Niederhofer","year":"2011","journal-title":"Medical Hypotheses"},{"issue":"2","key":"10.1002\/14651858.CD012069.pub2-BIB0302|cit302","doi-asserted-by":"publisher","first-page":"525","DOI":"10.2147\/VHRM.S5108","article-title":"A commentary on \"A young man with acute dilated cardiomyopathy associated with methylphenidate\"","volume":"5","author":"Ghanizadeh","year":"2009","journal-title":"Vascular Health and Risk Management"},{"issue":"2","key":"10.1002\/14651858.CD012069.pub2-BIB0303|cit303","doi-asserted-by":"crossref","first-page":"477","DOI":"10.2147\/VHRM.S2410","article-title":"A young man with acute dilated cardiomyopathy associated with methylphenidate","volume":"4","author":"Nymark","year":"2008","journal-title":"Vascular Health and Risk Management"},{"issue":"3","key":"10.1002\/14651858.CD012069.pub2-BIB0304|cit304","first-page":"117","article-title":"The effect of methylphenidate on time domain heart rate variability in the treatment of attention deficit and hyperactivity disorder","volume":"11","author":"\u00d6zcan","year":"2004","journal-title":"Turkish Journal of Child and Adolescent Mental Health"},{"issue":"3","key":"10.1002\/14651858.CD012069.pub2-BIB0305|cit305","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1177\/0269881113480989","article-title":"Neurotrophin 3 genotype and emotional adverse effects of osmotic-release oral system methylphenidate (OROS-MPH) in children with attention-deficit\/hyperactivity disorder","volume":"28","author":"Park","year":"2014","journal-title":"Journal of Psychopharmacology"},{"issue":"2","key":"10.1002\/14651858.CD012069.pub2-BIB0306|cit306","doi-asserted-by":"publisher","first-page":"51","DOI":"10.4038\/sljpsyc.v1i2.2575","article-title":"Assessment of outcome of an ADHD treatment program using parent feedback","volume":"1","author":"Perera","year":"2010","journal-title":"Sri Lanka Journal of Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD012069.pub2-BIB0307|cit307","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1177\/1087054712452135","article-title":"Do ADHD children with and without child behavior checklist-dysregulation profile have different clinical characteristics, cognitive features, and treatment outcomes?","volume":"19","author":"Peyre","year":"2012","journal-title":"Journal of Attention Disorders"},{"issue":"5","key":"10.1002\/14651858.CD012069.pub2-BIB0308|cit308","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1097\/JCP.0b013e3181f0c2f6","article-title":"Single- and multiple-dose pharmacokinetics of methylphenidate administered as methylphenidate transdermal system or osmotic-release oral system methylphenidate to children and adolescents with attention deficit hyperactivity disorder","volume":"30","author":"Pierce","year":"2010","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"2","key":"10.1002\/14651858.CD012069.pub2-BIB0309|cit309","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1001\/archpsyc.64.2.218","article-title":"Association of the adrenergic alpha2A receptor gene with methylphenidate improvement of inattentive symptoms in children and adolescents with attention-deficit\/hyperactivity disorder","volume":"64","author":"Polanczyk","year":"2007","journal-title":"Archives of General Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD012069.pub2-BIB0310|cit310","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1055\/s-0031-1275738","article-title":"Methylphenidate-induced visual hallucinations","volume":"42","author":"Porfirio","year":"2011","journal-title":"Neuropediatrics"},{"issue":"3","key":"10.1002\/14651858.CD012069.pub2-BIB0311|cit311","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1046\/j.1440-1754.2003.00107.x","article-title":"Slowing of growth in height and weight on stimulants: a characteristic pattern","volume":"39","author":"Poulton","year":"2003","journal-title":"Journal of Paediatrics and Child Health"},{"issue":"1","key":"10.1002\/14651858.CD012069.pub2-BIB0312|cit312","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/1687-9856-2012-30","article-title":"Weight loss on stimulant medication: how does it affect body composition and bone metabolism? - A prospective longitudinal study","volume":"2012","author":"Poulton","year":"2012","journal-title":"International Journal of Pediatric Endocrinology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD012069.pub2-BIB0313|cit313","doi-asserted-by":"publisher","first-page":"A4.A5","DOI":"10.1136\/archdischild-2014-306237.10","article-title":"Stimulant medication affects growth but not bone age","volume":"99","author":"Poulton","year":"2014","journal-title":"Archives of Disease in Childhood"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD012069.pub2-BIB0314|cit314","doi-asserted-by":"publisher","first-page":"A70","DOI":"10.1136\/archdischild-2014-306237.167","article-title":"Differential effects of dexamphetamine and methylphenidate on symptoms of inattention-overactivity, oppositional-defiant and weight","volume":"99","author":"Poulton","year":"2014","journal-title":"Archives of Disease in Childhood"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0315|cit315","doi-asserted-by":"publisher","first-page":"207","DOI":"10.12688\/f1000research.5163.1","article-title":"Case report: testicular failure possibly associated with chronic use of methylphenidate","volume":"3","author":"Ramasamy","year":"2014","journal-title":"F1000Research"},{"issue":"1","key":"10.1002\/14651858.CD012069.pub2-BIB0316|cit316","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1089\/104454604773840418","article-title":"Psychopharmacology in the school setting: therapeutic challenges in an adolescent with attention deficit hyperactivity disorder, possible bipolar disorder, and other comorbidity","volume":"14","author":"Rappaport","year":"2004","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"issue":"4","key":"10.1002\/14651858.CD012069.pub2-BIB0317|cit317","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1177\/01454455960204004","article-title":"Methylphenidate and attentional training. Comparative effects on behavior and neurocognitive performance in twin girls with attention-deficit\/hyperactivity disorder","volume":"20","author":"Rapport","year":"1996","journal-title":"Behavior Modification"},{"issue":"11","key":"10.1002\/14651858.CD012069.pub2-BIB0319|cit318","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/cpu.20055","article-title":"Somatic hallucinations with methylphenidate in a 10-year-old boy","volume":"9","year":"2007","journal-title":"Brown University Child and Adolescent Psychopharmacology Update"},{"issue":"8","key":"10.1002\/14651858.CD012069.pub2-BIB0318|cit319","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1097\/CHI.0b013e318067fd7c","article-title":"Methylphenidate and somatic hallucinations","volume":"46","author":"Rashid","year":"2007","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD012069.pub2-BIB0320|cit320","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s00787-005-0486-3","article-title":"12-month efficacy and safety of OROS MPH in children and adolescents with attention-deficit\/hyperactivity disorder switched from MPH","volume":"14","author":"Hoare","year":"2005","journal-title":"European Child and Adolescent Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD012069.pub2-BIB0321|cit321","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s00787-005-0467-6","article-title":"Symptom control in children and adolescents with attention-deficit\/hyperactivity disorder on switching from immediate-release MPH to OROS\u00ae MPH","volume":"14","author":"Remschmidt","year":"2005","journal-title":"European Child and Adolescent Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD012069.pub2-BIB0322|cit322","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1046\/j.1460-9592.1997.d01-34.x","article-title":"Unexpected interaction of methylphenidate (Ritalin) with anaesthetic agents","volume":"7","author":"Ririe","year":"1997","journal-title":"Paediatric Anaesthesia"},{"issue":"2","key":"10.1002\/14651858.CD012069.pub2-BIB0323|cit323","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1177\/0269881107069466","article-title":"Risperidone-to-methylphenidate switch reaction in children: three cases","volume":"21","author":"Sabuncuoglu","year":"2007","journal-title":"Journal of Psychopharmacology"},{"issue":"5","key":"10.1002\/14651858.CD012069.pub2-BIB0324|cit324","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/cpu.20043","article-title":"Severe adverse events following risperidone-to-methylphenidate switch","volume":"9","author":"Sabuncuoglu","year":"2007","journal-title":"Brown University Child and Adolescent Psychopharmacology Update"},{"issue":"4","key":"10.1002\/14651858.CD012069.pub2-BIB0325|cit325","doi-asserted-by":"publisher","first-page":"280","DOI":"10.3109\/13651501.2014.940054","article-title":"Effect of methylphenidate treatment on appetite and levels of leptin, ghrelin, adiponectin, and brain-derived neurotrophic factor in children and adolescents with attention deficit and hyperactivity disorder","volume":"18","author":"Sahin","year":"2014","journal-title":"International Journal of Psychiatry in Clinical Practice"},{"issue":"1","key":"10.1002\/14651858.CD012069.pub2-BIB0326|cit326","doi-asserted-by":"publisher","first-page":"80","DOI":"10.4067\/S0370-41062004000100014","article-title":"Methylphenidate: arterial hypertension, a side effect to take into account","volume":"75","author":"Saieh","year":"2004","journal-title":"Revista Chilena de Pediatria"},{"issue":"5","key":"10.1002\/14651858.CD012069.pub2-BIB0327|cit327","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s11920-007-0051-5","article-title":"Sleep disturbances and ADHD medications","volume":"9","author":"Rostain","year":"2007","journal-title":"Current Psychiatry Reports"},{"issue":"12","key":"10.1002\/14651858.CD012069.pub2-BIB0328|cit328","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1093\/sleep\/29.12.1573","article-title":"Effects of atomoxetine and methylphenidate on sleep in children with ADHD","volume":"29","author":"Sangal","year":"2006","journal-title":"Sleep"},{"issue":"5","key":"10.1002\/14651858.CD012069.pub2-BIB0329|cit329","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1111\/j.1365-2214.2006.00631.x","article-title":"Impact of comorbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: a retrospective and prospective effectiveness study","volume":"32","author":"Santosh","year":"2006","journal-title":"Child: Care, Health and Development"},{"issue":"4 Pt 1","key":"10.1002\/14651858.CD012069.pub2-BIB0330|cit330","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1542\/peds.98.4.763","article-title":"Predictors of weight loss in children with attention deficit hyperactivity disorder treated with stimulant medication","volume":"98","author":"Schertz","year":"1996","journal-title":"Pediatrics"},{"issue":"4","key":"10.1002\/14651858.CD012069.pub2-BIB0331|cit331","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1024\/1422-4917.30.4.295","article-title":"Waiver of EEG diagnostics prior to and during methylphenidate therapy: dangerous or justifiable?","volume":"30","author":"Schmidt","year":"2002","journal-title":"Zeitschrift fur Kinder- und Jugendpsychiatrie und Psychotherapie"},{"issue":"3","key":"10.1002\/14651858.CD012069.pub2-BIB0332|cit332","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s12402-010-0031-1","article-title":"A randomized, rater-blinded, crossover study comparing the clinical efficacy of Ritalin(\u00ae) LA (methylphenidate) treatment in children with attention-deficit hyperactivity disorder under different breakfast conditions over 2 weeks","volume":"2","author":"Schulz","year":"2010","journal-title":"Attention Deficit and Hyperactivity Disorders"},{"issue":"10","key":"10.1002\/14651858.CD012069.pub2-BIB0333|cit333","first-page":"25","article-title":"Priapism due to withdrawal from sustained-release methylphenidate","volume":"11","author":"Ginsberg","year":"2004","journal-title":"Primary Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD012069.pub2-BIB0334|cit334","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.jpeds.2003.12.039","article-title":"Stuttering priapism associated with withdrawal from sustained-release methylphenidate","volume":"144","author":"Schwartz","year":"2004","journal-title":"Journal of Pediatrics"},{"issue":"7","key":"10.1002\/14651858.CD012069.pub2-BIB0335|cit335","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1089\/cap.2015.0035","article-title":"An open-label, randomized trial of methylphenidate and atomoxetine treatment in children with attention-deficit\/hyperactivity disorder","volume":"25","author":"Shang","year":"2015","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"issue":"1","key":"10.1002\/14651858.CD012069.pub2-BIB0336|cit336","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/j.1475-3588.2008.00490.x","article-title":"Stimulant induced psychosis","volume":"14","author":"Shibib","year":"2009","journal-title":"Child and Adolescent Mental Health"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0337|cit337","doi-asserted-by":"publisher","first-page":"i2550","DOI":"10.1136\/bmj.i2550","article-title":"Cardiovascular safety of methylphenidate among children and young people with attention-deficit\/hyperactivity disorder (ADHD): nationwide self controlled case series study","volume":"353","author":"Shin","year":"2016","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0338|cit338","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.jad.2015.09.015","article-title":"Attention-deficit hyperactivity disorder, its treatment with medication and the probability of developing a depressive disorder: a nationwide population-based study in Taiwan","volume":"189","author":"Lee","year":"2016","journal-title":"Journal of Affective Disorders"},{"issue":"1-2","key":"10.1002\/14651858.CD012069.pub2-BIB0339|cit339","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.schres.2015.08.033","article-title":"Attention-deficit\/hyperactivity disorder, methylphenidate use and the risk of developing schizophrenia spectrum disorders: a nationwide population-based study in Taiwan","volume":"168","author":"Shyu","year":"2015","journal-title":"Schizophrenia Research"},{"issue":"4","key":"10.1002\/14651858.CD012069.pub2-BIB0340|cit340","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1089\/cap.2004.14.555","article-title":"Open-label study of dexmethylphenidate hydrochloride in children and adolescents with attention deficit hyperactivity disorder","volume":"14","author":"Silva","year":"2004","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"issue":"4","key":"10.1002\/14651858.CD012069.pub2-BIB0341|cit341","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1089\/104454602762599835","article-title":"Open label, pilot study of dexmethylphenidate in children with ADHD","volume":"12","author":"Tilker","year":"2002","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"issue":"4","key":"10.1002\/14651858.CD012069.pub2-BIB0342|cit342","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s12402-013-0113-y","article-title":"A non-interventional study of extended-release methylphenidate in the routine treatment of adolescents with ADHD: effectiveness, safety and adherence to treatment","volume":"5","author":"Sobanski","year":"2013","journal-title":"Attention Deficit and Hyperactivity Disorders"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0343|cit343","doi-asserted-by":"crossref","unstructured":"Song DH Choi S Joung YS Ha EH Kim BN Shin YJ Titrating optimal dose of osmotic-controlled release oral delivery (OROS)-methylphenidate and its efficacy and safety in Korean children with ADHD: a multisite open labeled study Psychiatry Investigation 2012 257 62 10.4306\/pi.2012.9.3.257","DOI":"10.4306\/pi.2012.9.3.257"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD012069.pub2-BIB0344|cit344","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1017\/S1461145710000635","article-title":"Titrating optimal dose of OROS-MPH and its efficacy and safety in Korean children with ADHD: multicenter, open labeled study","volume":"13","author":"Song","year":"2010","journal-title":"International Journal of Neuropsychopharmacology"},{"issue":"2","key":"10.1002\/14651858.CD012069.pub2-BIB0345|cit345","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1097\/00004583-199203000-00009","article-title":"Growth deficits in children treated with desipramine: a controlled study","volume":"31","author":"Spencer","year":"1992","journal-title":"Journal of the American Academy of Child & Adolescent Psychiatry"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD012069.pub2-BIB0346|cit346","first-page":"10","article-title":"Effects of treatment on the overall functioning of children with ADHD","volume":"14","author":"Hechtman","year":"2009","journal-title":"Journal of the Canadian Academy of Child and Adolescent Psychiatry"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD012069.pub2-BIB0347|cit347","doi-asserted-by":"publisher","first-page":"S442","DOI":"10.1017\/S1461145704004547","article-title":"The effectiveness of OROS\u00ae methylphenidate (Concerta\u00ae) vs. usual treatment with immediate-release methylphenidate (IR MPH) in children aged 6-12 years with attention deficit hyperactivity disorder (ADHD)","volume":"7","author":"Steele","year":"2004","journal-title":"International Journal of Neuropsychopharmacology"},{"issue":"1","key":"10.1002\/14651858.CD012069.pub2-BIB0348|cit348","first-page":"e50","article-title":"A randomized, controlled effectiveness trial of OROS-methylphenidate compared to usual care with immediate-release methylphenidate in ADHD","volume":"13","author":"Steele","year":"2006","journal-title":"Canadian Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0349|cit349","unstructured":"Steele MM Prinzo R Binder C Effectiveness of Concerta versus twice or thrice daily IR-MPH in children with ADHD 158th Annual Meeting of the American Psychiatric Association; 2005 May 21-26; Atlanta (GA) 2005"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0350|cit350","unstructured":"Steele MM Prinzo R Binder C Long-term effectiveness and safety of Concerta in children with ADHD: a six-month study 158th Annual Meeting of the American Psychiatric Association; 2005 May 21-26; Atlanta (GA) 2005"},{"issue":"3","key":"10.1002\/14651858.CD012069.pub2-BIB0351|cit351","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1177\/002221940203500308","article-title":"Sleep disturbances in adolescents with symptoms of attention-deficit\/hyperactivity disorder","volume":"35","author":"Stein","year":"2002","journal-title":"Journal of Learning Disabilities"},{"issue":"1","key":"10.1002\/14651858.CD012069.pub2-BIB0352|cit352","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1089\/cap.2008.0128","article-title":"Plasma methylphenidate concentration in youths treated with high-dose osmotic release oral system formulation","volume":"20","author":"Stevens","year":"2010","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"issue":"10","key":"10.1002\/14651858.CD012069.pub2-BIB0353|cit353","doi-asserted-by":"publisher","first-page":"919","DOI":"10.2165\/00002018-200730100-00105","article-title":"Reports of suicide related behaviour with methylphenidate and atomoxetine in children and adolescents","volume":"30","author":"Strandell","year":"2007","journal-title":"Drug Safety"},{"issue":"5","key":"10.1002\/14651858.CD012069.pub2-BIB0354|cit354","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1097\/JCP.0000000000000389","article-title":"Remission rate and functional outcomes during a 6-month treatment with Osmotic-Release Oral-System methylphenidate in children with attention-deficit\/hyperactivity disorder","volume":"35","author":"Su","year":"2015","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD012069.pub2-BIB0355|cit355","doi-asserted-by":"publisher","first-page":"S236","DOI":"10.1016\/S0022-510X(09)70898-6","article-title":"Improvement of cognitive function in attention deficit hyperactivity disorder (ADHD) treatment by methylphenidate (MPH) of elementary school students at Bantul District, Yogyakarta Special Regency","volume":"285","author":"Sudarmadji","year":"2009","journal-title":"Journal of the Neurological Sciences"},{"issue":"3","key":"10.1002\/14651858.CD012069.pub2-BIB0356|cit356","doi-asserted-by":"publisher","first-page":"PCC.09l00870","DOI":"10.4088\/PCC.09l00870pur","article-title":"Osmotic release oral system (OROS) methylphenidate-induced double incontinence: a case report","volume":"12","author":"Tang","year":"2010","journal-title":"Primary Care Companion to the Journal of Clinical Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD012069.pub2-BIB0357|cit357","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1089\/cap.2014.0155","article-title":"Effects of atomoxetine and osmotic release oral system-methylphenidate on executive functions in patients with combined type attention-deficit\/hyperactivity disorder","volume":"25","author":"Tasdelen","year":"2015","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"issue":"2","key":"10.1002\/14651858.CD012069.pub2-BIB0358|cit358","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1097\/JCP.0000000000000266","article-title":"Acute focal dystonic reaction after acute methylphenidate treatment in an adolescent patient","volume":"35","author":"Tekin","year":"2015","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"5","key":"10.1002\/14651858.CD012069.pub2-BIB0359|cit359","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1177\/1087054708320430","article-title":"Children's self-reports on perceived effects on taking stimulant medication for ADHD","volume":"12","author":"Thorell","year":"2009","journal-title":"Journal of Attention Disorders"},{"issue":"3","key":"10.1002\/14651858.CD012069.pub2-BIB0360|cit360","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.anpedi.2009.10.013","article-title":"Visual hallucinations caused by methylphenidate","volume":"72","author":"Tom\u00e1s Vila","year":"2010","journal-title":"Anales de Pediatria"},{"issue":"2","key":"10.1002\/14651858.CD012069.pub2-BIB0361|cit361","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.anpedi.2010.05.013","article-title":"Methylphenidate and sleep: results of a multicentre study on a population of children with attention deficit hyperactivity disorder","volume":"73","author":"Tom\u00e1s Vila","year":"2010","journal-title":"Anales de Pediatria"},{"issue":"8585","key":"10.1002\/14651858.CD012069.pub2-BIB0362|cit362","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/S0140-6736(88)91372-4","article-title":"Cerebral arteritis and oral methylphenidate","volume":"1","author":"Trugman","year":"1988","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0363|cit363","doi-asserted-by":"crossref","unstructured":"Tzang RF Wang YC Yeh CB Hsu CD Liang HY Yang PC Naturalistic exploration of the effect of osmotic release oral system-methylphenidate on remission rate and functional improvement in Taiwanese children with attention-deficit-hyperactivity disorder Psychiatry and Clinical Neurosciences 2012 53 63 10.1111\/j.1440-1819.2011.02289.x","DOI":"10.1111\/j.1440-1819.2011.02289.x"},{"issue":"10","key":"10.1002\/14651858.CD012069.pub2-BIB0364|cit364","first-page":"1338","article-title":"A young man with acute dilated cardiomyopathy","volume":"126","author":"T\u00f8ll\u00f8fsrud","year":"2006","journal-title":"Tidsskrift for Den Norske Laegeforening"},{"issue":"3","key":"10.1002\/14651858.CD012069.pub2-BIB0365|cit365","first-page":"181","article-title":"Diagnostic and therapeutic electroclinical correlation with immediate action methylphenidate in ADHD","volume":"60","author":"Valdizan Uson","year":"2004","journal-title":"Revista Espanola de Pediatria"},{"issue":"3","key":"10.1002\/14651858.CD012069.pub2-BIB0367|cit366","first-page":"67","article-title":"Methylphenidate in children and adolescents with attention-deficit\/ hyperactivity disorder: The DIHANA Study","volume":"71","author":"Valdiz\u00e1n Uson","year":"2013","journal-title":"Acta Pediatrica Espanola"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0366|cit367","doi-asserted-by":"publisher","first-page":"211","DOI":"10.2147\/NDT.S35836","article-title":"Response to methylphenidate by adult and pediatric patients with attention-deficit\/hyperactivity disorder: the Spanish multicenter DIHANA study","volume":"9","author":"Valdiz\u00e1n Uson","year":"2013","journal-title":"Neuropsychiatric Disease and Treatment"},{"issue":"1","key":"10.1002\/14651858.CD012069.pub2-BIB0368|cit368","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1007\/s00787-006-0574-z","article-title":"Does brief, clinically based, intensive multimodal behavior therapy enhance the effects of methylphenidate in children with ADHD?","volume":"16","author":"Oord","year":"2007","journal-title":"European Child and Adolescent Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD012069.pub2-BIB0369|cit369","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1053\/comp.2001.23145","article-title":"Emergence of tics in children with attention deficit hyperactivity disorder treated with stimulant medications","volume":"42","author":"Varley","year":"2001","journal-title":"Comprehensive Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD012069.pub2-BIB0370|cit370","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/j.1600-0536.2011.01949.x","article-title":"Allergic contact dermatitis caused by methylphenidate","volume":"65","author":"Vashi","year":"2011","journal-title":"Contact Dermatitis"},{"issue":"4","key":"10.1002\/14651858.CD012069.pub2-BIB0371|cit371","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1123\/apaq.27.4.337","article-title":"Fitness level and gross motor performance of children with attention-deficit hyperactivity disorder","volume":"27","author":"Verret","year":"2010","journal-title":"Adapted Physical Activity Quarterly"},{"issue":"4","key":"10.1002\/14651858.CD012069.pub2-BIB0372|cit372","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1176\/ajp.147.4.501","article-title":"Effects of methylphenidate on early adolescent growth","volume":"147","author":"Vincent","year":"1990","journal-title":"American Journal of Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD012069.pub2-BIB0373|cit373","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1289\/ehp.9866","article-title":"Does methylphenidate cause a cytogenetic effect in children with attention deficit hyperactivity disorder?","volume":"115","author":"Walitza","year":"2007","journal-title":"Environmental Health Perspectives"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0374|cit374","first-page":"290","article-title":"Does methylphenidate cause a cytogenetic effect in children with attention deficit hyperactivity disorder?","volume":"11","author":"Stopper","year":"2008","journal-title":"International Journal of Neuropsychopharmacology"},{"issue":"1","key":"10.1002\/14651858.CD012069.pub2-BIB0375|cit375","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.toxlet.2008.10.011","article-title":"No elevated genomic damage in children and adolescents with attention deficit\/hyperactivity disorder after methylphenidate therapy","volume":"184","author":"Walitza","year":"2009","journal-title":"Toxicology Letters"},{"issue":"3","key":"10.1002\/14651858.CD012069.pub2-BIB0376|cit376","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1080\/00048670601057767","article-title":"Atomoxetine versus methylphenidate in paediatric outpatients with attention deficit hyperactivity disorder: a randomized, double-blind comparison trial","volume":"41","author":"Wang","year":"2007","journal-title":"Australian and New Zealand Journal of Psychiatry"},{"issue":"8","key":"10.1002\/14651858.CD012069.pub2-BIB0377|cit377","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1016\/j.psyneuen.2011.02.014","article-title":"Association of salivary dehydroepiandrosterone levels and symptoms in patients with attention deficit hyperactivity disorder during six months of treatment with methylphenidate","volume":"36","author":"Wang","year":"2011","journal-title":"Psychoneuroendocrinology"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0378|cit378","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/1471-244X-11-65","article-title":"Clinical symptoms and performance on the Continuous Performance Test in children with attention deficit hyperactivity disorder between subtypes: a natural follow-up study for 6 months","volume":"11","author":"Wang","year":"2011","journal-title":"BMC Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD012069.pub2-BIB0379|cit379","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3109\/15622975.2010.512090","article-title":"Salivary dehydroepiandrosterone, but not cortisol, is associated with attention deficit hyperactivity disorder","volume":"12","author":"Wang","year":"2011","journal-title":"World Journal of Biological Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD012069.pub2-BIB0380|cit380","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1089\/cap.2013.0122","article-title":"Salivary neurosteroid levels and behavioural profiles of children with attention-deficit\/hyperactivity disorder during six months of methylphenidate treatment","volume":"24","author":"Wang","year":"2014","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"issue":"6","key":"10.1002\/14651858.CD012069.pub2-BIB0381|cit381","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.4088\/PCC.10m00996pur","article-title":"Methylphenidate transdermal system: a multisite, open-label study of dermal reactions in pediatric patients diagnosed with ADHD","volume":"12","author":"Warshaw","year":"2010","journal-title":"Primary Care Companion to the Journal of Clinical Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD012069.pub2-BIB0382|cit382","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s00112-002-0590-0","article-title":"Side effects of methylphenidate in children. Prevalence and associated factors","volume":"151","author":"Weber","year":"2003","journal-title":"Monatsschrift Kinderheilkunde"},{"issue":"5","key":"10.1002\/14651858.CD012069.pub2-BIB0383|cit383","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1089\/cap.2006.0101","article-title":"Once-daily multilayer-release methylphenidate in a double-blind, crossover comparison to immediate-release methylphenidate in children with attention-deficit\/hyperactivity disorder","volume":"17","author":"Weiss","year":"2007","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"issue":"3","key":"10.1002\/14651858.CD012069.pub2-BIB0384|cit384","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1089\/cap.2010.0083","article-title":"Pharmacokinetics and therapeutic effect of OROS methylphenidate under different breakfast conditions in children with attention-deficit\/hyperactivity disorder","volume":"21","author":"Wigal","year":"2011","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"issue":"3","key":"10.1002\/14651858.CD012069.pub2-BIB0385|cit385","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/cpu.20183\/epdf","article-title":"Liquid version of methylphenidate shows efficacy in school trial","volume":"15","year":"2013","journal-title":"Brown University Child and Adolescent Psychopharmacology Update"},{"issue":"1","key":"10.1002\/14651858.CD012069.pub2-BIB0386|cit386","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1089\/cap.2012.0073","article-title":"NWP06, an extended-release oral suspension of methylphenidate, improved attention-deficit\/hyperactivity disorder symptoms compared with placebo in a laboratory classroom study","volume":"23","author":"Wigal","year":"2013","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"issue":"4","key":"10.1002\/14651858.CD012069.pub2-BIB0387|cit387","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s40263-015-0241-3","article-title":"Efficacy of methylphenidate hydrochloride extended-release capsules (Aptensio XRTM) in children and adolescents with attention-deficit\/hyperactivity disorder: a phase III, randomized, double-blind study","volume":"29","author":"Wigal","year":"2015","journal-title":"CNS Drugs"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0388|cit388","doi-asserted-by":"crossref","unstructured":"Wiguna T Guerrero AP Wibisono S Sastroasmoro S Effect of 12-week administration of 20-mg long-acting methylphenidate on Glu\/Cr, NAA\/Cr, Cho\/Cr, and mI\/Cr ratios in the prefrontal cortices of school-age children in Indonesia: a study using 1H Magnetic Resonance Spectroscopy (MRS) Clinical Neuropharmacology 2012 81 5 10.1097\/WNF.0b013e3182452572","DOI":"10.1097\/WNF.0b013e3182452572"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD012069.pub2-BIB0389|cit389","doi-asserted-by":"crossref","first-page":"S447","DOI":"10.1016\/S0924-977X(03)92350-9","article-title":"Evaluation of once-daily OROS methylphenidate in children with attention-deficit\/hyperactivity disorder: effects on sleep, appetite, and tics","volume":"13","author":"Biederman","year":"2003","journal-title":"European Neuropsychopharmacology"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD012069.pub2-BIB0390|cit390","first-page":"S448","article-title":"Treatment of attention-deficit\/hyperactivity disorder with the once-daily OROS formulation of methylphenidate: effect on growth in children","volume":"13","author":"Biederman","year":"2003","journal-title":"European Neuropsychopharmacology"},{"issue":"2","key":"10.1002\/14651858.CD012069.pub2-BIB0391|cit391","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1177\/1087054706295663","article-title":"An analysis of patient adherence to treatment during a 1-year, open-label study of OROS methylphenidate in children with ADHD","volume":"11","author":"Faraone","year":"2007","journal-title":"Journal of Attention Disorders"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0392|cit392","unstructured":"Lerner MA Spencer T Analysis of growth in children with ADHD during long-term therapy with once-daily OROS\u00ae methylphenidate Pediatric Academic Societies' Annual Meeting; 2004 May 1-4; San Francisco (CA) 2004"},{"issue":"Suppl 7","key":"10.1002\/14651858.CD012069.pub2-BIB0393|cit393","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.1002\/ana.5049\/epdf","article-title":"Once-daily OROS methylphenidate: Impact on tics in children with attention deficit hyperactivity disorder","volume":"54","author":"Palumbo","year":"2003","journal-title":"Annals of Neurology"},{"issue":"5","key":"10.1002\/14651858.CD012069.pub2-BIB0394|cit394","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1097\/01.chi.0000205710.01690.d4","article-title":"Does prolonged therapy with a long-acting stimulant suppress growth in children with ADHD?","volume":"45","author":"Spencer","year":"2006","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD012069.pub2-BIB0395|cit395","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1097\/chi.0b013e31802ed960","article-title":"Effect of long-term treatment with stimulant medication on growth? Drs. Spencer et al. Reply","volume":"46","author":"Spencer","year":"2007","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD012069.pub2-BIB0396|cit396","doi-asserted-by":"publisher","first-page":"e120","DOI":"10.1542\/peds.2006-1402","article-title":"Hematologic and blood biochemistry monitoring during methylphenidate treatment in children with attention-deficit\/hyperactivity disorder: 2-year, open-label study results","volume":"120","author":"Wigal","year":"2007","journal-title":"Pediatrics"},{"issue":"1","key":"10.1002\/14651858.CD012069.pub2-BIB0397|cit397","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1097\/01.jcp.0000106223.36344.df","article-title":"Effects of once-daily osmotic-release methylphenidate on blood pressure and heart rate in children with attention-deficit\/hyperactivity disorder: results from a one-year follow-up study","volume":"24","author":"Wilens","year":"2004","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"10","key":"10.1002\/14651858.CD012069.pub2-BIB0398|cit398","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1097\/01.chi.0000173291.28688.e7","article-title":"ADHD treatment with once-daily OROS methylphenidate: final results from a long-term open-label study","volume":"44","author":"Wilens","year":"2005","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD012069.pub2-BIB0399|cit399","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1097\/00004583-200605000-00020","article-title":"ADHD treatment with once-daily OROS methylphenidate: final results from a long-term open-label study: erratum","volume":"45","author":"Wilens","year":"2006","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD012069.pub2-BIB0400|cit400","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1097\/01.CHI.0000046814.95464.7D","article-title":"ADHD treatment with once-daily OROS methylphenidate: interim 12-month results from a long-term open-label study","volume":"42","author":"Wilens","year":"2003","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD012069.pub2-BIB0405|cit401","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/cpu.20015","article-title":"Oral system methylphenidate for teen ADHD","volume":"8","year":"2006","journal-title":"Brown University Child and Adolescent Psychopharmacology Update"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD012069.pub2-BIB0401|cit402","first-page":"S448","article-title":"Effectiveness and safety of the once-daily OROS formulation of methylphenidate in adolescents with attention-deficit\/hyperactivity disorder","volume":"13","author":"Biederman","year":"2003","journal-title":"European Neuropsychopharmacology"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0402|cit403","unstructured":"Greenhill LL Safety and efficacy of OROS MPH in adolescents with ADHD 156th Annual Meeting of the American Psychiatric Association; 2003 May 17-22; San Francisco (CA) 2003"},{"issue":"3","key":"10.1002\/14651858.CD012069.pub2-BIB0403|cit404","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1089\/cap.2006.16.351","article-title":"Once-daily OROS methylphenidate is safe and well tolerated in adolescents with attention-deficit\/hyperactivity disorder","volume":"16","author":"McGough","year":"2006","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"issue":"3","key":"10.1002\/14651858.CD012069.pub2-BIB0404|cit405","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1089\/cap.2009.0102","article-title":"Dose-response characteristics in adolescents with attention-deficit\/hyperactivity disorder treated with OROS methylphenidate in a 4-week, open-label, dose-titration study","volume":"20","author":"Newcorn","year":"2010","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"issue":"1","key":"10.1002\/14651858.CD012069.pub2-BIB0406|cit406","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1001\/archpedi.160.1.82","article-title":"Multisite controlled study of OROS methylphenidate in the treatment of adolescents with attention-deficit\/hyperactivity disorder","volume":"160","author":"Wilens","year":"2006","journal-title":"Archives of Pediatrics and Adolescent Medicine"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD012069.pub2-BIB0407|cit407","doi-asserted-by":"publisher","first-page":"S562","DOI":"10.1016\/S0924-977X(08)70856-3","article-title":"Quality of life and parent satisfaction with the methylphenidate transdermal system","volume":"18","author":"L\u00f3pez","year":"2008","journal-title":"European Neuropsychopharmacology"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD012069.pub2-BIB0408|cit408","doi-asserted-by":"publisher","first-page":"S561","DOI":"10.1016\/S0924-977X(08)70855-1","article-title":"Effects of variable wear times on transdermal methylphenidate in attention-deficit\/hyperactivity disorder","volume":"18","author":"L\u00f3pez","year":"2008","journal-title":"European Neuropsychopharmacology"},{"issue":"12","key":"10.1002\/14651858.CD012069.pub2-BIB0409|cit409","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1185\/03007990903388797","article-title":"HRQL and medication satisfaction in children with ADHD treated with the methylphenidate transdermal system","volume":"25","author":"Manos","year":"2009","journal-title":"Current Medical Research and Opinion"},{"issue":"6","key":"10.1002\/14651858.CD012069.pub2-BIB0410|cit410","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1097\/CHI.0b013e31816bffdf","article-title":"Varying the wear time of the methylphenidate transdermal system in children with attention-deficit\/hyperactivity disorder","volume":"47","author":"Wilens","year":"2008","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"issue":"10","key":"10.1002\/14651858.CD012069.pub2-BIB0411|cit411","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/j.biopsych.2007.11.022","article-title":"Misinterpreting emotional expressions in attention-deficit\/hyperactivity disorder: evidence for a neural marker and stimulant effects","volume":"63","author":"Williams","year":"2008","journal-title":"Biological Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD012069.pub2-BIB0412|cit412","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/cpu.20141","article-title":"Resolution of enuresis with stimulant treatment of ADHD","volume":"13","year":"2011","journal-title":"Brown University Child and Adolescent Psychopharmacology Update"},{"issue":"1","key":"10.1002\/14651858.CD012069.pub2-BIB0413|cit413","first-page":"53","article-title":"Clinical case rounds in child and adolescent psychiatry: enuresis and ADHD in older children and an adolescent treated with stimulant medication: a case series","volume":"20","author":"Williamson","year":"2011","journal-title":"Journal of the Canadian Academy of Child and Adolescent Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD012069.pub2-BIB0414|cit414","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/BF00449120","article-title":"Methylphenidate oral dose plasma concentrations and behavioral response in children","volume":"76","author":"Winsberg","year":"1982","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1002\/14651858.CD012069.pub2-BIB0415|cit415","doi-asserted-by":"publisher","first-page":"e75","DOI":"10.1542\/peds.2008-3138","article-title":"Cardiac safety of methylphenidate versus amphetamine salts in the treatment of ADHD","volume":"124","author":"Winterstein","year":"2009","journal-title":"Pediatrics"},{"issue":"1","key":"10.1002\/14651858.CD012069.pub2-BIB0416|cit416","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1345\/aph.1K143","article-title":"Utilization of pharmacologic treatment in youths with attention deficit\/hyperactivity disorder in Medicaid database","volume":"42","author":"Winterstein","year":"2008","journal-title":"Annals of Pharmacotherapy"},{"issue":"12","key":"10.1002\/14651858.CD012069.pub2-BIB0417|cit417","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1097\/CHI.0b013e3181893620","article-title":"Methylphenidate and amphetamine do not induce cytogenetic damage in lymphocytes of children with ADHD","volume":"47","author":"Witt","year":"2008","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD012069.pub2-BIB0418|cit418","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1176\/appi.ajp.160.1.183","article-title":"Dexamphetamine for obsessive-compulsive disorder","volume":"160","author":"Woolley","year":"2003","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0419|cit419","doi-asserted-by":"crossref","unstructured":"Yalcin O Aslan AA Sari BA Turkbay T Possible methylphenidate related hoarseness and disturbances of voice quality: two pediatric cases Klinik Psikofarmakoloji B\u00fclteni [Bulletin of Clinical Psychopharmacology] 2012 278 82 10.5455\/bcp.20120731061626","DOI":"10.5455\/bcp.20120731061626"},{"issue":"2","key":"10.1002\/14651858.CD012069.pub2-BIB0420|cit420","doi-asserted-by":"publisher","first-page":"146","DOI":"10.5455\/bcp.20130708042604","article-title":"Effects of long acting methylphenidate on ghrelin levels in male children with attention deficit hyperactivity disorder: an open label trial","volume":"24","author":"Yalcin","year":"2014","journal-title":"Klinik Psikofarmakoloji B\u00fclteni [Bulletin of Clinical Psychopharmacology]"},{"issue":"1","key":"10.1002\/14651858.CD012069.pub2-BIB0421|cit421","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1440-1819.2004.01190.x","article-title":"Rapid improvement in academic grades following methylphenidate treatment in attention-deficit hyperactivity disorder","volume":"58","author":"Yang","year":"2004","journal-title":"Psychiatry and Clinical Neurosciences"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0422|cit422","doi-asserted-by":"crossref","unstructured":"Yang L Cao Q Shuai L Li H Chan RC Wang Y Comparative study of OROS-MPH and atomoxetine on executive function improvement in ADHD: a randomized controlled trial International Journal of Neuropsychopharmacology 2012 15 26 10.1017\/S1461145711001490","DOI":"10.1017\/S1461145711001490"},{"issue":"7","key":"10.1002\/14651858.CD012069.pub2-BIB0423|cit423","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.braindev.2013.08.006","article-title":"No association between catechol-O-methyltransferase (COMT) genotype and attention deficit hyperactivity disorder (ADHD) in Japanese children","volume":"36","author":"Yatsuga","year":"2014","journal-title":"Brain and Development"},{"issue":"1","key":"10.1002\/14651858.CD012069.pub2-BIB0424|cit424","first-page":"44","article-title":"Efficiency and tolerability of OROS-methylphenidate in Turkish children and adolescents with attention-deficit\/hyperactivity disorder","volume":"11","author":"Yildiz \u00d6\u00e7","year":"2010","journal-title":"Anadolu Psikiyatri Dergisi"},{"issue":"3","key":"10.1002\/14651858.CD012069.pub2-BIB0425|cit425","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s10578-010-0212-3","article-title":"Atomoxetine and methylphenidate treatment in children with ADHD: the efficacy, tolerability and effects on executive functions","volume":"42","author":"Yildiz","year":"2011","journal-title":"Child Psychiatry and Human Development"},{"issue":"8","key":"10.1002\/14651858.CD012069.pub2-BIB0426|cit426","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/cpu.20169","article-title":"Methylphenidate-induced orofacial and extremity dyskinesia","volume":"14","year":"2012","journal-title":"Brown University Child and Adolescent Psychopharmacology Update"},{"issue":"6","key":"10.1002\/14651858.CD012069.pub2-BIB0427|cit427","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1177\/0883073812449905","article-title":"Methylphenidate-induced acute orofacial and extremity dyskinesia","volume":"28","author":"Yilmaz","year":"2013","journal-title":"Journal of Child Neurology"},{"issue":"2","key":"10.1002\/14651858.CD012069.pub2-BIB0428|cit428","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s11920-010-0093-y","article-title":"Peripheral vasculopathy associated with psychostimulant treatment in children with attention-deficit\/hyperactivity disorder","volume":"12","author":"Yu","year":"2010","journal-title":"Current Psychiatry Reports"},{"issue":"7-8","key":"10.1002\/14651858.CD012069.pub2-BIB0429|cit429","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1002\/hup.1148","article-title":"Venlafaxine versus methylphenidate in pediatric outpatients with attention deficit hyperactivity disorder: a randomized, double-blind comparison trial","volume":"25","author":"Zarinara","year":"2010","journal-title":"Human Psychopharmacology"},{"issue":"4","key":"10.1002\/14651858.CD012069.pub2-BIB0430|cit430","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s12402-015-0168-z","article-title":"The clinical profile of children with ADHD that require OROS-methylphenidate combined with shorter-acting formulations","volume":"7","author":"Zelnik","year":"2015","journal-title":"ADHD Attention Deficit and Hyperactivity Disorders"},{"issue":"3","key":"10.1002\/14651858.CD012069.pub2-BIB0431|cit431","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1002\/ajmg.b.30474","article-title":"No significant association between response to methylphenidate and genes of the dopaminergic and serotonergic systems in a sample of Brazilian children with attention-deficit\/hyperactivity disorder","volume":"144B","author":"Zeni","year":"2007","journal-title":"American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics"},{"issue":"2","key":"10.1002\/14651858.CD012069.pub2-BIB0432|cit432","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1055\/s-0030-1261893","article-title":"Impact of long-term treatment of methylphenidate on height and weight of school age children with ADHD","volume":"41","author":"Zhang","year":"2010","journal-title":"Neuropediatrics"},{"issue":"20","key":"10.1002\/14651858.CD012069.pub2-BIB0433|cit433","first-page":"3269","article-title":"Prospective, naturalistic study of open-label OROS methylphenidate treatment in Chinese school-aged children with attention-deficit\/hyperactivity disorder","volume":"124","author":"Zheng","year":"2011","journal-title":"Chinese Medical Journal"},{"issue":"22","key":"10.1002\/14651858.CD012069.pub2-BIB0434|cit434","doi-asserted-by":"publisher","first-page":"2988","DOI":"10.4103\/0366-6999.168948","article-title":"An open-label, self-control, prospective study on cognitive function, academic performance, and tolerability of osmotic-release oral system methylphenidate in children with attention-deficit hyperactivity disorder","volume":"128","author":"Zheng","year":"2015","journal-title":"Chinese Medical Journal"},{"issue":"6","key":"10.1002\/14651858.CD012069.pub2-BIB0435|cit435","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1016\/j.ridd.2010.06.014","article-title":"A preliminary study on the effect of methylphenidate on motor performance in children with comorbid DCD and ADHD","volume":"31","author":"Bart","year":"2010","journal-title":"Research in Developmental Disabilities"},{"issue":"5","key":"10.1002\/14651858.CD012069.pub2-BIB0436|cit436","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1002\/ab.10066","article-title":"A linear growth curve analysis of inpatient treatment response by conduct-disordered, ADHD, and comorbid preadolescents","volume":"29","author":"Beauchaine","year":"2003","journal-title":"Aggressive Behavior"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD012069.pub2-BIB0437|cit437","doi-asserted-by":"publisher","first-page":"S267","DOI":"10.1007\/s00787-011-0204-2","article-title":"Relationship between quality of life and psychopathological profile: data from an observational study in children with ADHD","volume":"20","author":"Becker","year":"2011","journal-title":"European Child and Adolescent Psychiatry"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0438|cit438","volume-title":"Behavioral Disinhibition, Anxiety, and Response to Methylphenidate and Behavior Management in Children with Attention Deficit Hyperactivity Disorder [PhD thesis]","author":"Beery","year":"1994"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0439|cit439","doi-asserted-by":"publisher","first-page":"47","DOI":"10.2147\/NDT.S52338","article-title":"H-Magnetic resonance spectroscopy study of stimulant medication effect on brain metabolites in French Canadian children with attention deficit hyperactivity disorder","volume":"10","author":"Benamor","year":"2014","journal-title":"Neuropsychiatric Disease and Treatment"},{"issue":"2","key":"10.1002\/14651858.CD012069.pub2-BIB0440|cit440","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1542\/peds.104.2.e20","article-title":"Pharmacotherapy of attention-deficit\/hyperactivity disorder reduces risk for substance use disorder","volume":"104","author":"Biederman","year":"1999","journal-title":"Pediatrics"},{"issue":"1","key":"10.1002\/14651858.CD012069.pub2-BIB0441|cit441","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1542\/peds.2008-3347","article-title":"Do stimulants protect against psychiatric disorders in youth with ADHD? A 10-year follow-up study","volume":"124","author":"Biederman","year":"2009","journal-title":"Pediatrics"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0442|cit442","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.sbspro.2010.07.160","article-title":"Medication in attention deficit hyperactivity disorder and ADHD with Autistic Spectrum Disorder (ASD)","volume":"5","author":"Bohane","year":"2010","journal-title":"Procedia - Social and Behavioral Sciences"},{"issue":"6","key":"10.1002\/14651858.CD012069.pub2-BIB0443|cit443","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.1016\/j.ridd.2012.06.003","article-title":"Motor skills of children newly diagnosed with Attention Deficit Hyperactivity Disorder prior to and following treatment with stimulant medication","volume":"33","author":"Brossard-Racine","year":"2012","journal-title":"Research in Developmental Disabilities"},{"issue":"5","key":"10.1002\/14651858.CD012069.pub2-BIB0444|cit444","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1076\/jcen.20.5.613.1121","article-title":"Clinical assessment of psychopharmacological treatment of preschoolers with ADHD","volume":"20","author":"Byrne","year":"1998","journal-title":"Journal of Clinical and Experimental Neuropsychology"},{"issue":"2","key":"10.1002\/14651858.CD012069.pub2-BIB0445|cit445","first-page":"353","article-title":"Methylphenidate effects on a laboratory aggression measure in children with ADHD","volume":"31","author":"Casat","year":"1995","journal-title":"Psychopharmacology Bulletin"},{"issue":"1","key":"10.1002\/14651858.CD012069.pub2-BIB0446|cit446","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1590\/S0004-282X2007000100028","article-title":"Effects of methylphenidate in auditory processing evaluation of children and adolescents with attention deficit hyperactivity disorder","volume":"65","author":"Cavadas","year":"2007","journal-title":"Arquivos de Neuro-Psiquiatria"},{"issue":"4","key":"10.1002\/14651858.CD012069.pub2-BIB0447|cit447","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1111\/j.1460-9592.2011.03717.x","article-title":"Ingestion of stimulant medications does not alter bispectral index or clinical depth of anesthesia at 1 MAC sevoflurane in children","volume":"22","author":"Chambers","year":"2012","journal-title":"Paediatric Anaesthesia"},{"issue":"6 Pt 1","key":"10.1002\/14651858.CD012069.pub2-BIB0448|cit448","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1542\/peds.103.6.1290","article-title":"Hypoglycemia and propranolol in pediatric behavioral disorders","volume":"103","author":"Chavez","year":"1999","journal-title":"Pediatrics"},{"issue":"4","key":"10.1002\/14651858.CD012069.pub2-BIB0449|cit449","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.ntt.2010.04.031","article-title":"Effects of methylphenidate on motivation in children with attention-deficit\/hyperactivity disorder","volume":"32","author":"Chelonis","year":"2010","journal-title":"Neurotoxicology and Teratology"},{"issue":"2","key":"10.1002\/14651858.CD012069.pub2-BIB0450|cit450","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1037\/a0022794","article-title":"Effect of methylphenidate on motivation in children with attention-deficit\/hyperactivity disorder","volume":"19","author":"Chelonis","year":"2011","journal-title":"Experimental and Clinical Psychopharmacology"},{"issue":"9","key":"10.1002\/14651858.CD012069.pub2-BIB0451|cit451","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/S1388-2457(03)00112-3","article-title":"Effects of stimulant medications on children with attention-deficit\/hyperactivity disorder and excessive beta activity in their EEG","volume":"114","author":"Clarke","year":"2003","journal-title":"Clinical Neurophysiology"},{"issue":"1","key":"10.1002\/14651858.CD012069.pub2-BIB0452|cit452","doi-asserted-by":"publisher","first-page":"56","DOI":"10.3109\/15622975.2013.829584","article-title":"Autonomic hypoactivity in boys with attention-deficit\/hyperactivity disorder and the influence of methylphenidate","volume":"15","author":"Conzelmann","year":"2014","journal-title":"World Journal of Biological Psychiatry"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0454|cit453","unstructured":"Cooper WO E-mail regarding your study 'ADHD drugs and serious cardiovascular events in children and young adults' Email to: M Holmskov"},{"issue":"20","key":"10.1002\/14651858.CD012069.pub2-BIB0453|cit454","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1056\/NEJMoa1110212","article-title":"ADHD drugs and serious cardiovascular events in children and young adults","volume":"365","author":"Cooper","year":"2011","journal-title":"New England Journal of Medicine"},{"issue":"1-3","key":"10.1002\/14651858.CD012069.pub2-BIB0455|cit455","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1007\/s00213-008-1337-y","article-title":"Methylphenidate improves response inhibition but not reflection-impulsivity in children with attention deficit hyperactivity disorder (ADHD)","volume":"202","author":"DeVito","year":"2009","journal-title":"Psychopharmacology"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0456|cit456","doi-asserted-by":"crossref","unstructured":"De Zeeuw P Mandl RC Hulshoff Pol HE van Engeland H Durston S Decreased frontostriatal microstructural organization in attention deficit\/hyperactivity disorder Human Brain Mapping 2012 1941 51 10.1002\/hbm.21335","DOI":"10.1002\/hbm.21335"},{"issue":"4","key":"10.1002\/14651858.CD012069.pub2-BIB0457|cit457","first-page":"302","article-title":"The paradox effect of psychostimulants in the treatment of the child hyperkinetic syndrome","volume":"32","author":"Drt\u00edlkov\u00e1","year":"1990","journal-title":"Activitas Nervosa Superior"},{"issue":"2","key":"10.1002\/14651858.CD012069.pub2-BIB0458|cit458","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1001\/archpediatrics.2009.263","article-title":"Attention-deficit\/hyperactivity disorder outcomes for children treated in community-based pediatric settings","volume":"164","author":"Epstein","year":"2010","journal-title":"Archives of Pediatrics & Adolescent Medicine"},{"issue":"2","key":"10.1002\/14651858.CD012069.pub2-BIB0459|cit459","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1177\/1087054706295663","article-title":"An analysis of patient adherence to treatment during a 1-year, open-label study of OROS methylphenidate in children with ADHD","volume":"11","author":"Faraone","year":"2007","journal-title":"Journal of Attention Disorders"},{"issue":"4","key":"10.1002\/14651858.CD012069.pub2-BIB0460|cit460","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1024\/1422-4917.34.4.295","article-title":"Statement to questionable cardiac risks of application of stimulants","volume":"34","author":"Fegert","year":"2006","journal-title":"Zeitschrift f\u00fcr Kinder- und Jugendpsychiatrie und Psychotherapie"},{"issue":"7","key":"10.1002\/14651858.CD012069.pub2-BIB0461|cit461","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1097\/00004583-199607000-00007","article-title":"ADD and soft signs","volume":"35","author":"Foodman","year":"1996","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD012069.pub2-BIB0462|cit462","first-page":"19","article-title":"Visual event related potentials after methylphenidate and sodium valproate in children with attention deficit hyperactivity disorder","volume":"24","author":"Frank","year":"1993","journal-title":"Clinical EEG"},{"issue":"4","key":"10.1002\/14651858.CD012069.pub2-BIB0463|cit463","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1542\/peds.91.4.816","article-title":"Attention deficit hyperactivity disorder, creativity, and the effects of methylphenidate","volume":"91","author":"Funk","year":"1993","journal-title":"Pediatrics"},{"issue":"6","key":"10.1002\/14651858.CD012069.pub2-BIB0464|cit464","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1097\/DBP.0b013e3181c21c97","article-title":"Executive function in adolescence among children with attention-deficit\/hyperactivity disorder in Taiwan","volume":"30","author":"Gau","year":"2009","journal-title":"Journal of Developmental and Behavioral Pediatrics"},{"issue":"5","key":"10.1002\/14651858.CD012069.pub2-BIB0465|cit465","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1177\/000992280504400504","article-title":"Effects of stimulant medication on cognitive performance of children with ADHD","volume":"44","author":"Gimpel","year":"2005","journal-title":"Clinical Pediatrics"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD012069.pub2-BIB0466|cit466","first-page":"S8","article-title":"Eliciting patient preferences for ADHD treatment using Discrete Choice Experiment in Sweden, Norway and Denmark","volume":"14","author":"Glenng\u00e5rd","year":"2011","journal-title":"Journal of Mental Health Policy and Economics"},{"issue":"5","key":"10.1002\/14651858.CD012069.pub2-BIB0467|cit467","doi-asserted-by":"publisher","first-page":"351","DOI":"10.3109\/08039488.2012.748825","article-title":"Patient preferences and willingness-to-pay for ADHD treatment with stimulants using discrete choice experiment (DCE) in Sweden, Denmark and Norway","volume":"67","author":"Glenng\u00e5rd","year":"2013","journal-title":"Nordic Journal of Psychiatry"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD012069.pub2-BIB0468|cit468","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0924-9338(12)74460-7","article-title":"An additional mid-afternoon dose of immediate release methylphenidate (MPH-IR) with Concerta XL provides better symptom control in children and adolescents with attention deficit\/hyperactivity disorder (ADHD)","volume":"27","author":"Gormez","year":"2012","journal-title":"European Psychiatry"},{"issue":"9","key":"10.1002\/14651858.CD012069.pub2-BIB0469|cit469","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1176\/appi.ajp.2009.09040472","article-title":"Sudden death and use of stimulant medications in youths","volume":"166","author":"Gould","year":"2009","journal-title":"American Journal of Psychiatry"},{"issue":"12","key":"10.1002\/14651858.CD012069.pub2-BIB0470|cit470","doi-asserted-by":"publisher","first-page":"1,1","DOI":"10.1002\/pu.20105","article-title":"Study finds link between stimulants and sudden unexplained death in young people","volume":"20","author":"Gould","year":"2009","journal-title":"Brown University Psychopharmacology Update"},{"issue":"6","key":"10.1002\/14651858.CD012069.pub2-BIB0471|cit471","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1001\/jama.2009.1115","article-title":"Stimulant use linked to sudden death in children without heart problems","volume":"302","author":"Kuehn","year":"2009","journal-title":"JAMA: Journal of the American Medical Association"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0472|cit472","first-page":"46","article-title":"Stimulant therapy: sudden death cases under methylphenidate","volume":"26","author":"Uhl","year":"2009","journal-title":"Deutsche Apotheker Zeitung"},{"issue":"4","key":"10.1002\/14651858.CD012069.pub2-BIB0473|cit473","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0193-953X(18)30661-0","article-title":"Neuropharmacology of methylphenidate and a neural substrate for childhood hyperactivity","volume":"8","author":"Gualtieri","year":"1985","journal-title":"Psychiatric Clinics of North America"},{"issue":"5","key":"10.1002\/14651858.CD012069.pub2-BIB0474|cit474","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1017\/S1461145709000212","article-title":"MAOA is associated with methylphenidate improvement of oppositional symptoms in boys with attention deficit hyperactivity disorder","volume":"12","author":"Guimar\u00e3es","year":"2009","journal-title":"International Journal of Neuropsychopharmacology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD012069.pub2-BIB0475|cit475","doi-asserted-by":"publisher","first-page":"S170","DOI":"10.1007\/s00787-011-0181-5","article-title":"The effect of treatment on multiple symptom domains and quality of life in children and adolescents with ADHD: A 3-year follow-up study","volume":"20","author":"Gurkan","year":"2011","journal-title":"European Child and Adolescent Psychiatry"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0476|cit476","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1186\/1471-244X-13-219","article-title":"An observational study of response heterogeneity in children with attention deficit hyperactivity disorder following treatment switch to modified-release methylphenidate","volume":"13","author":"Hautmann","year":"2013","journal-title":"BMC Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD012069.pub2-BIB0477|cit477","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1111\/j.1365-2125.2011.04113.x","article-title":"Reported paediatric adverse drug reactions in the UK 2000-2009","volume":"73","author":"Hawcutt","year":"2012","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"2","key":"10.1002\/14651858.CD012069.pub2-BIB0478|cit478","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1007\/s00213-002-1235-7","article-title":"The effects of methylphenidate on prepulse inhibition during attended and ignored prestimuli among boys with attention-deficit hyperactivity disorder","volume":"165","author":"Hawk","year":"2003","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1002\/14651858.CD012069.pub2-BIB0479|cit479","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1007\/s00787-004-0365-3","article-title":"Objective measurement of hyperactivity, impulsivity, and inattention in children with hyperkinetic disorders before and after treatment with methylphenidate","volume":"13","author":"Heiser","year":"2004","journal-title":"European Child and Adolescent Psychiatry"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0480|cit480","doi-asserted-by":"crossref","unstructured":"Hidas A Noy AF Birman N Shapira J Matot I Steinberg D Oral health status, salivary flow rate and salivary quality in children, adolescents and young adults with ADHD Archives of Oral Biology 2011 1137 41 10.1016\/j.archoralbio.2011.03.018","DOI":"10.1016\/j.archoralbio.2011.03.018"},{"issue":"6","key":"10.1002\/14651858.CD012069.pub2-BIB0481|cit481","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1111\/j.1469-8749.2005.tb01162.x\/pdf","article-title":"Immediate effects of methylphenidate on cognitive attention skills of children with attention-deficit-hyperactivity disorder","volume":"47","author":"Hood","year":"2005","journal-title":"Developmental Medicine and Child Neurology"},{"issue":"2","key":"10.1002\/14651858.CD012069.pub2-BIB0482|cit482","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1177\/01454455920162002","article-title":"An examination of the 'dosage' effects of both behavior therapy and methylphenidate on the classroom performance of two ADHD children","volume":"16","author":"Hoza","year":"1992","journal-title":"Behavior Modification"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0483|cit483","doi-asserted-by":"crossref","unstructured":"Hwang J Kim B Kim Y Yoo H Methylphenidate-osmotic release oral delivery system reduces parenting stress in parents of children and adolescents with ADHD in Korea European Neuropsychopharmacology 2012 S415","DOI":"10.1016\/S0924-977X(12)70650-8"},{"issue":"3","key":"10.1002\/14651858.CD012069.pub2-BIB0484|cit484","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/1469-8986.3730334","article-title":"Attentional capacity, a probe ERP study: differences between children with attention-deficit hyperactivity disorder and normal control children and effects of methylphenidate","volume":"37","author":"Jonkman","year":"2000","journal-title":"Psychophysiology"},{"issue":"4","key":"10.1002\/14651858.CD012069.pub2-BIB0485|cit485","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1111\/1469-8986.3640419","article-title":"Perceptual and response interference in children with attention-deficit hyperactivity disorder, and the effects of methylphenidate","volume":"36","author":"Jonkman","year":"1999","journal-title":"Psychophysiology"},{"issue":"4","key":"10.1002\/14651858.CD012069.pub2-BIB0486|cit486","doi-asserted-by":"publisher","first-page":"247-55; quiz 25","DOI":"10.1024\/1422-4917.35.4.247","article-title":"Quantitative effect of treatment with methylphenidate on EEG - a pilot study","volume":"35","author":"Kerdar","year":"2007","journal-title":"Z Kinder Jugendpsychiatr Psychother"},{"issue":"8","key":"10.1002\/14651858.CD012069.pub2-BIB0487|cit487","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1002\/ajmg.b.30704","article-title":"Catechol-O-methyltransferase Val158Met polymorphism is associated with methylphenidate response in ADHD children","volume":"147B","author":"Kereszturi","year":"2008","journal-title":"American Journal of Medical Genetics"},{"issue":"1","key":"10.1002\/14651858.CD012069.pub2-BIB0488|cit488","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ejpn.2006.10.002","article-title":"Methylphenidate improves reading performance in children with attention deficit hyperactivity disorder and comorbid dyslexia: an unblinded clinical trial","volume":"11","author":"Keulers","year":"2007","journal-title":"European Journal of Paediatric Neurology"},{"issue":"1","key":"10.1002\/14651858.CD012069.pub2-BIB0489|cit489","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s00221-002-1105-x","article-title":"Effects of methylphenidate on saccadic responses in patients with ADHD","volume":"145","author":"Klein","year":"2002","journal-title":"Experimental Brain Research"},{"issue":"11","key":"10.1002\/14651858.CD012069.pub2-BIB0490|cit490","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1097\/00004583-200111000-00007","article-title":"Methylphenidate effects on task-switching performance in attention-deficit\/hyperactivity disorder","volume":"40","author":"Kramer","year":"2001","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD012069.pub2-BIB0491|cit491","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1375\/brim.6.1.21.65479","article-title":"Effects of methylphenidate on attention skills in children with attention deficit\/hyperactivity disorder","volume":"6","author":"Lajoie","year":"2005","journal-title":"Brain Impairment"},{"issue":"1","key":"10.1002\/14651858.CD012069.pub2-BIB0492|cit492","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s00213-005-0144-y","article-title":"Methylphenidate effects in attention deficit\/hyperactivity disorder: electrodermal and ERP measures during a continuous performance task","volume":"183","author":"Lawrence","year":"2005","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1002\/14651858.CD012069.pub2-BIB0493|cit493","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1097\/00004583-199203000-00007","article-title":"Methylphenidate response in aggressive and nonaggressive ADHD children: distinctions on laboratory measures of symptoms","volume":"31","author":"Matier","year":"1992","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"issue":"3 Pt 2","key":"10.1002\/14651858.CD012069.pub2-BIB0494|cit494","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.2466\/pms.1993.77.3f.1215","article-title":"Reliability of global impressions for assessing methylphenidate effects in children with attention-deficit hyperactivity disorder","volume":"77","author":"Mayes","year":"1993","journal-title":"Perceptual and Motor Skills"},{"issue":"2","key":"10.1002\/14651858.CD012069.pub2-BIB0495|cit495","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/j.1875-9114.1994.tb02812.x","article-title":"Application of actigraphy in the clinical setting: use in children with attention-deficit hyperactivity disorder","volume":"14","author":"Miller","year":"1994","journal-title":"Pharmacotherapy"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0496|cit496","doi-asserted-by":"crossref","unstructured":"Miller DC Kavcic V Leslie JE ERP changes induced by methylphenidate in boys with attention-deficit hyperactivity disorder Journal of Attention Disorders 1996 95 113 10.1177\/108705479600100203","DOI":"10.1177\/108705479600100203"},{"issue":"3","key":"10.1002\/14651858.CD012069.pub2-BIB0497|cit497","first-page":"335","article-title":"Treatment of children with ADHD: psychopedagogical program at school versus psychostimulant medication","volume":"18","author":"Miranda","year":"2006","journal-title":"Psicothema"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0498|cit498","doi-asserted-by":"crossref","unstructured":"Monden Y Dan H Nagashima M Dan I Kyutoku Y Okamoto M Clinically-oriented monitoring of acute effects of methylphenidate on cerebral hemodynamics in ADHD children using fNIRS Clinical Neurophysiology 2012 1147 57 10.1016\/j.clinph.2011.10.006","DOI":"10.1016\/j.clinph.2011.10.006"},{"issue":"1","key":"10.1002\/14651858.CD012069.pub2-BIB0499|cit499","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.nicl.2012.10.001","article-title":"Right prefrontal activation as a neuro-functional biomarker for monitoring acute effects of methylphenidate in ADHD children: an fNIRS study","volume":"1","author":"Monden","year":"2012","journal-title":"NeuroImage: Clinical"},{"issue":"2","key":"10.1002\/14651858.CD012069.pub2-BIB0500|cit500","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s00787-011-0233-x","article-title":"Late potentials in the signal-averaged electrocardiogram in pre-pubertal children with ADHD, before and after methylphenidate treatment","volume":"21","author":"Nahshoni","year":"2012","journal-title":"European Child and Adolescent Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD012069.pub2-BIB0501|cit501","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1901\/jaba.2005.116-02","article-title":"Evaluation of pharmacological treatment of impulsivity in children with attention deficit hyperactivity disorder","volume":"38","author":"Neef","year":"2005","journal-title":"Journal of Applied Behavior Analysis"},{"issue":"2","key":"10.1002\/14651858.CD012069.pub2-BIB0502|cit502","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1159\/000317548","article-title":"Autonomic correlates at rest and during evoked attention in children with attention-deficit\/hyperactivity disorder and effects of methylphenidate","volume":"63","author":"Negrao","year":"2011","journal-title":"Neuropsychobiology"},{"issue":"2","key":"10.1002\/14651858.CD012069.pub2-BIB0503|cit503","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0028-3932(96)00070-X","article-title":"Covert visual spatial attention in boys with attention deficit hyperactivity disorder: lateral effects, methylphenidate response and results for parents","volume":"35","author":"Nigg","year":"1996","journal-title":"Neuropsychologia"},{"issue":"512","key":"10.1002\/14651858.CD012069.pub2-BIB0504|cit504","first-page":"175","article-title":"Using n-of-1 trials as a clinical tool to improve prescribing","volume":"55","author":"Nikles","year":"2005","journal-title":"British Journal of General Practice"},{"issue":"4 Pt 1","key":"10.1002\/14651858.CD012069.pub2-BIB0505|cit505","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1542\/peds.103.4.730","article-title":"Stimulant medication withdrawal during long-term therapy in children with comorbid attention-deficit hyperactivity disorder and chronic multiple tic disorder","volume":"103","author":"Nolan","year":"1999","journal-title":"Pediatrics"},{"issue":"4","key":"10.1002\/14651858.CD012069.pub2-BIB0506|cit506","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1001\/archgenpsychiatry.2010.28","article-title":"Unraveling the nature of hyperactivity in children with attention-deficit\/hyperactivity disorder","volume":"67","author":"Ohashi","year":"2010","journal-title":"Archives of General Psychiatry"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD012069.pub2-BIB0507|cit507","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/0924-977X(96)87562-6","article-title":"Behavioural and cognitive effects of stimulant and non stimulant drugs in childhood attention deficit disorder","volume":"6","author":"Orgill","year":"1996","journal-title":"European Neuropsychopharmacology"},{"issue":"2","key":"10.1002\/14651858.CD012069.pub2-BIB0508|cit508","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1300\/J184v09n02_05","article-title":"The effect of ROSHI protocol and cranial electrotherapy stimulation on a nine-year-old anxious, dyslexic male with attention deficit disorder: a case study","volume":"9","author":"Overcash","year":"2005","journal-title":"Journal of Neurotherapy"},{"issue":"10","key":"10.1002\/14651858.CD012069.pub2-BIB0509|cit509","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1016\/j.ijporl.2004.04.023","article-title":"Effect of methylphenidate on auditory event related potential in boys with attention deficit hyperactivity disorder","volume":"68","author":"Ozdag","year":"2004","journal-title":"International Journal of Pediatric Otorhinolaryngology"},{"issue":"5","key":"10.1002\/14651858.CD012069.pub2-BIB0510|cit510","first-page":"183","article-title":"Involvement of community pharmacists on attention-deficit\/hyperactivity disorder patients. A pilot study","volume":"14","author":"Palomino","year":"2012","journal-title":"Pharmaceutical Care Espa\u00f1a"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0511|cit511","doi-asserted-by":"crossref","unstructured":"Park MH Kim JW Yang YH Hong SB Park S Kang H Regional brain perfusion before and after treatment with methylphenidate may be associated with the G1287A polymorphism of the norepinephrine transporter gene in children with attention-deficit\/hyperactivity disorder Neuroscience Letters 2012 159 63 10.1016\/j.neulet.2012.02.079","DOI":"10.1016\/j.neulet.2012.02.079"},{"issue":"4","key":"10.1002\/14651858.CD012069.pub2-BIB0512|cit512","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1037\/0021-843X.95.4.319","article-title":"Effects of continuous and partial reinforcement and methylphenidate on learning in children with Attention Deficit Disorder","volume":"95","author":"Pelham","year":"1986","journal-title":"Journal of Abnormal Psychology"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0513|cit513","doi-asserted-by":"crossref","unstructured":"Pelham WE Jr Waschbusch DA Hoza B Gnagy EM Greiner AR Sams SE Music and video as distractors for boys with ADHD in the classroom: comparison with controls, individual differences, and medication effects Journal of Abnormal Child Psychology 2011 1085 98 10.1007\/s10802-011-9529-z","DOI":"10.1007\/s10802-011-9529-z"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0514|cit514","doi-asserted-by":"crossref","unstructured":"Perera H Jeewandara KC Seneviratne S Guruge C Combined \u03c93 and \u03c96 supplementation in children with attention-deficit hyperactivity disorder (ADHD) refractory to methylphenidate treatment: a double-blind, placebo-controlled study Journal of Child Neurology 2012 747 53 10.1177\/0883073811435243","DOI":"10.1177\/0883073811435243"},{"issue":"4","key":"10.1002\/14651858.CD012069.pub2-BIB0515|cit515","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1089\/cap.2007.0148","article-title":"Pharmacokinetics of methylphenidate transdermal system (MTS): results from a laboratory classroom study","volume":"18","author":"Pierce","year":"2008","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"issue":"1","key":"10.1002\/14651858.CD012069.pub2-BIB0516|cit516","doi-asserted-by":"crossref","first-page":"29","DOI":"10.5694\/mja12.10931","article-title":"Growth and pubertal development of adolescent boys on stimulant medication for attention deficit hyperactivity disorder","volume":"198","author":"Poulton","year":"2013","journal-title":"Medical Journal of Australia"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0517|cit517","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.brainres.2011.02.075","article-title":"Methylphenidate does not improve interference control during a working memory task in young patients with attention-deficit hyperactivity disorder","volume":"1388","author":"Prehn-Kristensen","year":"2011","journal-title":"Brain Research"},{"issue":"1","key":"10.1002\/14651858.CD012069.pub2-BIB0518|cit518","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0091-3057(85)90133-9","article-title":"Rate-dependency and hyperactivity: methylphenidate effects on operant responding","volume":"23","author":"Rapport","year":"1985","journal-title":"Pharmacology, Biochemistry, and Behavior"},{"issue":"3","key":"10.1002\/14651858.CD012069.pub2-BIB0519|cit519","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s00213-004-1833-7","article-title":"Methylphenidate restores visual memory, but not working memory function in attention deficit-hyperkinetic disorder","volume":"175","author":"Rhodes","year":"2004","journal-title":"Psychopharmacology"},{"issue":"11","key":"10.1002\/14651858.CD012069.pub2-BIB0520|cit520","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1111\/j.1469-7610.2006.01633.x","article-title":"Acute neuropsychological effects of methylphenidate in stimulant drug-na\u00efve boys with ADHD II--broader executive and non-executive domains","volume":"47","author":"Rhodes","year":"2006","journal-title":"Journal of Child Psychology and Psychiatry, and Allied Disciplines"},{"issue":"6","key":"10.1002\/14651858.CD012069.pub2-BIB0521|cit521","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/00008571-200208000-00011","article-title":"Dopamine transporter gene and response to methylphenidate in attention-deficit\/hyperactivity disorder","volume":"12","author":"Roman","year":"2002","journal-title":"Pharmacogenetics"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0522|cit522","doi-asserted-by":"crossref","unstructured":"Rubia K Halari R Cubillo AI Taylor ET Methylphenidate modulates inferior and orbitofrontal brain activation in ADHD during sustained attention and reward European Neuropsychopharmacology 2009 S304 5 10.1016\/S0924-977X(09)70452-3","DOI":"10.1016\/S0924-977X(09)70452-3"},{"issue":"7-8","key":"10.1002\/14651858.CD012069.pub2-BIB0523|cit523","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.neuropharm.2009.08.013","article-title":"Methylphenidate normalises activation and functional connectivity deficits in attention and motivation networks in medication-na\u00efve children with ADHD during a rewarded continuous performance task","volume":"57","author":"Rubia","year":"2009","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1002\/14651858.CD012069.pub2-BIB0524|cit524","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s12402-010-0035-x","article-title":"A pilot study: differential effects of methylphenidate-OROS on working memory and attention functions in children with attention-deficit\/hyperactivity disorder with and without behavioural comorbidities","volume":"3","author":"Rubio","year":"2011","journal-title":"Attention Deficit and Hyperactivity Disorders"},{"issue":"11","key":"10.1002\/14651858.CD012069.pub2-BIB0525|cit525","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1016\/j.jpsychires.2011.05.011","article-title":"Effects of methylphenidate on olfaction and frontal and temporal brain oxygenation in children with ADHD","volume":"45","author":"Schecklmann","year":"2011","journal-title":"Journal of Psychiatric Research"},{"issue":"1","key":"10.1002\/14651858.CD012069.pub2-BIB0526|cit526","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1023\/A:1021729501230","article-title":"The effect of methylphenidate on three forms of response inhibition in boys with AD\/HD","volume":"31","author":"Scheres","year":"2003","journal-title":"Journal of Abnormal Child Psychology"},{"issue":"1","key":"10.1002\/14651858.CD012069.pub2-BIB0527|cit527","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1080\/10349120500510107","article-title":"Speed of inhibition predicts teacher-rated medication response in boys with attention deficit hyperactivity disorder","volume":"53","author":"Scheres","year":"2006","journal-title":"International Journal of Disability, Development and Education"},{"issue":"3","key":"10.1002\/14651858.CD012069.pub2-BIB0528|cit528","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1026\/0942-5403.18.3.137","article-title":"The mental process of negating values in children with ADHD and effects of medical treatment","volume":"18","author":"Schmiedeler","year":"2009","journal-title":"Kindheit und Entwicklung"},{"issue":"11","key":"10.1002\/14651858.CD012069.pub2-BIB0529|cit529","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1176\/appi.ajp.161.11.1990","article-title":"The effects of methylphenidate on neural systems of attention in attention deficit hyperactivity disorder","volume":"161","author":"Shafritz","year":"2004","journal-title":"American Journal of Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD012069.pub2-BIB0530|cit530","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1542\/peds.69.6.688","article-title":"Psychopharmacology of attention deficit disorder: pharmacokinetic, neuroendocrine, and behavioral measures following acute and chronic treatment with methylphenidate","volume":"69","author":"Shaywitz","year":"1982","journal-title":"Pediatrics"},{"issue":"1","key":"10.1002\/14651858.CD012069.pub2-BIB0531|cit531","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1136\/jnnp.66.1.57","article-title":"Effects of stimulant medication on the lateralisation of line bisection judgements of children with attention deficit hyperactivity disorder","volume":"66","author":"Sheppard","year":"1999","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD012069.pub2-BIB0532|cit532","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1080\/09297040701220005","article-title":"Effect of treatment with stimulant medication on nonverbal executive function and visuomotor speed in children with attention deficit\/hyperactivity disorder (ADHD)","volume":"14","author":"Snyder","year":"2008","journal-title":"Child Neuropsychology"},{"issue":"6","key":"10.1002\/14651858.CD012069.pub2-BIB0533|cit533","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1097\/00004583-198911000-00014","article-title":"Does methylphenidate constrict cognitive functioning?","volume":"28","author":"Solanto","year":"1989","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD012069.pub2-BIB0534|cit534","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1002\/hup.298","article-title":"The influence of three months of methylphenidate treatment on platelet-poor plasma biogenic amine levels in boys with attention deficit hyperactivity disorder","volume":"16","author":"Spivak","year":"2001","journal-title":"Human Psychopharmacology"},{"issue":"1","key":"10.1002\/14651858.CD012069.pub2-BIB0535|cit535","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1089\/104454601750143564","article-title":"Can methylphenidate facilitate sleep in children with attention deficit hyperactivity disorder?","volume":"11","author":"Jerome","year":"2001","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"issue":"3","key":"10.1002\/14651858.CD012069.pub2-BIB0536|cit536","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1089\/cap.1999.9.157","article-title":"Unravelling sleep problems in treated and untreated children with ADHD","volume":"9","author":"Stein","year":"1999","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"issue":"3","key":"10.1002\/14651858.CD012069.pub2-BIB0537|cit537","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1177\/155005948801900306","article-title":"Dose-response effects of chronic methylphenidate administration on late event-related potentials in attention deficit disorder","volume":"19","author":"Syrigou-Papavasiliou","year":"1988","journal-title":"Clinical Electroencephalography"},{"issue":"5","key":"10.1002\/14651858.CD012069.pub2-BIB0538|cit538","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s00787-006-0571-2","article-title":"Is OPTAx[TM] useful for monitoring the effect of stimulants on hyperactivity and inattention?","volume":"16","author":"Tabori-Kraft","year":"2007","journal-title":"European Child and Adolescent Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD012069.pub2-BIB0539|cit539","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1177\/1087054706289946","article-title":"Task demands interact with the single and combined effects of medication and contingencies on children with ADHD","volume":"10","author":"Tamm","year":"2007","journal-title":"Journal of Attention Disorders"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0540|cit540","volume-title":"A Double-Blind Study of the Central Auditory Processing and Auditory Continuous Test Performances of Children with Attention Deficit Hyperactivity Disorder and Central Auditory Processing Disorder Under Ritalin and Placebo Conditions [PhD thesis]","author":"Tillery","year":"1998"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD012069.pub2-BIB0541|cit541","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/pds.3512","article-title":"Hallucinations: a case\/noncase study in the French Pharmacovigilance Database","volume":"22","author":"Taam","year":"2013","journal-title":"Pharmacoepidemiology and Drug Safety"},{"issue":"10","key":"10.1002\/14651858.CD012069.pub2-BIB0544|cit542","first-page":"891","article-title":"Methylphenidate off-label use","volume":"35","author":"Trenque","year":"2012","journal-title":"Drug Safety"},{"issue":"10","key":"10.1002\/14651858.CD012069.pub2-BIB0542|cit543","doi-asserted-by":"publisher","first-page":"983","DOI":"10.2165\/11316660-000000000-00000","article-title":"Spontaneous reporting with methylphenidate: insufficient data","volume":"32","author":"Trenque","year":"2009","journal-title":"Drug Safety"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0543|cit544","unstructured":"Trenque T Maura G Herlem E Spontaneous reporting with methylphenidate: off-label use in growth? Fundamental and Clinical Pharmacology 2012 105"},{"issue":"3","key":"10.1002\/14651858.CD012069.pub2-BIB0545|cit545","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1046\/j.1440-1614.1999.00575.x","article-title":"Attention deficit hyperactivity disorder: anxiety phenomena in children treated with psychostimulant medication for 6 months or more","volume":"33","author":"Vance","year":"1999","journal-title":"Australian and New Zealand Journal of Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD012069.pub2-BIB0546|cit546","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1080\/09297040902758803","article-title":"Methylphenidate, interstimulus interval, and reaction time performance of children with attention deficit\/hyperactivity disorder: a pilot study","volume":"15","author":"Meere","year":"2009","journal-title":"Child Neuropsychology"},{"issue":"1","key":"10.1002\/14651858.CD012069.pub2-BIB0547|cit547","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1080\/09297049.2011.559159","article-title":"Prepotent response inhibition predicts treatment outcome in attention deficit\/hyperactivity disorder","volume":"18","author":"Oord","year":"2012","journal-title":"Child Neuropsychology"},{"issue":"3","key":"10.1002\/14651858.CD012069.pub2-BIB0548|cit548","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1080\/026404102317284763","article-title":"Gaze pursuit and arm control of adolescent males diagnosed with attention deficit hyperactivity disorder (ADHD) and normal controls: evidence of a dissociation in processing visual information of short and long duration","volume":"20","author":"Vickers","year":"2002","journal-title":"Journal of Sports Sciences"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0549|cit549","doi-asserted-by":"crossref","unstructured":"Vogt C Williams T Early identification of stimulant treatment responders, partial responders and non-responders using objective measures in children and adolescents with hyperkinetic disorder Child and Adolescent Mental Health 2011 144 9 10.1111\/j.1475-3588.2010.00593.x","DOI":"10.1111\/j.1475-3588.2010.00593.x"},{"issue":"6","key":"10.1002\/14651858.CD012069.pub2-BIB0550|cit550","doi-asserted-by":"publisher","first-page":"e1494","DOI":"10.1542\/peds.2007-0675","article-title":"Cardiac safety of central nervous system stimulants in children and adolescents with attention-deficit\/hyperactivity disorder","volume":"120","author":"Winterstein","year":"2007","journal-title":"Pediatrics"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0551|cit551","doi-asserted-by":"crossref","unstructured":"Winterstein AG Gerhard T Kubilis P Saidi A Linden S Crystal S Cardiovascular safety of central nervous system stimulants in children and adolescents: population based cohort study BMJ 2012 e4627 10.1136\/bmj.e4627","DOI":"10.1136\/bmj.e4627"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0552|cit552","doi-asserted-by":"crossref","unstructured":"Wong CG Stevens MC The effects of stimulant medication on working memory functional connectivity in attention-deficit\/hyperactivity disorder Biological Psychiatry 2012 458 66 10.1016\/j.biopsych.2011.11.011","DOI":"10.1016\/j.biopsych.2011.11.011"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0553|cit553","doi-asserted-by":"crossref","unstructured":"Yeh CB Huang WS Lo MC Chang CJ Ma KH Shyu JF The rCBF brain mapping in adolescent ADHD comorbid developmental coordination disorder and its changes after MPH challenging European Journal of Paediatric Neurology 2012 613 8 10.1016\/j.ejpn.2012.02.007","DOI":"10.1016\/j.ejpn.2012.02.007"},{"issue":"2","key":"10.1002\/14651858.CD012069.pub2-BIB0554|cit554","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.ridd.2004.12.004","article-title":"Effects of long-term psychostimulant medication on growth of children with ADHD","volume":"27","author":"Zachor","year":"2006","journal-title":"Research in Developmental Disabilities"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0555|cit555","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1100\/tsw.2003.94","article-title":"Attention patterns in children with attention deficit disorder with or without hyperactivity","volume":"3","author":"Zalsman","year":"2003","journal-title":"Scientific World Journal"},{"issue":"8","key":"10.1002\/14651858.CD012069.pub2-BIB0556|cit556","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.braindev.2004.11.009","article-title":"Functional MRI in attention-deficit hyperactivity disorder: evidence for hypofrontality","volume":"27","author":"Zang","year":"2005","journal-title":"Brain and Development"},{"issue":"11","key":"10.1002\/14651858.CD012069.pub2-BIB0557|cit557","first-page":"837","article-title":"The clinical use of a double-blind placebo-controlled trial with methylphenidate: advantages and limitations","volume":"42","author":"Arnold-von Saher","year":"2000","journal-title":"Tijdschrift voor Psychiatrie"},{"issue":"6","key":"10.1002\/14651858.CD012069.pub2-BIB0558|cit558","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/cap.2014.0020","article-title":"Cardiovascular safety of stimulants in children with attention-deficit\/hyperactivity disorder: a nationwide prospective cohort study","volume":"24","author":"Dalsgaard","year":"2014","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"issue":"8","key":"10.1002\/14651858.CD012069.pub2-BIB0559|cit559","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/S2215-0366(15)00271-0","article-title":"Effect of drugs on the risk of injuries in children with attention deficit hyperactivity disorder: a prospective cohort study","volume":"2","author":"Dalsgaard","year":"2015","journal-title":"Lancet Psychiatry"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD012069.pub2-BIB0560|cit560","doi-asserted-by":"publisher","first-page":"S107","DOI":"10.1007\/s00787-011-0181-5","article-title":"Long-term cardiac adverse effects of ADHD medication in children and adolescents: a nationwide register based follow-up study","volume":"20","author":"Dalsgaard","year":"2011","journal-title":"European Child and Adolescent Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD012069.pub2-BIB0561|cit561","first-page":"14","article-title":"Methylphenidate a stimulant in treatment of children with minimal brain dysfunction","volume":"57","author":"Flapper","year":"1989","journal-title":"Tijdschrift voor Kindergeneeskunde"},{"issue":"7","key":"10.1002\/14651858.CD012069.pub2-BIB0562|cit562","first-page":"329","article-title":"Priapism in childhood - case report of 14-year-old boy","volume":"85","author":"Hus\u00e1r","year":"2006","journal-title":"Rozhledy V Chirurgii"},{"issue":"4","key":"10.1002\/14651858.CD012069.pub2-BIB0563|cit563","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1089\/cap.2014.0148","article-title":"The relationship between acute dyskinesia with a single dose of methylphenidate and recent risperidone discontinuation in a child with attention-deficit\/hyperactivity disorder","volume":"25","author":"Ince","year":"2015","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"issue":"4","key":"10.1002\/14651858.CD012069.pub2-BIB0564|cit564","first-page":"323","article-title":"Methylphenidate therapy in 141 patients with hyperkinetic disorder or with pervasive developmental disorder and hyperkinesia","volume":"33","author":"Ishizaki","year":"2001","journal-title":"No To Hattatsu"},{"issue":"2","key":"10.1002\/14651858.CD012069.pub2-BIB0565|cit565","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1080\/15289168.2015.1014991","article-title":"Effectiveness of psychoanalytic psychotherapy and behavioral therapy treatment in children with attention deficit hyperactivity disorder and oppositional defiant disorder","volume":"14","author":"Laezer","journal-title":"Journal of Infant, Child, and Adolescent Psychotherapy"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD012069.pub2-BIB0566|cit566","first-page":"S34","article-title":"Pharmacological management of attention deficit hyperactivity disorder with methylphenidate and atomoxetine within a context of epilepsy","volume":"58","author":"Mulas","year":"2014","journal-title":"Revista de Neurologia"},{"issue":"8","key":"10.1002\/14651858.CD012069.pub2-BIB0568|cit567","first-page":"415","article-title":"Effect of medication on anthropometric characteristic of ADHD children","volume":"104","author":"Pt\u00e1\u010dek","year":"2008","journal-title":"Ceska a Slovenska Psychiatrie"},{"issue":"Suppl","key":"10.1002\/14651858.CD012069.pub2-BIB0567|cit568","first-page":"104","article-title":"Developmental changes in children with ADHD and effecto [sic] of medication on growth","volume":"13","author":"Pt\u00e1\u010dek","year":"2009","journal-title":"Psychiatrie"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0569|cit569","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.yebeh.2015.02.019","article-title":"Methylphenidate improves the quality of life of children and adolescents with ADHD and difficult-to-treat epilepsies","volume":"46","author":"Radziuk","year":"2015","journal-title":"Epilepsy and Behavior"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0570|cit570","doi-asserted-by":"crossref","unstructured":"Socanski D Aurlien D Herigstad A Thomsen PH Larsen TK Attention deficit\/hyperactivity disorder and interictal epileptiform discharges: it is safe to use methylphenidate? Seizure 2015 80 3 10.1016\/j.seizure.2015.01.002","DOI":"10.1016\/j.seizure.2015.01.002"},{"issue":"6","key":"10.1002\/14651858.CD012069.pub2-BIB0571|cit571","first-page":"436","article-title":"Clinical assessment of the effect of switch from immediate-release to extended-release methylphenidate in 181 patients with isolated attention deficit\/hyperactivity disorder (AD\/HD) or AD\/HD associated with pervasive developmental disorder","volume":"41","author":"Sugama","year":"2009","journal-title":"No to Hattatsu"},{"issue":"1","key":"10.1002\/14651858.CD012069.pub2-BIB0574|cit572","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/cpu.20155","article-title":"Polypharmacy in treating severe childhood aggression","volume":"14","year":"2012","journal-title":"Brown University Child and Adolescent Psychopharmacology Update"},{"issue":"1","key":"10.1002\/14651858.CD012069.pub2-BIB0572|cit573","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jaac.2013.09.022","article-title":"What does risperidone add to parent training and stimulant for severe aggression in child attention-deficit\/hyperactivity disorder?","volume":"53","author":"Aman","year":"2014","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD012069.pub2-BIB0573|cit574","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/1753-2000-5-36","article-title":"The treatment of severe child aggression (TOSCA) study: design challenges","volume":"5","author":"Farmer","year":"2011","journal-title":"Child and Adolescent Psychiatry and Mental Health"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0575|cit575","first-page":"A374","article-title":"Assessing the impact of methylphenidate on sleep in children with ADHD using polysomnography and actigraphy","volume":"35","author":"Gendron","year":"2012","journal-title":"Sleep"},{"issue":"5","key":"10.1002\/14651858.CD012069.pub2-BIB0576|cit576","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/jsr.12402","article-title":"Concordance of actigraphy with polysomnography in children with and without attention-deficit\/hyperactivity disorder","volume":"25","author":"Waldon","year":"2016","journal-title":"Journal of Sleep Research"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD012069.pub2-BIB0577|cit577","first-page":"S158","article-title":"Henoch-Sch\u00f6nlein Purpura with attention deficit hyperactivity disorder","volume":"24","author":"Yusufoglu","year":"2014","journal-title":"Klinik Psikofarmakoloji B\u00fclteni [Bulletin of Clinical Psychopharmacology]"},{"issue":"S1","key":"10.1002\/14651858.CD012069.pub2-BIB0578|cit578","doi-asserted-by":"publisher","first-page":"S208","DOI":"10.1002\/pds.1806","article-title":"Spontaneous report safety signals profile and comparative Bayesian analysis of ADHD medication in children in the UK","volume":"18","author":"Beau","year":"2009","journal-title":"Pharmacoepidemiology and Drug Safety"},{"issue":"48","key":"10.1002\/14651858.CD012069.pub2-BIB0579|cit579","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1471-244X-14-48","article-title":"The effects of Psychotropic drugs On Developing brain (ePOD) study: methods and design","volume":"14","author":"Bottelier","year":"2014","journal-title":"BMC Psychiatry"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0580|cit580","unstructured":"Dahlgren J Wentz E Overweight and obese children with diagnosed attention deficit hyperactivity disorder have a favourable weight loss with methylphenidate - one year data Obesity Facts 2012 208"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD012069.pub2-BIB0583|cit581","doi-asserted-by":"publisher","first-page":"S74","DOI":"10.1007\/s00787-015-0714-4","article-title":"Factors that may predict a good response to pharmacological treatment","volume":"24","author":"Castro-Manglano","year":"2015","journal-title":"European Child and Adolescent Psychiatry"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD012069.pub2-BIB0581|cit582","doi-asserted-by":"publisher","first-page":"S74","DOI":"10.1007\/s00787-015-0714-4","article-title":"Long term effects of medication for ADHD in weight and height in children and adolescents","volume":"24","author":"D\u00edez-Su\u00e1rez","year":"2015","journal-title":"European Child and Adolescent Psychiatry"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD012069.pub2-BIB0582|cit583","doi-asserted-by":"publisher","first-page":"S175","DOI":"10.1007\/s00787-015-0714-4","article-title":"Weight, height and body mass index in patients with adhd treated with methylphenidate","volume":"24","author":"D\u00edez-Su\u00e1rez","year":"2015","journal-title":"European Child and Adolescent Psychiatry"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD012069.pub2-BIB0584|cit584","doi-asserted-by":"publisher","first-page":"S137","DOI":"10.1007\/s00787-015-0714-4","article-title":"Clinical and neurocognitive predictive factors for good response to methylphenidate treatment in a ADHD sample in Spain: a naturalistic follow-up study","volume":"24","author":"Vallejo-Valdivielso","year":"2015","journal-title":"European Child and Adolescent Psychiatry"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD012069.pub2-BIB0585|cit585","doi-asserted-by":"publisher","first-page":"S396","DOI":"10.1016\/S0924-9338(09)70629-7","article-title":"School children with ADHD - effects of once-daily OROS methylphenidate treatment ADHD symptoms included improvement academic functioning","volume":"24","author":"Djurkovic-Lazic","year":"2009","journal-title":"European Psychiatry"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD012069.pub2-BIB0586|cit586","doi-asserted-by":"publisher","first-page":"S152","DOI":"10.1002\/pds.2019","article-title":"The influence of using methylphenidate on the coming up of psychiatric disorders in children with ADHD","volume":"19","author":"Gau","year":"2010","journal-title":"Pharmacoepidemiology and Drug Safety"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD012069.pub2-BIB0587|cit587","doi-asserted-by":"publisher","first-page":"S120","DOI":"10.1007\/s00787-011-0181-5","article-title":"Individualised methylphenidate therapy based on pharmacogenomics: focus on carboxylesterase1 (CES1)","volume":"20","author":"Houmann","year":"2011","journal-title":"European Child and Adolescent Psychiatry"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD012069.pub2-BIB0588|cit588","doi-asserted-by":"publisher","first-page":"S415","DOI":"10.1016\/S0924-977X(12)70651-X","article-title":"Obesity is associated with non-response to prolonged-release methylphenidate treatment in ADHD","volume":"22","author":"Yook","year":"2012","journal-title":"European Neuropsychopharmacology"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0589|cit589","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1472-6904-9-4","article-title":"Information about ADRs explored by pharmacovigilance approaches: a qualitative review of studies on antibiotics, SSRIs and NSAIDs","volume":"9","author":"Aagaard","year":"2009","journal-title":"BMC Clinical Pharmacology"},{"issue":"5","key":"10.1002\/14651858.CD012069.pub2-BIB0590|cit590","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1111\/j.1365-2125.2010.03732.x","article-title":"Adverse drug reactions reported for systemic antibacterials in Danish children over a decade","volume":"70","author":"Aagaard","year":"2010","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"4","key":"10.1002\/14651858.CD012069.pub2-BIB0591|cit591","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1111\/j.1365-2125.2010.03682.x","article-title":"Information about adverse drug reactions reported in children: a qualitative review of empirical studies","volume":"70","author":"Aagaard","year":"2010","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0592|cit592","doi-asserted-by":"crossref","unstructured":"Aagaard L Hansen EH The occurrence of adverse drug reactions reported for attention deficit hyperactivity disorder (ADHD) medications in the pediatric population: a qualitative review of empirical studies Neuropsychiatric Disease and Treatment 2011 729 44","DOI":"10.2147\/NDT.S26403"},{"issue":"5","key":"10.1002\/14651858.CD012069.pub2-BIB0593|cit593","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1542\/peds.2011-2654","article-title":"ADHD: clinical practice guideline for the diagnosis, evaluation, and the treatment of attention-deficit\/hyperactivity disorder in children and adolescents","volume":"128","author":"Wolraich","year":"2011","journal-title":"Pediatrics"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0594|cit594","unstructured":"Abali O Possible inclusion of 'Methylphenidate induced hallucinations: case report' in a Cochrane systematic review [personal communication] Email to: EL Ramstad"},{"issue":"1","key":"10.1002\/14651858.CD012069.pub2-BIB0595|cit595","doi-asserted-by":"publisher","first-page":"184","DOI":"10.3810\/pgm.2010.01.2112","article-title":"Review of medication adherence in children and adults with ADHD","volume":"122","author":"Adler","year":"2010","journal-title":"Postgraduate Medicine"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0596|cit596","unstructured":"Adrian N Questions regarding your article 'Explosive outbursts associated with methylphenidate' [personal communication] Email to: HB Krogh"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0597|cit597","unstructured":"Aguilera-Albesa S Inclusion of 'Alucinaciones tras la introducci\u00f3n de metilfenidato en dosis bajas' in a systematic review [personal communication] Email to: EL Ramstad"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0598|cit598","unstructured":"Akinbami LJ Liu X Pastor PN Reuben CA Attention deficit hyperactivity disorder among children aged 5-17 years in the United States, 1998-2009 NCHS Data Brief 2011 1 8"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0599|cit599","unstructured":"Alpaslan AH Supplemental data [personal communication] Email to: MJ Kielsholm"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0600|cit600","unstructured":"Aman M Questions regarding the TOSCA study [personal communication] Email to: EL Ramstad"},{"issue":"7","key":"10.1002\/14651858.CD012069.pub2-BIB0601|cit601","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.jclinepi.2012.03.013","article-title":"GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendations","volume":"66","author":"Andrews","year":"2013","journal-title":"Journal of Clinical Epidemiology"},{"issue":"7","key":"10.1002\/14651858.CD012069.pub2-BIB0602|cit602","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.jclinepi.2013.02.003","article-title":"GRADE guidelines: 15. Going from evidence to recommendation - determinants of a recommendation's direction and strength","volume":"66","author":"Andrews","year":"2013","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0603|cit603","volume-title":"Diagnostic and Statistical Manual of Mental Disorders (DSM-III)","author":"American Psychiatric Association","year":"1980"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0604|cit604","volume-title":"Diagnostic and Statistical Manual of Mental Disorders (DSM III-R)","author":"American Psychiatric Association","year":"1987"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0605|cit605","volume-title":"Diagnostic and Statistical Manual of Mental Disorders (DSM-IV)","author":"American Psychiatric Association","year":"1994"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0606|cit606","volume-title":"Diagnostic and Statistical Manual of Mental Disorders: Text revision (DSM-IV-TR)","author":"American Psychiatric Association","year":"2000"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0607|cit607","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and Statistical Manual of Mental Disorders (DSM-5)","author":"American Psychiatric Association","year":"2013"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0608|cit608","unstructured":"Arneja J Questions regarding your study 'Comparative short term efficacy and tolerability of methylphenidate and atomoxetine in attention deficit hyperactivity disorder' [personal communication] Email to: SS Nielsen"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0609|cit609","unstructured":"Arnold LE Questions regarding a study of yours - inclusion in a Cochrane systematic review [personal communication] Email to: EL Ramstad"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0610|cit610","unstructured":"Arnold L Questions regarding your study 'A double-blind, placebo-controlled withdrawal trial of dexmethylphenidate hydrochloride in children with attention deficit hyperactivity disorder' [personal communication] Email to: HB Krogh"},{"issue":"1","key":"10.1002\/14651858.CD012069.pub2-BIB0611|cit611","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1744-9081-1-2","article-title":"Methylphenidate improves prefrontal cortical cognitive function through \u03b12 adrenoceptor and dopamine D1 receptor actions: relevance to therapeutic effects in Attention Deficit Hyperactivity Disorder","volume":"1","author":"Arnsten","year":"2005","journal-title":"Behavioral and Brain Functions"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0612|cit612","unstructured":"Artul S Supplemental data [personal communication] Email to: SS Nielsen"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0613|cit613","unstructured":"Arun P Methylphenidate and suicidal ideation IQ [personal communication] Email to: M Holmskov"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0614|cit614","unstructured":"Ashkenasi A Questions regarding your study 'Effect of transdermal methylphenidate wear times on sleep in children with attention deficit hyperactivity disorder' [personal communication] Email to: HB Krogh"},{"issue":"5","key":"10.1002\/14651858.CD012069.pub2-BIB0615|cit615","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.euroneuro.2017.03.002","article-title":"Trends in ADHD medication use in children and adolescents in five western countries, 2005-2012","volume":"27","author":"Bachmann","year":"2017","journal-title":"European Neuropsychopharmacology"},{"issue":"4","key":"10.1002\/14651858.CD012069.pub2-BIB0616|cit616","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.jclinepi.2010.07.015","article-title":"GRADE guidelines: 3. Rating the quality of evidence","volume":"64","author":"Balshem","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0617|cit617","unstructured":"Barker MJ Inclusion of one of your studies in a Cochrane systematic review [personal communication] Emails to: EL Ramstad (22 October, 6 December 2013)"},{"issue":"2","key":"10.1002\/14651858.CD012069.pub2-BIB0618|cit618","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1111\/j.1469-7610.1977.tb00425.x","article-title":"A review of stimulant drug research with hyperactive children","volume":"18","author":"Barkley","year":"1977","journal-title":"Journal of Child Psychology and Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD012069.pub2-BIB0619|cit619","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1542\/peds.86.2.184","article-title":"Side effects of methylphenidate in children with attention deficit hyperactivity disorder: a systemic, placebo-controlled evaluation","volume":"86","author":"Barkley","year":"1990","journal-title":"Pediatrics"},{"issue":"25","key":"10.1002\/14651858.CD012069.pub2-BIB0620|cit620","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1056\/NEJM200006223422506","article-title":"A comparison of observational studies and randomized, controlled trials","volume":"342","author":"Benson","year":"2000","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0621|cit621","unstructured":"Bereket A 'Height, weight, IGF-I, IGFBP-3 and thyroid functions in prepubertal children with attention deficit hyperactivity disorder' questions [personal communication] Email to: T Nilausen"},{"issue":"6","key":"10.1002\/14651858.CD012069.pub2-BIB0622|cit622","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1001\/jama.288.6.728","article-title":"Cognitive and behavioral outcomes of school-aged children who were born preterm: a meta-analysis","volume":"288","author":"Bhutta","year":"2002","journal-title":"Journal of the American Medical Association"},{"issue":"Suppl 11","key":"10.1002\/14651858.CD012069.pub2-BIB0623|cit623","first-page":"3","article-title":"Pharmacotherapy for attention-deficit\/hyperactivity disorder (ADHD) decreases the risk for substance abuse: findings from a longitudinal follow-up of youths with and without ADHD","volume":"64","author":"Biederman","year":"2003","journal-title":"Journal of Clinical Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD012069.pub2-BIB0624|cit624","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/ADM.0000000000000115","article-title":"Prevalent intravenous abuse of methylphenidate among treatment-seeking patients with substance abuse disorders: a descriptive population-based study","volume":"9","author":"Bjarnadottir","year":"2015","journal-title":"Journal of Addiction Medicine"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0625|cit625","unstructured":"BNF Methylphenidate hydrochloride: indications and dose British National Formulary 10.18578\/BNF.995526496"},{"issue":"2","key":"10.1002\/14651858.CD012069.pub2-BIB0626|cit626","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.jclinepi.2012.04.012","article-title":"GRADE guidelines: 10. Considering resource use and rating the quality of economic evidence","volume":"66","author":"Brunetti","year":"2013","journal-title":"Journal of Clinical Epidemiology"},{"issue":"4","key":"10.1002\/14651858.CD012069.pub2-BIB0627|cit627","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1365-2869.1996.00251.x","article-title":"The Sleep Disturbance Scale for Children (SDSC). Construction and validation of an instrument to evaluate sleep disturbances in childhood and adolescence","volume":"5","author":"Bruni","year":"1996","journal-title":"Journal of Sleep Research"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0628|cit628","unstructured":"Buchmann J Questions regarding your study 'Restoration of disturbed intracortical motor inhibition and facilitation in attention deficit hyperactivity disorder children by methylphenidate' [personal communication] Email to: FL Magnusson"},{"issue":"7","key":"10.1002\/14651858.CD012069.pub2-BIB0629|cit629","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1017\/S0033291713002158","article-title":"Extremely preterm birth and adolescent mental health in a geographical cohort born in the 1990s","volume":"44","author":"Burnett","year":"2014","journal-title":"Psychological Medicine"},{"issue":"1","key":"10.1002\/14651858.CD012069.pub2-BIB0630|cit630","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1753-2000-7-19","article-title":"Suicide related events and attention deficit hyperactivity disorder treatments in children and adolescents: a meta-analysis of atomoxetine and methylphenidate comparator clinical trials","volume":"7","author":"Bushe","year":"2013","journal-title":"Child and Adolescent Psychiatry and Mental Health"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0631|cit631","volume-title":"Canadian ADHD Practice Guidelines","volume":"3rd Edition","author":"Canadian Attention Deficit Hyperactivity Disorder Resource Alliance","year":"2011"},{"issue":"4","key":"10.1002\/14651858.CD012069.pub2-BIB0632|cit632","doi-asserted-by":"crossref","first-page":"154","DOI":"10.5694\/mja15.00791","article-title":"ADHD medication overdose and misuse: the NSW Poisons Information Centre experience, 2004-2014","volume":"204","author":"Cairns","year":"2016","journal-title":"Medical Journal of Australia"},{"issue":"3","key":"10.1002\/14651858.CD012069.pub2-BIB0633|cit633","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.tics.2006.01.011","article-title":"Characterizing cognition in ADHD: beyond executive dysfunction","volume":"10","author":"Castellanos","year":"2006","journal-title":"Trends in Cognitive Sciences"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0634|cit634","unstructured":"Castro-Manglano P Questions regarding your study 'Long-term effects of medication for ADHD in weight and height in children and adolescents' [personal communication] Email to: SS Nielsen"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0635|cit635","doi-asserted-by":"crossref","unstructured":"Centers for Disease Control and Prevention (CDC) QuickStats: percentage of children aged 5-17 years with diagnosed attention deficit\/hyperactivity disorder (ADHD), by poverty status and sex - National Health Interview Survey, 2011-2014 Morbidity and Mortality Weekly Report 2015 1156","DOI":"10.15585\/mmwr.mm6440a11"},{"issue":"3","key":"10.1002\/14651858.CD012069.pub2-BIB0636|cit636","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s10802-011-9575-6","article-title":"The effects of childhood ADHD symptoms on early-onset substance use: a Swedish twin study","volume":"40","author":"Chang","year":"2012","journal-title":"Journal of Abnormal Child Psychology"},{"issue":"3","key":"10.1002\/14651858.CD012069.pub2-BIB0637|cit637","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1001\/jamapsychiatry.2013.4174","article-title":"Serious transport accidents in adults with ADHD, and the effect of medication: a population based study","volume":"71","author":"Chang","year":"2014","journal-title":"JAMA Psychiatry"},{"issue":"8","key":"10.1002\/14651858.CD012069.pub2-BIB0638|cit638","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1111\/jcpp.12164","article-title":"Stimulant ADHD medication and risk for substance abuse","volume":"55","author":"Chang","year":"2014","journal-title":"Journal of Child Psychology and Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD012069.pub2-BIB0639|cit639","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1001\/jamapsychiatry.2017.0659","article-title":"Associations between medication use for attention-deficit\/hyperactivity disorder and risk of motor vehicle crashes","volume":"74","author":"Chang","year":"2017","journal-title":"JAMA Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD012069.pub2-BIB0640|cit640","doi-asserted-by":"publisher","first-page":"e1584-604","DOI":"10.1542\/peds.2012-0974","article-title":"Interventions for preschool children at high risk for ADHD: a comparative effectiveness review","volume":"131","author":"Charach","year":"2013","journal-title":"Pediatrics"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0641|cit641","doi-asserted-by":"crossref","first-page":"g3769","DOI":"10.1136\/bmj.g3769","article-title":"Drug treatment for attention-deficit\/hyperactivity disorder and suicidal behaviour: register based study","volume":"348","author":"Chen","year":"2014","journal-title":"BMJ"},{"issue":"1","key":"10.1002\/14651858.CD012069.pub2-BIB0642|cit642","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S1389-9457(99)00009-X","article-title":"Pediatric Sleep Questionnaire (PSQ): validity and reliability of scales for sleep-disordered breathing, snoring, sleepiness, and behavioral problems","volume":"1","author":"Chervin","year":"2000","journal-title":"Sleep Medicine"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0643|cit643","unstructured":"Chou WJ Remission in children and adolescents further information [personal communication] Email to: T Nilausen"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0644|cit644","unstructured":"Cockcroft K Regarding your study 'Sleep and daytime sleepiness in methylphenidate medicated and un-medicated children with attention-deficit\/hyperactivity disorder (ADHD)' [personal communication] Emails to: EL Ramstad (8 October 2013, 27 January 2014)"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0645|cit645","unstructured":"Cohen HA Questions regarding your study 'Fixed drug eruption of the scrotum due to methylphenidate' [personal communication] Email to: HB Krogh"},{"issue":"7612","key":"10.1002\/14651858.CD012069.pub2-BIB0646|cit646","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1136\/bmj.39238.399444.55","article-title":"Body mass index cut offs to define thinness in children and adolescents: international survey","volume":"335","author":"Cole","year":"2007","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0647|cit647","unstructured":"BioStat Comprehensive Meta Analysis www.meta-analysis.com"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0648|cit648","unstructured":"Confino-Cohen R Questions regarding your case report 'Successful desensitization of methylphenidate-induced rash' [personal communication] Email to: HB Krogh"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0649|cit649","unstructured":"Corrigall R Questions regarding your case report 'Methylphenidate euphoria' [personal communication] Email to: HB Krogh"},{"issue":"1","key":"10.1002\/14651858.CD012069.pub2-BIB0650|cit650","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1176\/appi.ajp.2015.15020266","article-title":"Association between ADHD and obesity: a systematic review and meta-analysis","volume":"173","author":"Cortese","year":"2016","journal-title":"American Journal of Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD012069.pub2-BIB0651|cit651","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/00004583-200403000-00007","article-title":"Impact of methylphenidate delivery profiles on driving performance of adolescents with attention-deficit\/hyperactivity disorder: a pilot study","volume":"43","author":"Cox","year":"2004","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0652|cit652","unstructured":"Co\u015fkun M Questions regarding four of your case reports\/series [personal communication] Email to: EL Ramstad"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0653|cit653","unstructured":"Co\u015fkun M Questions regarding four of your case reports\/series [personal communication] Email to: EL Ramstad"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0654|cit654","unstructured":"Co\u015fkun M Questions regarding four of your case reports\/series [personal communication] Email to: EL Ramstad"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0655|cit655","unstructured":"Co\u015fkun M Questions regarding four of your case reports\/series [personal communication] Email to: EL Ramstad"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0656|cit656","unstructured":"Curatolo P Possible inclusion of 'Methylphenidate-induced visual hallucinations' in a Cochrane systematic review [personal communication] Email to: EL Ramstad"},{"issue":"15","key":"10.1002\/14651858.CD012069.pub2-BIB0657|cit657","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1002\/sim.1207","article-title":"Meta-analysis combining parallel and cross-over clinical trials. III: The issue of carry over","volume":"21","author":"Curtin","year":"2002","journal-title":"Statistics in Medicine"},{"issue":"5","key":"10.1002\/14651858.CD012069.pub2-BIB0658|cit658","doi-asserted-by":"publisher","first-page":"e63859","DOI":"10.1371\/journal.pone.0063859","article-title":"Children with ADHD symptoms have a higher risk for reading, spelling and math difficulties in the GINIplus and LISAplus cohort studies","volume":"8","author":"Czamara","year":"2013","journal-title":"PLOS ONE"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0659|cit659","unstructured":"Dahlgren J Questions regarding 'Overweight and obese children with diagnosed attention deficit hyperactivity disorder have a favourable weight loss with methylphenidate - one year data' [personal communication] Email to: EL Ramstad"},{"issue":"8","key":"10.1002\/14651858.CD012069.pub2-BIB0660|cit660","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/S2215-0366(15)00271-0","article-title":"Effect of drugs on the risk of injuries in children with attention deficit hyperactivity disorder: a prospective cohort study","volume":"2","author":"Dalsgaard","year":"2015","journal-title":"Lancet Psychiatry"},{"issue":"9983","key":"10.1002\/14651858.CD012069.pub2-BIB0661|cit661","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.1016\/S0140-6736(14)61684-6","article-title":"Mortality in children, adolescents, and adults with attention deficit hyperactivity disorder: a nationwide cohort study","volume":"385","author":"Dalsgaard","year":"2015","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0662|cit662","unstructured":"Danish Health and Medicines Authority Produktresum\u00e9er-human www.produktresume.dk\/docushare\/dsweb\/View\/Collection-96"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0663|cit663","unstructured":"Davari-Ashtiani R Buspirone versus methylphenidate additional data [personal communication] Email to: T Nilausen"},{"issue":"12","key":"10.1002\/14651858.CD012069.pub2-BIB0664|cit664","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1136\/adc.2009.175562","article-title":"Low quality of reporting adverse drug reactions in paediatric randomised controlled trials","volume":"95","author":"Vries","year":"2010","journal-title":"Archives of Disease in Childhood"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0665|cit665","unstructured":"DeSoysa R Questions regarding your abstract 'Use of methylphenidate for attention-deficit-hyperactivity disorder in childhood' [personal communication] Email to: HB Krogh"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0666|cit666","unstructured":"Dodangi N Questions regarding your abstract 'Duloxetine in comparison with methylphenidate in treatment of adolescents with ADHD' [personal communication] Email to: TD Nilausen"},{"issue":"7109","key":"10.1002\/14651858.CD012069.pub2-BIB0667|cit667","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"issue":"4","key":"10.1002\/14651858.CD012069.pub2-BIB0668|cit668","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s00787-014-0597-9","article-title":"Minor neurodevelopmental impairments are associated with increased occurrence of ADHD symptoms in children born extremely preterm","volume":"24","author":"Elgen","year":"2015","journal-title":"European Child and Adolescent Psychiatry"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0669|cit669","unstructured":"European Medicines Agency Guideline on multiplicity issues in clinical trials Committee for Human Medicinal products (CHMP) 2017"},{"issue":"4","key":"10.1002\/14651858.CD012069.pub2-BIB0670|cit670","doi-asserted-by":"publisher","first-page":"322","DOI":"10.2174\/157015908787386069","article-title":"Dopaminergic and noradrenergic contributions to functionality in ADHD: the role of methylphenidate","volume":"6","author":"Engert","year":"2008","journal-title":"Current Neuropharmacology"},{"issue":"10","key":"10.1002\/14651858.CD012069.pub2-BIB0671|cit671","first-page":"841-50","article-title":"Long-term outcomes of attention-deficit\/hyperactivity disorder and conduct disorder: a systematic review and meta-analysis","volume":"55","author":"Erskine","year":"2016","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD012069.pub2-BIB0672|cit672","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1037\/1064-1297.9.2.163","article-title":"Dose-response effects of methylphenidate on ecologically valid measures of academic performance and classroom behavior in adolescents with ADHD","volume":"9","author":"Evans","year":"2001","journal-title":"Experimental and Clinical Psychopharmacology"},{"issue":"1","key":"10.1002\/14651858.CD012069.pub2-BIB0673|cit673","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0006-3223(00)00889-1","article-title":"Attention-deficit\/hyperactivity disorder in adults: an overview","volume":"48","author":"Faraone","year":"2000","journal-title":"Biological Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD012069.pub2-BIB0674|cit674","doi-asserted-by":"crossref","first-page":"468-73","DOI":"10.1097\/00004714-200210000-00005","article-title":"Comparative efficacy of Adderall and methylphenidate in attention-deficit\/hyperactivity disorder: a meta-analysis.","volume":"22","author":"Faraone","year":"2002","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"4","key":"10.1002\/14651858.CD012069.pub2-BIB0675|cit675","first-page":"4","article-title":"Comparing the efficacy of medications for A DHD using meta-analysis","volume":"8","author":"Faraone","year":"2006","journal-title":"Medscape General Medicine"},{"issue":"6","key":"10.1002\/14651858.CD012069.pub2-BIB0676|cit676","doi-asserted-by":"crossref","first-page":"754","DOI":"10.4088\/JCP.08m04902pur","article-title":"A comparison of the efficacy of medications for adult attention-deficit\/hyperactivity disorder using meta-analysis of effect sizes","volume":"71","author":"Faraone","year":"2010","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0677|cit677","unstructured":"Fern\u00e1ndez-Fern\u00e1mdez MA Interest in including 'Infantile psychosis secondary to methylphenidate' in a Cochrane systematic review [personal communication] Email to: EL Ramstad"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0678|cit678","unstructured":"Fern\u00e1ndez-Fern\u00e1ndez MA Cardiovascular side effects questions on diagnosis and IQ Email to: E Ramstad"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0679|cit679","unstructured":"Fischer R AW: Cochrane review on MPH Email to: OJ Storeb\u00f8"},{"issue":"10","key":"10.1002\/14651858.CD012069.pub2-BIB0680|cit680","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1038\/mp.2011.138","article-title":"The genetics of attention deficit\/hyperactivity disorder in adults, a review","volume":"17","author":"Franke","year":"2012","journal-title":"Molecular Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD012069.pub2-BIB0681|cit681","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1159\/000439273","article-title":"Patterns of methylphenidate use and assessment of its abuse among the general population and individuals with drug dependence","volume":"22","author":"Frauger","year":"2016","journal-title":"European Addiction Research"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0682|cit682","unstructured":"Gadow KD Regarding your study 'Efficacy of methylphenidate for attention-deficit hyperactivity disorder in children with tic disorder' [personal communication] Email to: KD Gadow"},{"issue":"5","key":"10.1002\/14651858.CD012069.pub2-BIB0683|cit683","doi-asserted-by":"crossref","first-page":"38","DOI":"10.7453\/gahmj.2013.008","article-title":"The CARE Guidelines: Consensus-based Clinical Case Reporting Guideline Development","volume":"2","author":"Gagnier","year":"2013","journal-title":"Global Advances in Health and Medicine"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0684|cit684","unstructured":"Galland B Regarding your study [personal communication] Email to: M Holmskov"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0685|cit685","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ejim.2016.03.020","article-title":"Evidence-based clinical practice: overview of threats to the validity of evidence and how to minimise them","volume":"32","author":"Garattini","year":"2016","journal-title":"European Journal of Internal Medicine"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0686|cit686","unstructured":"Gau S Questions regarding your study 'An open-label, randomized, active- controlled equivalent trial of osmotic release oral system methylphenidate in children with attention-deficit\/hyperactivity disorder in Taiwan' [personal communication] Email to: HB Krogh"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0687|cit687","unstructured":"Gau CS Possible inclusion of 'The influence of using methylphenidate on the coming up of psychiatric disorders in children with ADHD' in a Cochrane systematic review [personal communication] Email to: EL Ramstad"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0688|cit688","unstructured":"Ghanizadeh A Questions regarding 'Insomnia, night terror, and depression related to clonidine in attention-deficit\/hyperactivity disorder' [personal communication] Email to: EL Ramstad"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0689|cit689","unstructured":"Ghanizadeh A Questions regarding your study 'Nortriptyline for treating enuresis in ADHD--a randomized double-blind controlled clinical trial' [personal communication] Email to: FL Magnusson"},{"issue":"3","key":"10.1002\/14651858.CD012069.pub2-BIB0690|cit690","doi-asserted-by":"crossref","first-page":"219","DOI":"10.7326\/0003-4819-149-3-200808050-00023","article-title":"Correction: reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses","volume":"149","author":"Gluud","year":"2008","journal-title":"Annals of Internal Medicine"},{"issue":"5","key":"10.1002\/14651858.CD012069.pub2-BIB0691|cit691","doi-asserted-by":"publisher","first-page":"e1001026","DOI":"10.1371\/journal.pmed.1001026","article-title":"Meta-analyses of adverse effects data derived from randomised controlled trials as compared to observational studies: methodological overview","volume":"8","author":"Golder","year":"2011","journal-title":"PLOS Medicine"},{"issue":"2","key":"10.1002\/14651858.CD012069.pub2-BIB0692|cit692","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/BF00919127","article-title":"Normative data on revised Conners Parent and Teacher Rating Scales","volume":"6","author":"Goyette","year":"1978","journal-title":"Journal of Abnormal Child Psychology"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0693|cit693","unstructured":"Gracious B Questions regarding your study 'Atrioventricular nodal re-entrant tachycardia associated with stimulant treatment' [personal communication] Email to: HB Krogh"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0694|cit694","unstructured":"McMaster University (developed by Evidence Prime, Inc.). GRADEpro GDT 2015"},{"issue":"1","key":"10.1002\/14651858.CD012069.pub2-BIB0695|cit695","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00787-010-0140-6","article-title":"European guidelines on managing adverse effects of medication for ADHD","volume":"20","author":"Graham","year":"2011","journal-title":"European Child and Adolescent Psychiatry"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0696|cit696","unstructured":"Grcevich S Questions regarding your study 'Retrospective comparison of Adderall and methylphenidate in the treatment of attention deficit hyperactivity disorder' [personal communication] Email to: HB Krogh"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0697|cit697","unstructured":"Green T Possible inclusion of 'Effect of methylphenidate on neurocognitive functioning in velocardiofacial syndrome: a randomized placebo-controlled trial' in a Cochrane systematic review [personal communication] Email to: EL Ramstad"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0698|cit698","doi-asserted-by":"crossref","unstructured":"Greenhill LL Vitiello B Fisher P Levine J Davies M Abikoff H Comparison of increasingly detailed elicitation methods for the assessment of adverse events in pediatric psychopharmacology Journal of the American Academy of Child and Adolescent Psychiatry 2004 1488 96 10.1097\/01.chi.0000142668.29191.13","DOI":"10.1097\/01.chi.0000142668.29191.13"},{"issue":"11","key":"10.1002\/14651858.CD012069.pub2-BIB0699|cit699","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1097\/01.chi.0000235077.32661.61","article-title":"Efficacy and safety of immediate-release methylphenidate treatment for preschoolers with ADHD","volume":"45","author":"Greenhill","year":"2006","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0700|cit700","unstructured":"Grossman N Questions regarding your study 'Methylphenidate and idiopathic thrombocytopenic purpura--is there an association?' [personal communication] Email to: HB Krogh"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0701|cit701","unstructured":"Gualtieri C Questions regarding your study 'Tryptophan antagonism of stimulant-induced tics' [personal communication] Email to: HB Krogh"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0702|cit702","unstructured":"Guerreiro MM Inclusion of 'Attention deficit disorder: treatment with methylphenidate' in a Cochrane systematic review [personal communication] Email to: EL Ramstad"},{"issue":"4","key":"10.1002\/14651858.CD012069.pub2-BIB0703|cit703","doi-asserted-by":"publisher","first-page":"383-94","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"4","key":"10.1002\/14651858.CD012069.pub2-BIB0704|cit704","doi-asserted-by":"crossref","first-page":"395-400","DOI":"10.1016\/j.jclinepi.2010.09.012","article-title":"GRADE guidelines: 2. Framing the question and deciding on important outcomes","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"4","key":"10.1002\/14651858.CD012069.pub2-BIB0705|cit705","doi-asserted-by":"publisher","first-page":"407-15","DOI":"10.1016\/j.jclinepi.2010.07.017","article-title":"GRADE guidelines: 4. Rating the quality of evidence- study limitations (risk of bias)","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"12","key":"10.1002\/14651858.CD012069.pub2-BIB0706|cit706","doi-asserted-by":"publisher","first-page":"1283-93","DOI":"10.1016\/j.jclinepi.2011.01.012","article-title":"GRADE guidelines 6. Rating the quality of evidence - imprecision","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"12","key":"10.1002\/14651858.CD012069.pub2-BIB0707|cit707","doi-asserted-by":"publisher","first-page":"1294-302","DOI":"10.1016\/j.jclinepi.2011.03.017","article-title":"GRADE guidelines: 7. Rating the quality of evidence - inconsistency","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"12","key":"10.1002\/14651858.CD012069.pub2-BIB0708|cit708","doi-asserted-by":"publisher","first-page":"1303-10","DOI":"10.1016\/j.jclinepi.2011.04.014","article-title":"GRADE guidelines: 8. Rating the quality of evidence - indirectness","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"12","key":"10.1002\/14651858.CD012069.pub2-BIB0709|cit709","doi-asserted-by":"publisher","first-page":"1311-6","DOI":"10.1016\/j.jclinepi.2011.06.004","article-title":"GRADE guidelines: 9. Rating up the quality of evidence","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"2","key":"10.1002\/14651858.CD012069.pub2-BIB0710|cit710","doi-asserted-by":"publisher","first-page":"151-7","DOI":"10.1016\/j.jclinepi.2012.01.006","article-title":"GRADE guidelines: 11. Making an overall rating of confidence in effect estimates for a single outcome and for all outcomes","volume":"66","author":"Guyatt","year":"2013","journal-title":"Journal of Clinical Epidemiology"},{"issue":"2","key":"10.1002\/14651858.CD012069.pub2-BIB0711|cit711","doi-asserted-by":"publisher","first-page":"158-72","DOI":"10.1016\/j.jclinepi.2012.01.012","article-title":"GRADE guidelines: 12. Preparing summary of findings tables - binary outcomes","volume":"66","author":"Guyatt","year":"2013","journal-title":"Journal of Clinical Epidemiology"},{"issue":"2","key":"10.1002\/14651858.CD012069.pub2-BIB0712|cit712","doi-asserted-by":"publisher","first-page":"173-83","DOI":"10.1016\/j.jclinepi.2012.08.001","article-title":"GRADE guidelines: 13. Preparing summary of findings tables and evidence profiles - continuous outcomes","volume":"66","author":"Guyatt","year":"2013","journal-title":"Journal of Clinical Epidemiology"},{"issue":"224","key":"10.1002\/14651858.CD012069.pub2-BIB0713|cit713","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1001\/jama.2011.1830","article-title":"ADHD medications and risk of serious cardiovascular events in young and middle-aged adults","volume":"306","author":"Habel","year":"2011","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0714|cit714","unstructured":"Halevy A Questions regarding 'Methylphenidate induction of complex visual hallucinations' [personal communication] Email to: EL Ramstad"},{"issue":"1","key":"10.1002\/14651858.CD012069.pub2-BIB0715|cit715","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00913458","article-title":"Reading-disabled hyperactive children: a distinct subgroup of attention deficit disorder with hyperactivity?","volume":"12","author":"Halperin","year":"1984","journal-title":"Journal of Abnormal Child Psychology"},{"issue":"3","key":"10.1002\/14651858.CD012069.pub2-BIB0716|cit716","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.jcin.2008.01.008","article-title":"Randomized clinical trials and observational studies: guidelines for assessing respective strengths and limitations","volume":"1","author":"Hannan","year":"2008","journal-title":"JACC Cardiovascular Interventions"},{"issue":"1","key":"10.1002\/14651858.CD012069.pub2-BIB0717|cit717","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/1471-244X-11-176","article-title":"Comparative efficacy and acceptability of methylphenidate andatomoxetine in treatment of attention deficit hyperactivity disorder in children and adolescents: a meta-analysis","volume":"11","author":"Hanwella","year":"2011","journal-title":"BMC Psychiatry"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0718|cit718","unstructured":"Harsanyi Z Questions regarding your study 'Once-daily multilayer-release methylphenidate in a double-blind, crossover comparison to immediate-release methylphenidate in children with attention-deficit\/hyperactivity disorder' [personal communication] Email to: HB Krogh"},{"issue":"9","key":"10.1002\/14651858.CD012069.pub2-BIB0719|cit719","doi-asserted-by":"crossref","first-page":"713","DOI":"10.2165\/00023210-200620090-00002","article-title":"Methylphenidate and its isomers: their role in the treatment of attention-deficit hyperactivity disorder using a transdermal delivery system","volume":"20","author":"Heal","year":"2006","journal-title":"CNS Drugs"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0720|cit720","unstructured":"Hechtman L 'Treatment of ADHD in patients unresponsive to methylphenidate' [personal communication] Email to: HB Krogh"},{"issue":"9","key":"10.1002\/14651858.CD012069.pub2-BIB0721|cit721","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1002\/pds.1992","article-title":"Cardiovascular safety of ADHD medications: rationale for and design of an investigator-initiated observational study","volume":"19","author":"Hennessy","year":"2010","journal-title":"Pharmacoepidemiology and Drug Safety"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0722|cit722","unstructured":"Heyman I Questions regarding your case report 'Dexamphetamine for obsessive- compulsive disorder' [personal communication] Email to: HB Krogh"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0723|cit723","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"2","key":"10.1002\/14651858.CD012069.pub2-BIB0724|cit724","doi-asserted-by":"publisher","first-page":"PCC.10m01031","DOI":"10.4088\/PCC.10m01031","article-title":"Risk of injury associated with attention-deficit\/hyperactivity disorder in adults enrolled in employer-sponsored health plans: a retrospective analysis","volume":"13","author":"Hodgkins","year":"2011","journal-title":"Primary Care Companion for CNS Disorders"},{"issue":"7","key":"10.1002\/14651858.CD012069.pub2-BIB0725|cit725","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1007\/s00431-013-1969-8","article-title":"Management of ADHD in children across Europe: patient demographics, physician characteristics and treatment patterns","volume":"172","author":"Hodgkins","year":"2013","journal-title":"European Journal of Pediatrics"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0726|cit726","unstructured":"Hollis C Questions regarding your case report 'Acute dyskinesia on starting methylphenidate after risperidone withdrawal' [personal communication] Email to: HB Krogh"},{"issue":"1-2","key":"10.1002\/14651858.CD012069.pub2-BIB0727|cit727","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.psychres.2014.05.049","article-title":"Blood manganese levels in relation to comorbid behavioral and emotional problems in children with attention-deficit\/hyperactivity disorder","volume":"220","author":"Hong","year":"2014","journal-title":"Psychiatry Research"},{"issue":"3","key":"10.1002\/14651858.CD012069.pub2-BIB0728|cit728","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1289\/ehp.1307420","article-title":"Environmental lead exposure and attention deficit\/hyperactivity disorder symptom domains in a community sample of South Korean school-age children","volume":"123","author":"Hong","year":"2015","journal-title":"Environmental Health Perspectives"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0729|cit729","unstructured":"Houmann T Inclusion of INDICES in a Cochrane systematic review [personal communication] Email to: EL Ramstad"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0730|cit730","unstructured":"Hulvershorn LA Methylphenidate [personal communication] Email to: EL Ramstad"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0731|cit731","unstructured":"Hungund A Questions regarding the study 'Methylphenidate oral dose plasma concentrations and behavioral response in children' [personal communication] Email to: HB Krogh"},{"issue":"2","key":"10.1002\/14651858.CD012069.pub2-BIB0732|cit732","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1001\/jamapsychiatry.2017.3644","article-title":"Association between methylphenidate and amphetamine use in pregnancy and risk of congenital malformations: a cohort study from the international pregnancy safety study consortium","volume":"75","author":"Huybrechts","year":"2018","journal-title":"JAMA Psychiatry"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0733|cit733","unstructured":"International Council for Harmonisation Expert Working Group International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use. ICH harmonised tripartite guideline. Guideline for good clinical practice E6(R1) 1996 www.ich.org\/fileadmin\/Public_Web_Site\/ICH_Products\/Guidelines\/Efficacy\/E6\/E6_R1_Guideline.pdf"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0734|cit734","unstructured":"Ilgenli F Regarding your study 'Acute effect of methylphenidate on QT interval duration and dispersion in children with attention deficit hyperactivity disorder' [personal communication] Email to: TD Nilausen"},{"issue":"5","key":"10.1002\/14651858.CD012069.pub2-BIB0735|cit735","doi-asserted-by":"publisher","first-page":"F445","DOI":"10.1136\/adc.2003.038943","article-title":"Psychiatric symptoms and disorders in adolescents with low birth weight","volume":"89","author":"Indredavik","year":"2004","journal-title":"Archives of Disease in Childhood. Fetal and Neonatal Edition"},{"issue":"9142","key":"10.1002\/14651858.CD012069.pub2-BIB0736|cit736","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1016\/S0140-6736(05)79825-1","article-title":"Reporting of safety data from randomised trials","volume":"352","author":"Ioannidis","year":"1998","journal-title":"Lancet"},{"issue":"19","key":"10.1002\/14651858.CD012069.pub2-BIB0737|cit737","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1001\/archinternmed.2009.313","article-title":"Adverse events in randomized trials: neglected, restricted, distorted, and silenced","volume":"169","author":"Ioannidis","year":"2009","journal-title":"Archives of Internal Medicine"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0738|cit738","unstructured":"Irmak A Supplemental data (treatment choice in association of ADHD with Williams and Moebius Syndromes) [personal communication] Email to: MJ Kielsholm"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0739|cit739","doi-asserted-by":"publisher","first-page":"i2874","DOI":"10.1136\/bmj.i2874","article-title":"The cardiovascular safety of methylphenidate","volume":"353","author":"Jackson","year":"2016","journal-title":"BMJ"},{"issue":"2","key":"10.1002\/14651858.CD012069.pub2-BIB0740|cit740","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1097\/00004583-200102000-00009","article-title":"ADHD comorbidity findings from the MTA study: comparing comorbid subgroups","volume":"40","author":"Jensen","year":"2001","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0741|cit741","unstructured":"Jones A Inquiry to Celgene regarding dexmethylphenidate HCI [personal communication] Email to: HB Krogh"},{"issue":"4","key":"10.1002\/14651858.CD012069.pub2-BIB0742|cit742","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1111\/1469-7610.00742","article-title":"The comorbidity of ADHD in the general population of Swedish school-age children","volume":"42","author":"Kadesj\u00f6","year":"2001","journal-title":"Journal of Child Psychology and Psychiatry and Allied Disciplines"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0743|cit743","volume-title":"ADHD in Children and Adults","author":"Kadesj\u00f6","year":"2002"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0744|cit744","unstructured":"Karabekiroglu K Questions regarding your study 'Can we predict short-term side effects of methylphenidate immediate-release?' [personal communication] Email to: SS Nielsen"},{"issue":"6","key":"10.1002\/14651858.CD012069.pub2-BIB0745|cit745","doi-asserted-by":"crossref","first-page":"457-70","DOI":"10.2165\/00003088-199937060-00002","article-title":"Pharmacokinetics and clinical effectiveness of methylphenidate","volume":"37","author":"Kimko","year":"1999","journal-title":"Clinical Pharmacokinetics"},{"issue":"11","key":"10.1002\/14651858.CD012069.pub2-BIB0746|cit746","doi-asserted-by":"crossref","first-page":"982","DOI":"10.7326\/0003-4819-135-11-200112040-00010","article-title":"Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses","volume":"135","author":"Kjaergard","year":"2001","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0747|cit747","unstructured":"Klykylo WM Questions regarding your study 'Medication-induced seizures' [personal communication] Email to: HB Krogh"},{"issue":"8","key":"10.1002\/14651858.CD012069.pub2-BIB0748|cit748","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1080\/15389588.2015.1029068","article-title":"Traffic and criminal behavior of adults with attention deficit-hyperactivity with a prospective follow-up from birth to the age of 40 years","volume":"16","author":"Koisaari","year":"2015","journal-title":"Traffic Injury Prevention"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0749|cit749","volume-title":"Children's Depression Inventory","author":"Kovacs","year":"1992"},{"issue":"8","key":"10.1002\/14651858.CD012069.pub2-BIB0750|cit750","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1007\/s00787-014-0641-9","article-title":"Maternal smoking and offspring inattention and hyperactivity: results from a cross-national European survey","volume":"24","author":"Kovess","year":"2015","journal-title":"European Child and Adolescent Psychiatry"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0751|cit751","unstructured":"Kratochvil C Questions regarding your study 'Atomoxetine and methylphenidate treatment in children with ADHD: a prospective, randomized, open-label trial' [personal communication] Email to: FL Magnusson"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0752|cit752","unstructured":"Lakic A Answers to questions [personal communication] Email to: EL Ramstad"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0753|cit753","unstructured":"Larra\u00f1aga-Fragoso P Questions regarding your study 'The effects of methylphenidate on refraction and anterior segment parameters in children with attention deficit hyperactivity disorder' [personal communication Email to: SS Nielsen"},{"issue":"5","key":"10.1002\/14651858.CD012069.pub2-BIB0754|cit754","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/jcpp.12140","article-title":"Family income in early childhood and subsequent attention deficit\/hyperactivity disorder: a quasi-experimental study","volume":"55","author":"Larsson","year":"2014","journal-title":"Journal of Child Psychology and Psychiatry and Allied Disciplines"},{"issue":"4","key":"10.1002\/14651858.CD012069.pub2-BIB0755|cit755","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1097\/00004583-198907000-00015","article-title":"The Yale Global Tic Severity Scale: initial testing of a clinician-rated scale of tic severity","volume":"28","author":"Leckman","year":"1989","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0756|cit756","unstructured":"Lee M This is more data about BP [personal communication] Email to: M Holmskov"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0757|cit757","unstructured":"Lewis J IQ in glaucoma patient treated with methylphenidate [personal communication] Email to: OJ Storeb\u00f8"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0758|cit758","unstructured":"Li AY Questions regarding your study [personal communication] Email to: HB Krogh"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0759|cit759","doi-asserted-by":"publisher","first-page":"b2700","DOI":"10.1136\/bmj.b2700","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration","volume":"339","author":"Liberati","year":"2009","journal-title":"BMJ"},{"issue":"21","key":"10.1002\/14651858.CD012069.pub2-BIB0760|cit760","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1056\/NEJMoa1203241","article-title":"Medication for attention deficit-hyperactivity disorder and criminality","volume":"367","author":"Lichtenstein","year":"2012","journal-title":"Engl J Med"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0761|cit761","unstructured":"Loke YK Price D Herxheimer A Chapter 14: Adverse effects. In Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbok.cochrane.org"},{"issue":"12","key":"10.1002\/14651858.CD012069.pub2-BIB0762|cit762","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.MR000033.pub2","article-title":"Industry sponsorship and research outcome","author":"Lundh","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD012069.pub2-BIB0763|cit763","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.MR000033.pub3","article-title":"Industry sponsorship and research outcome","author":"Lundh","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0764|cit764","unstructured":"Machado A Possible inclusion of 'Is methylphenidate-induced chorea responsive to chlorpromazine?' in a Cochrane systematic review [personal communication] Email to: A Machado"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0765|cit765","doi-asserted-by":"crossref","unstructured":"Maia CR Cortese S Caye A Deakin TK Polanczyk GV Polanczyk GV Long-term efficacy of methylphenidate immediate-release for the treatment of childhood ADHD Journal of Attention Disorders 2017 3 13 10.1177\/1087054714559643","DOI":"10.1177\/1087054714559643"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0766|cit766","unstructured":"McLaren JL Questions regarding your case study 'Aripiprazole induced acute dystonia after discontinuation of a stimulant medication' [personal communication] Email to: HB Krogh"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0767|cit767","unstructured":"Medicines and Healthcare Products Regulatory Agency (MHRA) Medicines information: SPC & PILs www.mhra.gov.uk\/Safetyinformation\/Medicinesinformation\/SPCandPILs\/"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0768|cit768","unstructured":"Mohammadi MR Questions regarding 'Amantadine versus methylphenidate in children and adolescents with attention deficit\/hyperactivity disorder: a randomized, double- blind trial' [personal communication] Email to: EL Ramstad"},{"issue":"9128","key":"10.1002\/14651858.CD012069.pub2-BIB0769|cit769","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0140-6736(98)01085-X","article-title":"Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analysis?","volume":"352","author":"Moher","year":"1998","journal-title":"Lancet"},{"issue":"7","key":"10.1002\/14651858.CD012069.pub2-BIB0770|cit770","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Medicine"},{"issue":"1","key":"10.1002\/14651858.CD012069.pub2-BIB0771|cit771","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2046-4053-4-1","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement","volume":"4","author":"Moher","year":"2015","journal-title":"Systematic Reviews"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0772|cit772","unstructured":"Monta\u00f1es-Rada F Possible inclusion of '50\/50 prolonged-release methylphenidate (medikinet\u00ae) twice daily, prospective open study' in a Cochrane systematic review [personal communication] Email to: EL Ramstad"},{"issue":"12","key":"10.1002\/14651858.CD012069.pub2-BIB0773|cit773","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1001\/archpsyc.56.12.1073","article-title":"A 14-month randomized clinical trial of treatment strategies for attention-deficit\/hyperactivity disorder. The MTA Cooperative Group","volume":"56","author":"MTA Cooperation Group","year":"1999","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0774|cit774","unstructured":"Mueller B Supplemental information [personal communication] Email to: ML Kielsholm"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0775|cit775","unstructured":"Munk K Supplementary data [personal communication] Email to: ML Kielsholm"},{"issue":"15","key":"10.1002\/14651858.CD012069.pub2-BIB0776|cit776","doi-asserted-by":"publisher","first-page":"2618","DOI":"10.1002\/sim.2477","article-title":"Sample sizes for self-controlled case series studies","volume":"25","author":"Musonda","year":"2006","journal-title":"Statistics in Medicine"},{"issue":"7","key":"10.1002\/14651858.CD012069.pub2-BIB0777|cit777","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/j.jclinepi.2013.02.004","article-title":"The GRADE approach is reproducible in assessing the quality of evidence of quantitative evidence syntheses","volume":"66","author":"Mustafa","year":"2013","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0778|cit778","volume-title":"A Decade Later: A Follow-up of Social Class and Mental Illness","author":"Myers","year":"1968"},{"issue":"2","key":"10.1002\/14651858.CD012069.pub2-BIB0779|cit779","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0780|cit780","unstructured":"National Collaborating Centre for Mental Health (NCCMH) commissioned by the National Institute for Health and Clinical Excellence Attention deficit hyperactivity disorder: diagnosis and management of ADHD in children, young people and adults. National Clinical Practice Guideline Number 72 www.nccmh.org.uk\/downloads\/ADHD\/CG72FullGuideline.pdf"},{"issue":"9","key":"10.1002\/14651858.CD012069.pub2-BIB0781|cit781","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.jaac.2010.06.008","article-title":"Meta-analysis of genome-wide association studies of attention-deficit\/hyperactivity disorder","volume":"49","author":"Neale","year":"2010","journal-title":"Journal of the American Academy of Child & Adolescent Psychiatry"},{"issue":"Suppl 12","key":"10.1002\/14651858.CD012069.pub2-BIB0782|cit782","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1017\/S1092852900003199","article-title":"Co-morbidity in adults with ADHD","volume":"13","author":"Newcorn","year":"2008","journal-title":"CNS Spectrums"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0783|cit783","unstructured":"National Collaborating Centre for Mental Health (NCCMH) commissioned by the National Institute for Health and Clinical Excellence Attention deficit hyperactivity disorder: diagnosis and management of ADHD in children, young people and adults. National Clinical Practice Guideline Number 72 www.nice.org.uk\/guidance\/cg72\/resources\/attention-deficit-hyperactivity-disorder-diagnosis-and-management-975625063621"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0784|cit784","unstructured":"Niederhofer H Questions regarding your study 'Combining carbamazepine, neuroleptics and acetylcholinesterase inhibitors with methylphenidate only reduces adverse side effects, but is less effective than a combination with atomoxetine' [personal communication] Email to: HB Krogh"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0785|cit785","unstructured":"Niederhofer H Questions regarding your study 'Combining carbamazepine, neuroleptics and acetylcholinesterase inhibitors with methylphenidate only reduces adverse side effects, but is less effective than a combination with atomoxetine' [personal communication] Email to: HB Krogh"},{"issue":"3","key":"10.1002\/14651858.CD012069.pub2-BIB0786|cit786","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1017\/S0954579405050376","article-title":"An integrative theory of attention-deficit\/hyperactivity disorder based on the cognitive and affective neurosciences","volume":"17","author":"Nigg","year":"2005","journal-title":"Development and Psychopathology"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0787|cit787","doi-asserted-by":"crossref","unstructured":"Obel C Zhu JL Olsen J Breining S Li J Gr\u00f8nborg TK The risk of attention deficit hyperactivity disorder in children exposed to maternal smoking during pregnancy - a reexamination using a sibling design Journal of Child Psychology and Psychiatry 2016 532 7 10.1111\/jcpp.12478","DOI":"10.1111\/jcpp.12478"},{"issue":"8","key":"10.1002\/14651858.CD012069.pub2-BIB0788|cit788","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1093\/sleep\/23.8.1d","article-title":"The Children's Sleep Habits Questionnaire (CSHQ): psychometric properties of a survey instrument for school-aged children","volume":"23","author":"Owens","year":"2000","journal-title":"Sleep"},{"issue":"8","key":"10.1002\/14651858.CD012069.pub2-BIB0789|cit789","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S2215-0366(17)30166-9","article-title":"Quetiapine extended release versus aripiprazole in children and adolescents with first-episode psychosis: the multicentre, double-blind, randomised tolerability and efficacy of antipsychotics (TEA) trial","volume":"4","author":"Pagsberg","year":"2017","journal-title":"Lancet Psychiatry"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0790|cit790","unstructured":"Panei P Questions regarding your study 'The Italian ADHD National Registry' [personal communication] Email to: HB Krogh"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0791|cit791","unstructured":"Panei P Questions regarding your study 'Safety of methylphenidate and atomoxetine in children with attention-deficit\/hyperactivity disorder (ADHD): data from the Italian National ADHD Registry' [personal communication] Email to: HB Krogh"},{"issue":"9","key":"10.1002\/14651858.CD012069.pub2-BIB0792|cit792","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1176\/appi.ajp.161.9.1692","article-title":"Safety reporting in randomized trials of mental health interventions","volume":"161","author":"Papanikolaou","year":"2004","journal-title":"American Journal of Psychiatry"},{"issue":"7","key":"10.1002\/14651858.CD012069.pub2-BIB0793|cit793","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.braindev.2006.11.010","article-title":"Attention and executive functions profile in drug naive ADHD subtypes","volume":"29","author":"Pasini","year":"2007","journal-title":"Brain and Development"},{"issue":"2","key":"10.1002\/14651858.CD012069.pub2-BIB0794|cit794","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1080\/02796015.1993.12085647","article-title":"Pharmacotherapy for children with attention-deficit hyperactivity disorder","volume":"22","author":"Pelham","year":"1993","journal-title":"School Psychology Review"},{"issue":"6","key":"10.1002\/14651858.CD012069.pub2-BIB0795|cit795","doi-asserted-by":"publisher","first-page":"E105","DOI":"10.1542\/peds.107.6.e105","article-title":"Once-a-day Concerta methylphenidate versus three-times-daily methylphenidate in laboratory and natural settings","volume":"107","author":"Pelham","year":"2001","journal-title":"Pediatrics"},{"issue":"2","key":"10.1002\/14651858.CD012069.pub2-BIB0796|cit796","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1037\/1064-1297.13.2.111","article-title":"Transdermal methylphenidate, behavioral, and combined treatment for children with ADHD","volume":"13","author":"Pelham","year":"2005","journal-title":"Experimental and Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0797|cit797","unstructured":"Perera H Questions regarding your study 'Assessment of outcome of an ADHD treatment program using parent feedback' [personal communication] Email to: SS Nielsen"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0798|cit798","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.jad.2014.06.053","article-title":"Comorbidity between attention deficit hyperactivity disorder (ADHD) and bipolar disorder in a specialized mood disorders outpatient clinic","volume":"168","author":"Perroud","year":"2014","journal-title":"Journal of Affective Disorders"},{"issue":"19","key":"10.1002\/14651858.CD012069.pub2-BIB0799|cit799","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1001\/archinternmed.2009.306","article-title":"Reporting of safety results in published reports of randomized controlled trials","volume":"169","author":"Pitrou","year":"2009","journal-title":"Archives of Internal Medicine"},{"issue":"7","key":"10.1002\/14651858.CD012069.pub2-BIB0800|cit800","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1097\/chi.0b013e318054e724","article-title":"Practice parameter for the assessment and treatment of children and adolescents with attention-deficit\/hyperactivity disorder","volume":"46","author":"Pliszka","year":"2007","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD012069.pub2-BIB0801|cit801","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1097\/YCO.0b013e3281568d7a","article-title":"Epidemiology of attention-deficit\/hyperactivity disorder across the lifespan","volume":"20","author":"Polanczyk","year":"2007","journal-title":"Current Opinion in Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD012069.pub2-BIB0802|cit802","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1093\/ije\/dyt261","article-title":"ADHD prevalence estimates across three decades: an updated systematic review and meta-regression analysis","volume":"43","author":"Polanczyk","year":"2014","journal-title":"International Journal of Epidemiology"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0803|cit803","doi-asserted-by":"crossref","unstructured":"Poulton A Questions regarding your study 'Slowing of growth in height and weight on stimulants: a characteristic pattern' (2003) [personal communication] Email to: HB Krogh","DOI":"10.1046\/j.1440-1754.2003.00107.x"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0804|cit804","unstructured":"Poulton A Questions [personal communication] Email to: H Krogh"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0805|cit805","unstructured":"Pranav D Supplemental information [personal communication] Email to: Kielsholm ML"},{"issue":"1","key":"10.1002\/14651858.CD012069.pub2-BIB0806|cit806","doi-asserted-by":"crossref","first-page":"ns","DOI":"10.21307\/sjcapp-2018-003","article-title":"Hallicunations and other psychotic symptoms in response to methylphenidate in children and adolescents with attention deficit hyperactivity disorder (ADHD): a Cochrane Systematic Review with Meta-analysis and Trial Sequential Analysis.","volume":"6","author":"Ramstad","year":"2018 [Epub ahead of print]","journal-title":"Scandinavian Journal of Child and Adolescent Psychiatry and Psychology"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0807|cit807","unstructured":"Rappaport N Psychopharmacology in the school setting [personal communication] Email to: Krogh HB"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0808|cit808","unstructured":"Rashid J Questions regarding 'Methylphenidate and somatic hallucinations' - possible inclusion in a Cochrane systematic review [personal communication] Email to: Ramstad EL"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0809|cit809","unstructured":"Reeves BC Deeks JJ Higgins JPT Wells GA Chapter 14: Including non-randomized studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0810|cit810","unstructured":"Nordic Cochrane Centre, The Cochrane Collaboration Review Manager 5 (RevMan 5) 2014"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0811|cit811","volume-title":"Revised Children's Manifest Anxiety Scale. RCMAS Manual","author":"Reynolds","year":"1985"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0812|cit812","unstructured":"Ririe D Questions regarding your study 'Unexpected interaction of methylphenidate (Ritalin) with anaesthetic agents' [personal communication] Email to: HB Krogh"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0813|cit813","unstructured":"Roland F Questions regarding your study 'Comparison of the efficacy of two different modified release methylphenidate preparations for children and adolescents with attention-deficit\/hyperactivity disorder in a natural setting' [personal communication] Email to: HB Krogh"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0814|cit814","unstructured":"Sabuncuoglu O Severe adverse events IQ questions [personal communication] Email to: HB Krogh"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0815|cit815","unstructured":"Saieh AC Possible inclusion of 'Methylphenidate: high blood pressure, an effect to take into account' in a Cochrane systematic review [personal communication] Emails to: EL Ramstad (23 October, 2 December 2013)"},{"issue":"35","key":"10.1002\/14651858.CD012069.pub2-BIB0816|cit816","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta16350","article-title":"Influence of reported study design characteristics on intervention effect estimates from randomised controlled trials: combined analysis of meta-epidemiological studies","volume":"16","author":"Savovi\u0107","year":"2012","journal-title":"Health Technology Assessment"},{"issue":"6","key":"10.1002\/14651858.CD012069.pub2-BIB0817|cit817","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1097\/00004583-199706000-00023","article-title":"Children's Yale-Brown Obsessive Compulsive Scale: reliability and validity","volume":"36","author":"Scahill","year":"1997","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD012069.pub2-BIB0818|cit818","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S1056-4993(18)30106-8","article-title":"Epidemiology of ADHD in school-age children","volume":"9","author":"Scahill","year":"2000","journal-title":"Child and Adolescent Psychiatric Clinics of North America"},{"issue":"6","key":"10.1002\/14651858.CD012069.pub2-BIB0819|cit819","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1097\/00004583-199706000-00011","article-title":"Behavioral, situational, and temporal effects of treatment of ADHD with methylphenidate","volume":"36","author":"Schachar","year":"1997","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0820|cit820","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/1471-244X-9-58","article-title":"Developmental psychopathology: attention deficit hyperactivity disorder (ADHD)","volume":"9","author":"Schmidt","year":"2009","journal-title":"BMC Psychiatry"},{"issue":"8","key":"10.1002\/14651858.CD012069.pub2-BIB0821|cit821","doi-asserted-by":"publisher","first-page":"e1002101","DOI":"10.1371\/journal.pmed.1002101","article-title":"Assessment of adverse events in protocols, clinical study reports, and published papers of trials of Orlistat: a document analysis","volume":"13","author":"Schroll","year":"2016","journal-title":"PLOS Medicine"},{"issue":"36","key":"10.1002\/14651858.CD012069.pub2-BIB0822|cit822","doi-asserted-by":"publisher","first-page":"615","DOI":"10.3238\/arztebl.2010.0615","article-title":"The changing prevalence of attention-deficit\/hyperactivity disorder and methylphenidate prescriptions: a study of data from a random sample of insurees of the AOK Health Insurance Company in the German state of Hesse, 2000-2007","volume":"107","author":"Schubert","year":"2010","journal-title":"Deutsches \u00c4rzteblatt International"},{"issue":"5","key":"10.1002\/14651858.CD012069.pub2-BIB0823|cit823","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.1995.03520290060030","article-title":"Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials","volume":"273","author":"Schulz","year":"1995","journal-title":"JAMA"},{"issue":"9","key":"10.1002\/14651858.CD012069.pub2-BIB0824|cit824","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1001\/archgenpsychiatry.2011.2053","article-title":"Common and unique therapeutic mechanisms of stimulant and nonstimulant treatments for attention-deficit\/hyperactivity disorder","volume":"69","author":"Schulz","year":"2012","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0825|cit825","unstructured":"Schumock G Questions regarding your study 'Drugs associated with adverse events in children and adolescents' [personal communication] Email to: ML Kielsholm"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0826|cit826","unstructured":"Schwartz RH Questions regarding 'Stuttering priapism associated with withdrawal from sustained-release methylphenidate' [personal communication] Email to: EL Ramstad"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0827|cit827","unstructured":"Scottish Intercollegiate Guidelines Network (SIGN) Management of attention deficit and hyperkinetic disorders in children and young people. A national clinical guideline www.sign.ac.uk\/pdf\/sign112.pdf"},{"issue":"7","key":"10.1002\/14651858.CD012069.pub2-BIB0828|cit828","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.neubiorev.2003.08.004","article-title":"The top and the bottom of ADHD: a neuropsychological perspective","volume":"27","author":"Sergeant","year":"2003","journal-title":"Neuroscience and Biobehavioural Reviews"},{"issue":"7","key":"10.1002\/14651858.CD012069.pub2-BIB0829|cit829","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1097\/00004583-199607000-00012","article-title":"The NIMH Diagnostic Interview Schedule for Children Version 2.3 (DISC-2.3): description, acceptability, prevalence rates, and performance in the MECA Study. Methods for the Epidemiology of Child and Adolescent Mental Disorders Study","volume":"35","author":"Shaffer","year":"1996","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0830|cit830","unstructured":"Shalev RS Possible inclusion of 'Hallucinations during methylphenidate therapy' in a Cochrane systematic review [personal communication] Email to: EL Ramstad"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0831|cit831","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/1741-7015-10-99","article-title":"A systematic review and analysis of long-term outcomes in attention deficit hyperactivity disorder: effects of treatment and non-treatment","volume":"10","author":"Shaw","year":"2012","journal-title":"BMC Medicine"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0832|cit832","unstructured":"Shibib S Questions regarding 'Stimulant induced psychosis' - possible inclusion in a Cochrane systematic review [personal communication] Email to: EL Ramstad"},{"issue":"2","key":"10.1002\/14651858.CD012069.pub2-BIB0833|cit833","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.amjmed.2008.09.030","article-title":"From randomized controlled trials to observational studies","volume":"122","author":"Silverman","year":"2009","journal-title":"American Journal of Medicine"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0834|cit834","unstructured":"Sinzig J Questions regarding your study 'Waiver of diagnosis before starting and undergoing therapy with methylphenidate: dangerous or justified' [personal communication] Email to: HB Krogh"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0835|cit835","unstructured":"Skoog M Saarim\u00e4ki JM Gluud C Sheinin M Erlendsson K Aamdal S Transparency and registration in clinical research in the Nordic countries NordicTrial Alliance, NordForsk 2015 1 108"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0836|cit836","unstructured":"Smeeth L Questions regarding your abstract 'Spontaneous report safety signals profile and comparative Bayesian analysis of ADHD medication in children in the UK' [personal communication] Email to: HB Krogh"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0837|cit837","unstructured":"Sobanski E Regarding your study 'A non-interventional study of extended-release methylphenidate in the routine treatment of adolescents with ADHD: effectiveness, safety and adherence to treatment' [personal communication] Email to: M Holmskov"},{"issue":"1","key":"10.1002\/14651858.CD012069.pub2-BIB0838|cit838","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/S0166-4328(97)00175-7","article-title":"Neuropsychopharmacological mechanisms of stimulant drug action in attention-deficit hyperactivity disorder: a review and integration","volume":"94","author":"Solanto","year":"1998","journal-title":"Behavioural Brain Research"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0839|cit839","unstructured":"Soyata A Supplemental information [personal communication] Email to: MJ Kielsholm"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0840|cit840","unstructured":"Sterne JAC Higgins JPT Reeves BC on behalf of the development group for ACROBAT-NRSI A Cochrane Risk Of Bias Assessment Tool: for Non-Randomised Studies of Interventions (ACROBAT-NRSI), Version 1.0.0, 24 September 2014 www.riskofbias.info"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0841|cit841","doi-asserted-by":"crossref","unstructured":"Sterne JA Hern\u00e1n MA Reeves BC Savovi\u0107 J Berkman ND Viswanathan M ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions BMJ 2016 10.1136\/bmj.i4919","DOI":"10.1136\/bmj.i4919"},{"issue":"5","key":"10.1002\/14651858.CD012069.pub2-BIB0842|cit842","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/S0031-3955(16)36764-5","article-title":"Stimulant medication therapy in the treatment of children with attention deficit hyperactivity disorder","volume":"36","author":"Stevenson","year":"1989","journal-title":"Pediatric Clinics of North America"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0843|cit843","unstructured":"Stopper H Question regarding your study 'Does methylphenidate cause a cytogenetic effect in children with attention deficit hyperactivity disorder?' [personal communication] Email to: EL Ramstad"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0844|cit844","unstructured":"Stopper H Questions regarding your study 'Does methylphenidate cause a cytogenetic effect in children with attention deficit hyperactivity disorder?' for a Cochrane Systematic Review [personal communication] Email to: HB Krogh"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0845|cit845","unstructured":"Stopper H AW: Questions regarding your study Email to: HB Krogh"},{"issue":"11","key":"10.1002\/14651858.CD012069.pub2-BIB0846|cit846","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009885.pub2","article-title":"Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD)","author":"Storeb\u00f8","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD012069.pub2-BIB0847|cit847","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1001\/archpsyc.60.2.204","article-title":"Development of a new once-a-day formulation of methylphenidate for the treatment of attention-deficit\/hyperactivity disorder: proof-of-concept and proof-of-product studies","volume":"60","author":"Swanson","year":"2003","journal-title":"Archives of General Psychiatry"},{"issue":"3 Pt 1","key":"10.1002\/14651858.CD012069.pub2-BIB0848|cit848","doi-asserted-by":"crossref","first-page":"e206","DOI":"10.1542\/peds.113.3.e206","article-title":"A comparison of once-daily extended-release methylphenidate formulations in children with attention-deficit\/hyperactivity disorder in the laboratory school (the Comacs study)","volume":"113","author":"Swanson","year":"2004","journal-title":"Pediatrics"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0849|cit849","unstructured":"Swanson J The MTA follow-up into adolescence: implications for personalized treatment International Society for Research in Child and Adolescent Psychopathology (ISRCAP); 2009 June 19, Seattle 2009"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0850|cit850","unstructured":"Tasdelen BI Supplemental information [personal communication] Email to: SS Nielsen"},{"issue":"4","key":"10.1002\/14651858.CD012069.pub2-BIB0851|cit851","doi-asserted-by":"publisher","first-page":"e994","DOI":"10.1542\/peds.2014-3482","article-title":"Prevalence of attention-deficit\/hyperactivity disorder: a systematic review and meta-analysis","volume":"135","author":"Thomas","year":"2015","journal-title":"Pediatrics"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0852|cit852","unstructured":"Thorell L Possible inclusion of 'Children's self-reports on perceived effects on taking stimulant medication for ADHD' in a Cochrane systematic review [personal communication] Email to: EL Ramstad"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0853|cit853","unstructured":"Tom\u00e1s Vila M Questions regarding 'Visual hallucinations caused by methylphenidate' - possible inclusion in a Cochrane systematic review [personal communication] Email to: EL Ramstad"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0854|cit854","unstructured":"Tom\u00e1s Vila M Possible inclusion of 'Methylphenidate and sleep: Results of a multicentre study on a population of children with attention deficit hyperactivity disorder' in a Cochrane systematic review [personal communication] Email to: EL Ramstad"},{"issue":"4","key":"10.1002\/14651858.CD012069.pub2-BIB0855|cit855","doi-asserted-by":"publisher","first-page":"435-41","DOI":"10.1002\/pds.2348","article-title":"Trends in the consumption of attention deficit hyperactivity disorder medications in Castilla y Le\u00f3n (Spain): changes in the consumption pattern following the introduction of extended release methylphenidate","volume":"21","author":"Trece\u00f1o","year":"2012","journal-title":"Pharmacoepidemiology and Drug Safety"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0856|cit856","unstructured":"Trugman J Questions regarding your case report 'Cerebral arteritis and oral methylphenidate' [personal communication] Email to: HB Krogh"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0857|cit857","unstructured":"T\u00f8ll\u00f8fsrud C About the article 'Young man with acute dilated cardiomyopathy' [personal communication] Email to: HB Krogh"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0858|cit858","unstructured":"US Food Drug Administration (FDA) Communication about an ongoing safety review of stimulant medications used in children with attention-deficit\/hyperactivity disorder (ADHD) 1.usa.gov\/1M5AYoq"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0859|cit859","unstructured":"US Food Drug Administration (FDA) FDA approved drug products www.accessdata.fda.gov\/scripts\/cder\/drugsatfda\/index.cfm"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0860|cit860","unstructured":"Valdiz\u00e1n Us\u00f3n JR Regarding your study 'Response to methylphenidate by adult and pediatric patients with attention-deficit\/hyperactivity disorder: the Spanish multicenter DIHANA study' [personal communication] Email to: M Holmskov"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0861|cit861","unstructured":"Van der Oord S Regarding your study 'Does brief, clinically based, intensive multimodal behavior therapy enhance the effects of methylphenidate in children with ADHD?' [personal communication] Email to: TD Nilausen"},{"issue":"3","key":"10.1002\/14651858.CD012069.pub2-BIB0862|cit862","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1542\/peds.2014-3143","article-title":"Mental health of extremely low birth weight survivors in their 30s","volume":"135","author":"Lieshout","year":"2015","journal-title":"Pediatrics"},{"issue":"5","key":"10.1002\/14651858.CD012069.pub2-BIB0863|cit863","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1503\/cmaj.051484","article-title":"What is the best evidence for determining harms of medical treatment?","volume":"174","author":"Vandenbroucke","year":"2006","journal-title":"Canadian Medical Association Journal"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0864|cit864","unstructured":"Vashi N Questions regarding your article 'Allergic contact dermatitis caused by methylphenidate' [personal communication] Email to: HB Krogh"},{"issue":"3","key":"10.1002\/14651858.CD012069.pub2-BIB0865|cit865","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1523\/JNEUROSCI.4461-11.2012","article-title":"Methylphenidate-elicited dopamine increases in ventral striatum are associated with long-term symptom improvement in adults with attention deficit hyperactivity disorder","volume":"32","author":"Volkow","year":"2012","journal-title":"Journal of Neuroscience"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0866|cit866","unstructured":"Wang LJ Regarding two of your studies from 2011 [personal communication] Email to: TD Nilausen"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0867|cit867","unstructured":"Weber P Questions regarding your study 'Nebenwirkungen einer Methylphenidat-Therapie bei Schulkindern' [personal communication] Email to: HB Krogh"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0868|cit868","volume-title":"International Classification of Diseases, Ninth Revision","volume":"1","author":"World Health Organization","year":"1977"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0869|cit869","volume-title":"The ICD-10 Classification of Mental and Behavioural Disorders. Clinical Descriptions and Diagnostic Guidelines","author":"World Health Organization","year":"1992"},{"issue":"3","key":"10.1002\/14651858.CD012069.pub2-BIB0870|cit870","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1007\/s13311-012-0135-8","article-title":"The prevalence of DSM-IV attention-deficit\/hyperactivity disorder: a meta-analytic review","volume":"9","author":"Willcutt","year":"2012","journal-title":"Neurotherapeutics"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0871|cit871","unstructured":"Williams L Regarding your study 'Misinterpreting emotional expressions in attention-deficit\/hyperactivity disorder: evidence for a neural marker and stimulant effects' [personal communication] Email to: M Holmskov"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0872|cit872","unstructured":"Witt KL Questions regarding your study 'Methylphenidate and amphetamine do not induce cytogenetic damage in lymphocytes of children with ADHD' [personal communication] Email to: FL Magnusson"},{"issue":"4","key":"10.1002\/14651858.CD012069.pub2-BIB0873|cit873","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1542\/peds.108.4.883","article-title":"Randomized, controlled trial of OROS methylphenidate once a day in children with attention-deficit\/hyperactivity disorder","volume":"108","author":"Wolraich","year":"2001","journal-title":"Pediatrics"},{"issue":"7644","key":"10.1002\/14651858.CD012069.pub2-BIB0874|cit874","doi-asserted-by":"crossref","first-page":"601-5","DOI":"10.1136\/bmj.39465.451748.AD","article-title":"Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study","volume":"336","author":"Wood","year":"2008","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0875|cit875","unstructured":"Yalcin O Interest in including 'Possible methylphenidate related hoarseness and disturbances of voice quality: two pediatric cases' in a Cochrane systematic review [personal communication] Email to: EL Ramstad"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0876|cit876","unstructured":"Yilmaz AE Question regarding your study 'Methylphenidate-induced orofacial and extremity dyskinesia' [personal communication] Email to: T Nilausen"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0877|cit877","unstructured":"Yook KH Questions regarding 'Oobesity is associated with non-response to prolonged-release methylphenidate treatment in ADHD' [personal communication] Email to: EL Ramstad"},{"issue":"10","key":"10.1002\/14651858.CD012069.pub2-BIB0878|cit878","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1111\/j.1469-7610.2012.02567.x","article-title":"Childhood ADHD is strongly associated with a broad range of psychiatric disorders: a population-based birth cohort study","volume":"53","author":"Yoshimasu","year":"2012","journal-title":"Journal of Child Psychology and Psychiatry and Allied Disciplines"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0879|cit879","unstructured":"Yu Z Questions regarding your article 'Peripheral vasculopathy associated with psychostimulant treatment in children with attention-deficit\/hyperactivity disorder' [personal communication] Email to: HB Krogh"},{"key":"10.1002\/14651858.CD012069.pub2-BIB0880|cit880","unstructured":"Zeni C Regarding your study 'No significant association between response to methylphenidate and genes of the dopaminergic and serotonergic systems in a sample of Brazilian children with attention-deficit\/hyperactivity disorder' [personal communication] Email to: CR Moreira Maia"},{"issue":"5","key":"10.1002\/14651858.CD012069.pub2-BIB0881|cit881","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1111\/j.1600-0447.2010.01607.x","article-title":"Use of ADHD drugs in the Nordic countries: a population-based comparison study","volume":"123","author":"Zo\u00ebga","year":"May 2011","journal-title":"Acta Psychiatrica Scandinavica"},{"issue":"2","key":"10.1002\/14651858.CD012069.pub2-BIB0882|cit882","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012069","article-title":"Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of harmful effects in non-randomised studies","author":"Storeb\u00f8","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD012069.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T17:18:28Z","timestamp":1720286308000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD012069.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Developmental, Psychosocial and Learning Problems Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,5,10]]},"references-count":883,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd012069.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,10]]}}}